UNITED STATES

SECURITIES AND EXHANGE COMMISSION

Washington, D.C. 20549

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

 

 Filed by the Registrant

 Filed by a party other than the Registrant

 

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to 240.14a-12

 

M.D.C. HOLDINGS, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)

(1)

Title of each class of securities to which transaction applies:

(2)

(2)

Aggregate number of securities to which transaction applies:

(3)

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)

(4)

Proposed maximum aggregate value of transaction:

(5)

(5)

Total fee paid:

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

(1)

Amount Previously Paid:

(2)

(2)

Form, Schedule or Registration Statement No.:

(3)

(3)

Filing Party:

(4)

(4)

Date Filed:


 

M.D.C. HOLDINGS, INC.

4350 South Monaco Street, Suite 500

Denver, Colorado 80237

January 30, 2015

 

To Our Shareholders:

 

You are invited to attend the 20142015 Annual Meeting of Shareholders (the “Meeting”"Meeting") of M.D.C. Holdings, Inc. (the “Company”"Company") to be held at 4350 South Monaco Street, 6thFloor, Assembly Room, Denver, Colorado, on Monday, May 19, 2014,March 23, 2015, at 8:00 a.m., Mountain Time. The Notice of the Annual Meeting and the Proxy Statement, which follow this letter, describe the matters to be acted upon at the Meeting.

 

We are utilizing the rules of the Securities and Exchange Commission that allow us to furnish your proxy materials over the Internet, to lower the cost and environmental impact of our annual meeting. More details are included in the materials that follow.

 

Your vote is important. Please vote promptly, even if you plan to attend the meeting, by following the instructions in the Proxy Statement that was provided to you.

 

Sincerely,

Larry A. Mizel

Chairman of the Board


 

 

Larry A. Mizel

Chairman of the Board

March 24, 2014

Important Notice Regarding the Availability of Proxy Materials

for the Shareholder Meeting to Be Held on May 19, 2014:
March 23, 2015:

The Proxy Statement and the Annual Report on Form 10-K are available at:

www.rdgir.com/mdc-holdings-inc

 

Important Voting Information

 

Under New York Stock Exchange rules, unless you provide specific instructions, your broker is not permitted to vote on your behalf on the election of directorsDirectors and on any of the proposals other than ratification of the selection of the Company’s auditors. It is important that you provide specific instructions by completing and returning the broker’s Voting Instruction Form or following the instructions provided to you to vote your shares by telephone or the Internet.


TABLETABLE OF CONTENTS

 

2014 PROXY STATEMENT SUMMARY

i

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

vi

GENERAL INFORMATION

1

HOUSEHOLDING OF PROXY MATERIALS

5

CORPORATE GOVERNANCE

5

BENEFICIAL OWNERSHIP OF COMMON STOCK

9

10

PROPOSAL ONE—ONEELECTION OF DIRECTORS

11

12

INFORMATION CONCERNING THE BOARD OF DIRECTORS

14

15

EXECUTIVE OFFICERS

17

18

COMPENSATION PROCESSES AND PROCEDURES

18

19

COMPENSATION DISCUSSION AND ANALYSIS

21

22

EMPLOYMENT AGREEMENTS

27

29

COMPENSATION COMMITTEE REPORT

30

32

2013 SUMMARY COMPENSATION TABLE

31

33

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

32

34

GRANTS OF PLAN-BASED AWARDS IN 20132014

32

35

OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 20132014

33

36

OPTION EXERCISES AND STOCK VESTED IN 20132014

35

38

PENSION BENEFITS AT DECEMBER 31, 20132014

35

38

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

36

39

20132014 DIRECTOR COMPENSATION

37

40

COMPENSATION POLICIES AND PRACTICES AND RISK MANAGEMENT

38

41

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

38

41

PROPOSAL TWO—TWOADVISORY VOTE ON EXECUTIVE COMPENSATION

38

41

PROPOSAL THREE–APPROVAL OF AN AMENDMENT TO THE M.D.C. HOLDINGS, INC. 2011 EQUITY INCENTIVE PLAN42
PROPOSAL FOUR–APPROVAL OF AN AMENDMENT TO THE M.D.C. HOLDINGS, INC. 2011 STOCK OPTON PLAN FOR NON-EMPLOYEE DIRECTORS48

AUDIT COMMITTEE REPORT

39

52

TRANSACTIONS WITH RELATED PERSONS

39

52

REVIEW OF TRANSACTIONS WITH RELATED PERSONS

40

53

SECTION 16(A)16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

40

53

PROPOSAL THREE—FIVEINDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

40

54

OTHER MATTERS

41

55

SHAREHOLDER PROPOSALS

42

55

INCORPORATION BY REFERENCE

55

42APPENDIX A – SECOND AMENDMENT TO THE M.D.C. HOLDINGS, INC. 2011 EQUITY INCENTIVE PLAN56

APPENDIX B – FIRST AMENDMENT TO THE M.D.C. HOLDINGS, INC. 2011 STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS

57

Back to Contents

This page intentionally left blank.


Table Of Contents

20152014 PROXY STATEMENT SUMMARY

 

This summary highlights and supplements information contained elsewhere in this proxy statement. The summary does not contain all of the information that you should consider and the entire proxy statement should be read carefully before voting. This Proxy Statement, a proxy card and the Notice of Annual Meeting (the “Proxy Materials”"Proxy Materials") are first being sent to our shareholders on or about March 27, 2014.February 2, 2015.

 

Annual Meeting of Shareholders

 

Time and Date

8:00 a.m., May 19, 2014March 23, 2015

   

Place

4350 South Monaco Street, 6thFloor, Assembly Room, Denver, Colorado 80237

   

Record Date

March 21, 2014

January 29, 2015

 

Agenda

 

The election of threetwo Class IIIII Directors

  

Advisory vote on executive compensation

  

Approval of an amendment to the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan to increase the shares authorized for issuance under the plan

Approval of an amendment to the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors to increase the shares authorized for issuance under the plan

Ratification of the selection of Ernst & Young LLP as the Company’sCompany's independent registered public accounting firm for 20142015

  
Such other business as may properly come before the meeting

Such other business as may properly come before the meeting

 

Voting Matters

 

Proposal

Board Recommendation

Page Reference

ProposalBoard Recommendation

(for more detail)

1. Election of Class IIIII Directors

FOR each Nominee

11

12

2. Advisory Vote on Executive Compensation

FOR

FOR38

41

3. Amendment to the 2011 Equity Incentive Plan

FOR

42

4. Amendment to the 2011 Stock Option Plan for Non-Employee Directors

FOR

48

5. Ratification of Ernst & Young LLP as auditor for 20142015

FOR

FOR40

54

M.D.C. HOLDINGS, INC. -2015 Proxy Statementi

Table Of Contents

 

20132014 Performance Summary

 

Our Chief Executive Officer, Larry A. Mizel, and our President and Chief Operating Officer, David D. Mandarich, the principals who have guided the Company for almost 4243 years and 3738 years, respectively, are two of the most senior veterans of the U.S. homebuilding industry. By virtue of their leadership, foresight and experience, they have been responsible for the growth of our Company, creating significant long-term shareholder value by successfully coping with multiple economic cycles and challenges over the years. Their determined emphasis on

In 2014, Mr. Mizel and Mr. Mandarich have guided the Company through a challenging and often volatile period of recovery in the homebuilding industry, employing their strategy of balancing risk and reward mitigating potential lossesin pursuit of earnings and growth and thereby maintaining the financial integrity of the balance sheet, as opposed to pursuing high-risk and speculative investments, has allowedCompany. As a result, the Company continues to maintainretain one of the strongest balance sheets and highest credit ratings in the industry as evidenced by its investment grade rating.industry.

 

Furthermore, the Company paid the highest annual dividend of all public homebuilders during 2014.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statementi

The achievements of the Company in 2013, as outlined below,2014 are directly attributed to theirthe outstanding leadership.leadership of Messrs. Mizel and Mandarich.

 

M.D.C. HOLDINGS, INC. -2015 Proxy Statementii

Table Of Contents

Full Year 20132014 Operational and Financial Highlights

 •

We reduced our interest costs and extended our next senior note maturity to 2020 by eliminating $500 million of existing senior notes and issuing $250 million of new senior notes

 •We increased our line of credit from $450 million to $550 million and extended the maturity of the line by one year to December of 2019
Net income of $314.4M, or $6.34 per diluted share vs. $62.7M,was $63.1 million, or $1.29 per diluted share in 2012vs. net income of $314.4 million, or $6.34 per diluted share

-

2013 included a benefit from a $187.6 million reversal of deferred tax asset valuation allowance for the homebuilding segment while 2014 included a charge resulting from $22.5 million in debt extinguishment-related expenses

  
 Home sale revenues increased slightly to $1.65 billion in 2014, despite a 13% decrease in the value of beginning backlog
Pretax incomemore than doubled overall andmore than tripled for the homebuilding segment
 •Gross margin from home sales of 17.0% in 2014 vs. 17.8% in 2013
 •Our SG&A rate declined to 12.3%, a year-over-year improvement of 80 basis points
   
 -Includes benefit from $187.6M reversal of deferred tax asset allowanceSG&A rate was at lowest rate in 2013 second quarteralmost 10 years
   
Home sale revenuesWe increased 41%our active subdivision count to 159, up 9% year-over-year to $1.63B
Double-digit increases for both home deliveries and average selling price
   
Pretax operating margin for homebuilding improved by 340 basis pointsThe value of net new orders increased 19% year-over-year to 6.2%
Improvement in both gross margin from home sales and SG&A rate$1.83 billion
   
Monthly net home orders improved 21% to 2.5Our backlog value at year end of $663.2 million was up 31% from 2013
   
Acquired almost 8,000We acquired 4,213 lots in 168112 communities, including 12882 new communities
Active community count is now growing, setting the stage for success in 2014 and beyond
$350M of 30 year unsecured bonds issued at 6.0% interest rate
New $450M unsecured line of credit negotiated with an accordion feature to increase up to $1.0B
Liquidity improved by 75% to $1.24B
Stockholders’ equity increased by 38% to $1.21B
Industry-leading dividend of $1.00 per share (paid in advance in December 2012)

 

Mr. Mizel and Mr. Mandarich have achieved success in 2013 through their strategy of focusing on and balancing risk and reward – the pursuit of earnings and growth – while mitigating risk and maintaining the financial integrity of the Company. Their discipline has allowed the Company to preserve one of the strongest balance sheets in the industry in the face of volatile and uncertain economic conditions, as evidenced by maintaining our long-held investment grade ratings (one of only two homebuilders in the industry with an investment grade rating by two of the major rating agencies).

Investment Grade Rating

 

MDC is one of only two homebuilders to maintain an “investment
grade” rating from two major agencies through the downturn

Maintaining a strong balance sheet is central to the Company’s long term operating philosophy. As such, incentivizing executive performance, balanced with risk/reward considerations, is carefully considered by the Compensation Committee when determining the various components of executive compensation each year.

M.D.C. HOLDINGS, INC. - 2014 Proxy Statementii

Executive Compensation Overview

 

The Compensation Committee believes that there is a strong link between long-term shareholder value and (1) return on equity and (2) earnings per share growth, particularly the profits generated by the Company’s core homebuilding business.share. As such, for 20132014 the Committee based the performance goal for our Chief Executive Officer (CEO) and Chief Operating Officer (COO) on achieving specified objectives for both return on equity and homebuildingconsolidated pre-tax income per share, excluding any one-time charges attributable toor expenses incurred in connection with debt extinguishment (“HomebuildingPretax EPS”). Also, whenWhen establishing the 20132014 Performance Goal, the Committee carefully considered the appropriateness of the thresholds established for HomebuildingPretax EPS given the Company’s emphasis on risk management, financial stability and long-term value. The design of the 2014 Performance Goal contained two key Performance Objectives:

 

 •

First, a condition precedent for payment under the 2014 Performance Goal that the adjusted pre-tax return on beginning equity (excluding any charges or expenses incurred in connection with the early extinguishment of debt) must exceed 6.5 percent.


 •

Second, Pretax EPS had been achieved in accordance with a range of thresholds (with corresponding bonus levels ranging from zero to a maximum of $6.0 million).

In addition to requiring a base minimum return on equity exceeding 6% as a condition precedent to

M.D.C. HOLDINGS, INC. -2015 Proxy Statementiii

Table Of Contents

The Committee originally established the award of any bonus at all, the Committee established a range of Homebuilding EPS thresholds, including a minimum, target and maximum, as illustrated in the chart below. A description of the 20132014 Performance Goal established byunder the Committee was included in the 2013 Proxy Statement, prior to the Company receiving shareholder approval of its 2013 Executive Officer Performance-Based Compensation Plan (“2013(the “2013 Performance-Based Plan”) as set forth in a Form 8-K dated February 25, 2014. Following the Annual Meeting of Shareholders on May 19, 2014, the Committee reviewed the Company’s compensation processes and procedures and engaged in discussions with its independent compensation consultant and a 96% positive advisory shareholder vote on executive compensation.number of the Company’s largest shareholders. On September 22, 2014, the Committee determined to exercise its discretion under the 2013 Performance-Based Plan and reduced the potential bonus payout under the 2014 Performance Goal, including:

 

2013 Performance Goal:The bonus payout for Pretax EPS achieved at the maximum level was reduced from $10.0 million to $6.0 million


Homebuilding

The bonus payout for Pretax EPS achieved at the target level was reduced from $6.0 million to $4.0 million


The bonus payouts for Pretax EPS achieved at other levels were also proportionately reduced (see table detailing changes in the “Compensation Discussion and Analysis” below).

 

Performance goal was achieved at the maximum level

*Excludes $0.21 per share of 2012 non-recurring legal recoveries

 

By linking the performance goal to the Company’s homebuilding earnings per share (as opposed, for example, to a “total shareholder return”),Pretax EPS, the Committee determined that the annual bonus would be directly dependent on the actual defined performance specified byof the Committee. While total shareholder returns (TSRs) are used by some compensation committees, TSRs are generally impacted by external factors that are beyond the control of our executives and can cause a disconnect between compensation and their superior or inferior performance.Company. The Committee striveshas sought to align the executive’s interest with the shareholders by balancing short-term objectives with long-term rewards. The Committee believes that short-term performance should be based on factors that the executives can directly influence. The Committee addresses long-term shareholder returns through long-term equity compensation.

 

M.D.C. HOLDINGS, INC. -The 2014 Proxy Statementiii

The 2013 Performance Goal was achieved at the maximum level by our CEOtarget level. In particular:

The Company attained an adjusted pre-tax return on beginning equity of 10.1%, exceeding the required threshold of 6.5%, which was the condition precedent.


The Company attained a Pretax EPS of $2.52 (excluding $0.46 of charges and COOexpenses incurred in connection with the early extinguishment of debt.)

The payout for each participant was $4.0 million and constituted overapproximately 80% of theirthe CEO’s and COO’s total compensation for the year. They received the same base pay for the past ten years. They were not granted any equity compensation in 2013.1

 

The Company reinforced its commitment to pay for performance in 2013 by the termination of post-retirement pension benefit accruals effective June 30, 2013.2014 CEO Executive Compensation

2013 Positive Shareholder Advisory Vote on Say on Pay

In 2013, the Company received a 96% positive advisory shareholder vote on executive compensation. The Company believes that its positive advisory vote was the result of:

A commitment to ongoing dialogue with its shareholders, including inquiries representing more than 40 percent

1)

Base Annual Salary. $1 million (no increase from 2013).


2)

2014 Annual Bonus Incentive. Achieved at the target level of shares not held by affiliates each year$4 million ($6 million decrease from 2012 through 2014, with regard to executive compensation;

Aligning the Company’s executive compensation design and governance with shareholder interests utilizing shareholder feedback and the guidance of an independent compensation consultant; and
The significant changes to its short and long-term incentive design, as well as the modifications to its compensation governance practices in prior periods (2011 and 2012)2013).

 

2013 CEO Executive Compensation

1.Base Annual Salary. $1 million (no increase).
2.2013 Annual Bonus Incentive. The 2013 Performance Goal contained the following features (as previously described in the 2013 Proxy Statement):

First, there was acondition precedentfor payment of any bonus under the 2013 Performance Goal that the adjusted pre-tax return on beginning equity (excluding any charge for debt extinguishment) must exceed 6 percent.
Second, a bonus amount was earned based on the Company achieving specified objectives for homebuilding pre-tax income per weighted average diluted share outstanding, excluding any charge for debt extinguishment (“Homebuilding EPS”). In particular:

An objective of $0.76 of Homebuilding EPS was required to earn a bonus of $3.5 million. This represented a 62% increase over 2012 (excluding $0.21 per share of 2012 non-recurring legal recoveries). Homebuilding EPS below this objective would result in no bonus.
A target objective of $0.90 of Homebuilding EPS was required to earn a bonus of $6 million. This represented a 91% increase over 2012 Homebuilding EPS (excluding $0.21 per share of non-recurring legal recoveries).
A range of intermediate objectives up to a Homebuilding EPS of $1.87 were required to earn up to a maximum bonus of $10 million. This maximum bonus constituted almost a threefold increase in Homebuilding EPS (excluding the $0.21 per share in non-recurring legal recoveries).

3.Post Retirement Benefits. Terminated effective June 30, 2013.
4.Stock Based Compensation. No stock-based compensation was granted in 2013.

2013 Annual Incentive Results

The 2013 annual bonus incentive was earned at the maximum amount of $10 million.2In particular:

The Company attained a pre-tax return on beginning equity of 15%, exceeding the required threshold of 6%, which was the condition precedent.
The Company attained a Homebuilding EPS of $2.05, which was 336% higher than the Homebuilding EPS achieved in 2012 (excluding $0.21 per share of non-recurring legal recoveries) and exceeded the $1.87 maximum threshold required for the maximum bonus.

 

1     As a part of the Committee’s commitment to pay for performance, a long-term equity incentive grant was awarded in 2012 subject to performance vesting. A three year time limit was set for the achievement of the established performance vesting goals. The award was in lieu of any further equity grants until 2015.

2     See calculation in the “2013 Annual Incentive Bonus Awards” section under Compensation Discussion and Analysis below.

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statementiv


Table Of Contents
Back to Contents

Total CEO Compensation for 20133

As shown in the graph below, Total Compensation for the CEO increaseddecreased from 20122013 to 20132014 as a result of the Company’s maximum achievement of the 2013 Performance Goal established by the Compensation Committee in accordance with the shareholder-approved 2013 Performance-Based Plan.of:

 

Total Compensation for 2013 - CEO

 

2014 CEO Compensation

In 2014, our CEO will receive the same base pay that he has for the past ten years. He will not receive any equity awards or options for 2014. The only incentive compensation he will receive will need to be earned in accordance with the terms of the shareholder approved 2013 Performance-Based Plan. The principal terms of the 2014 Performance Goal established by the Compensation Committee under the 2013 Performance-Based Plan are as follows:

First, there is acondition precedentfor any payment under the Performance Goal requiring that the adjusted pre-tax return on beginning equity (excluding any charge for debt extinguishment) must exceed 6.5 percent.
Second, earnings per share (pre-tax income divided by the weighted average fully diluted shares outstanding for 2014 and excluding any charges or expenses incurred in the early extinguishment of debt) (“Pretax EPS”) must be achieved, using a range of fourteen possible thresholds (with corresponding bonus levels ranging from zero to a maximum of $10.0 million). The following represent the minimum, target and maximum thresholds:

 

1.

An objective of $1.61 of Pretax EPS must be achieved

Lower potential bonus payouts under the 2014 Performance Goal when compared to earn a bonus of $2.0 million. Pretax EPS below this objective would result in no bonus.the 2013 Performance Goal, based on shareholder feedback and the prior year say-on-pay vote


 

2.

Achievement of the target Performance Goal in 2014 versus achievement of the maximum Performance Goal in 2013


 

3.

A target objective of $2.41 of Pretax EPS to earn a bonus of $6 million.
A maximum objective of $4.01 of Pretax EPS to earn a bonus of $10 million.

No post-retirement benefits (terminated in 2013), based on shareholder feedback

These thresholds were established based on the Compensation Committee’s review of the internal Company forecasts as well as general and industry specific economic conditions. The maximum bonus of $10.0 million for 2014 is equal to the bonus earned by the executive for 2013 and requires the Company toincrease Pretax EPS by more than 50% for 2014. If Pretax EPS in 2014 is less than the $4.01 maximum threshold, the bonus for the executives will decrease in 2014. An increase in the bonus which can be paid to the CEO for 2014 is not possible based on the 2014 Performance Goal.

 

Recommendation for Vote in Favor of Company’s Executive Compensation

 

Based on the Company’s achievement of the 2013revised 2014 Performance Goal at the target level under the shareholder approvedshareholder-approved 2013 Performance-Based Plan and the accomplishments of the executive officers as described in this Proxy Statement, the Board of Directors is recommending an affirmative non-binding vote approving the compensation of the Company’s named executive officers.

 

 

3     In the 2013 Proxy Statement, the Company calculated and disclosed “Total Realized Compensation” as a supplement to its Total Compensation disclosure required by the SEC. However, Total Realized Compensation was not included in this Proxy Statement as it did not differ significantly from Total Compensation in 2012 or 2013.

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statementv


Table Of Contents
Back to Contents

 

 

M.D.C. HOLDINGS, INC.

4350 South Monaco Street, Suite 500

Denver, Colorado 80237

 

NOTICENotice of Annual MeetingOF ANNUAL MEETING OF

of ShareholdersSHAREHOLDERS

Monday, May 19, 2014

8:00 a.m.Mountain Time,

4350 South Monaco Street, 6thFloor, Assembly Room, Denver, Colorado

 

To Our Shareholders:

 

The 20142015 Annual Meeting of Shareholders (the “Meeting”"Meeting") of M.D.C. Holdings, Inc. (the “Company”"Company") will be held at 4350 South Monaco Street, 6thFloor, Assembly Room, Denver, Colorado, on Monday, May 19, 2014,March 23, 2015, at 8:00 a.m., Mountain Time. Only shareholders of record at the close of business on March 21, 2014,January 29, 2015, the record date, will be entitled to vote. At the Meeting, we plan to consider and act upon the following matters:

 

1.

the election of David D. Mandarich, Paris G. Reece IIIRaymond T. Baker and David SiegelE. Blackford as Class IIIII Directors for three-year terms expiring in 2017;2018;

2.

2.

a non-binding advisory vote to approve the compensation of our named executive officers disclosed in this proxy statement;

3.

approval of an amendment to the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan to increase the shares authorized for issuance under the plan;

4.

approval of an amendment to the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors to increase the shares authorized for issuance under the plan; and

5.

3.

ratification of the selection of Ernst & Young LLP as the Company’sCompany's independent registered public accounting firm for the 20142015 fiscal year.

 

And such other business as properly may come before the Meeting and any postponements or adjournments thereof.

 

Our Board of Directors recommends that you voteFORall Proposals.

 

Important Notice Regarding the Availability of Proxy Materials

for the Shareholder Meeting to Be Held on May 19, 2014:
March 23, 2015:

The Proxy Statement and the Annual Report on Form 10-K are available at:

www.rdgir.com/mdc-holdings-inc

 

Management and the Board of Directors desire to have maximum representation at the Meeting and request that you vote promptly, even if you plan to attend the meeting.

 

BY ORDER OF THE BOARD OF DIRECTORS,

 

Denver, Colorado

BY ORDER OF THE BOARD OF DIRECTORS,

Joseph H. Fretz

March 24, 2014

Secretary

Denver, Colorado

January 30, 2015


Table Of Contents

M.D.C. HOLDINGS, INC.

4350 South Monaco Street, Suite 500

Denver, Colorado 80237


 

PROXY STATEMENT

 

ANNUAL MEETING OF SHAREHOLDERS

 

May 19, 2014March 23, 2015

 


GENERALINFORMATION

 

GENERAL INFORMATION

Why am I receiving these materials?

 

This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors (the “Board"Board of Directors”Directors" or the “Board”"Board") of M.D.C. Holdings, Inc. (the “Company”"Company") to be used at the Annual Meeting of Shareholders of the Company (the “Meeting”"Meeting") to be held at our principal executive offices, 4350 South Monaco Street, 6thFloor, Assembly Room, Denver, Colorado 80237, on Monday, May 19, 2014,March 23, 2015, at 8:00 a.m., Mountain Time, and any postponements or adjournments thereof. The record date for determining Shareholdersshareholders entitled to vote at the Meeting is March 21, 2014January 29, 2015 (the “Record Date”). The Meeting is being held for the purposes set forth in the accompanying Notice of Annual Meeting of Shareholders. Our shareholders are invited to attend the meeting and are encouraged to vote on the matters described in this Proxy Statement.

 

What proxy materials are being delivered?

 

We are utilizing the rules of the Securities and Exchange Commission (“SEC”("SEC") that allow us to deliver proxy materials to our Shareholdersshareholders on the Internet. Under these rules, we are sending most of our Shareholdersshareholders a Notice of Internet Availability of Proxy Materials (the “Notice”"Notice") instead of a full set of proxy materials. If you receive the Notice, you will not receive printed copies of the proxy materials unless you specifically request them. Instead, the Notice tells you how to access and review on the Internet all of the important information contained in the proxy materials. The Notice also tells you how to vote your proxy card on the Internet and how to request a printed copy of our proxy materials. We expect to mail, or provide the Notice and electronic delivery of, this Proxy Statement, the proxy card and the Notice of Annual Meeting (the “Proxy Materials”"Proxy Materials") on or about March 27, 2014.February 2, 2015.

 

The Company’s 2013Company's 2014 Annual Report on Form 10-K, which includes the Company’s 2013Company's 2014 audited financial statements, will accompany these Proxy Materials. Except to the extent expressly referenced in this Proxy Statement, the Annual Report is not incorporated into this Proxy Statement.

 

Who is paying for this proxy solicitation?

 

The Company will pay the cost of solicitation. The Company also will reimburse bankers, brokers and others holding shares in their names or in the names of nominees or otherwise for reasonable out-of-pocket expenses incurred in sending the Proxy Materials to the beneficial owners of such shares. In addition to the original solicitation of proxies, solicitations may be made in person, by telephone or by other means of communication by Directors, officers and employees of the Company, who will not be paid any additional compensation for these activities.

 

We have retained the services of Alliance Advisors, LLC to solicit proxies. We will pay all reasonable costs associated with such firm, which we anticipate will not exceed $12,500 plus costs and expenses.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1


Table Of Contents

Who is entitled to vote at or attend the Annual Meeting?

 

Holders of shares of the Company’sCompany's common stock, $.01 par value, (the “Common Stock”) at the close of business on the Record Date are entitled to notice of, and to vote at, the Meeting. All shareholders of record and beneficial owners wishing to attend the Meeting must bring with them a government issued picture identification of themselves and check in at the registration desk at the meeting. Beneficial owners must also bring proof of ownership as described below. Attendees must comply with the rules of conduct available at the registration desk. A list of shareholders of record entitled to vote at the Meeting will be available for examination by any shareholder at the Meeting and for ten days prior to the Meeting at our principal executive offices.

 

Shareholders will have sufficient time immediately following the Annual Meeting, to ask questions of and have a dialogue with the Company’s Chairman and CEO, President and COO, and each of the members of the Board of Directors in attendance regarding, among other things, the Company’s executive compensation policy and pay practices.

 

Shareholders of Record.If, on the Record Date, your shares were registered directly in your name with the Company’sCompany's transfer agent, Continental Stock Transfer & Trust Company, then you are a shareholder of record. As a shareholder of record, you may vote in person at the meeting or vote by proxy.

 

Beneficial Owners.If, on the Record Date, your shares were not held in your name, but rather were held in an account at a brokerage firm, bank or other nominee (commonly referred to as being held in “street name”"street name"), or through our 401(k) savings plan, you are the beneficial owner of those shares. The organization holding your account is considered to be the shareholder of record for purposes of voting at the annual meeting. As a beneficial owner, you have the right to direct your broker or other nominee regarding how to vote the shares held in your account. You are also invited to attend the Annual Meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the meeting unless you obtain a valid legal proxy from your broker or other nominee and bring the legal proxy to the annual meeting. (Legal proxies are not available for shares held through our 401(k) savings plan; you must vote those shares as provided below.) If you want to attend the annual meeting, but not vote at the annual meeting, you must provide proof of beneficial ownership as of the Record Date, such as your most recent account statement prior to the Record Date.

 

How do I vote my shares?

 

By Telephone or the Internet.Shareholders can vote their shares via telephone or the Internet as instructed in the Notice of Internet Availability of Proxy Materials. The telephone and Internet procedures are designed to authenticate a stockholder’sshareholder's identity, allow stockholdersshareholders to vote their shares and confirm that their instructions have been properly recorded. The telephone and Internet voting facilities will close at 11:59 p.m., Eastern Time, on May 18, 2014.March 22, 2015. (Participants in our 401(k) savings plan have an earlier deadline – see below.)

 

By Mail.Shareholders who receive a paper proxy card may vote by mail and should complete, sign and date their proxy card and mail it in the pre-addressed envelope that accompanied the delivery of the paper proxy card. Proxy cards submitted by mail must be received by the time of the meeting in order for your shares to be voted. Beneficial Shareholdersshareholders (shares held in street name) may vote by mail by requesting a paper proxy card according to the instructions received from their broker or other agent, and then completing, signing and dating the voting instruction card provided by the broker or other agent and mailing it in the pre-addressed envelope provided.

 

401(k) Savings Plan.If your shares are held through our 401(k) savings plan, you will receive the Notice of Internet Availability of Proxy Materials, or copies of the Proxy Materials, and you are entitled to instruct the plan trustee how to vote the shares allocated to your account following the instructions described above. You must provide your instructions no later than 11:59 p.m., Eastern Time, on May 13, 2014.March 17, 2015.

 

At the Meeting.Shares held in your name as the shareholder of record may be voted by you in person at the Annual Meeting. Shares held beneficially in street name may be voted by you in person at the Annual Meeting only if you obtain a legal proxy from the broker or other agent that holds your shares, giving you the right to vote the shares, and you bring the legal proxy to the Annual Meeting.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement2


Table Of Contents

What if I receive more than one Notice of Internet Availability of Proxy Materials?

 

If you receive more than one Notice, you hold shares in more than one name or shares in different accounts. To ensure that all of your shares are voted, you will need to vote separately by telephone or the Internet using the specific control number contained in each Notice that you receive.

 

Can I change my vote or revoke my proxy?

 

You can change your vote or revoke your proxy before the Meeting. You can do this by casting a later proxy through any of the available methods described above. If you are a shareholder of record, you can also revoke your proxy by delivering written notice of revocation to the Secretary of the Company, by presenting to the Company a later-dated proxy card executed by the person executing the prior proxy card or by attending the Meeting and voting in person. If you are a beneficial owner, you can revoke your proxy by following the instructions sent to you by your broker, bank or other agent.

 

How are votes counted?

 

Shares of Common Stockcommon stock represented by properly executed proxy cards, or voted by proxy, by telephone or the Internet, and received in time for the Meeting will be voted in accordance with the instructions specified in the proxies. Unless contrary instructions are indicated in a proxy, the shares of Common Stockcommon stock represented by such proxy will be votedFORthe election as Directors of the nominees named in this Proxy Statement andFORall of the other proposals. If you grant a proxy (other than for shares held in our 401(k) savings plan), either of the officers named as proxy holders, Michael Touff and Joseph H. Fretz, or their nominees or substitutes, will have the discretion to vote your shares on any additional matters that are properly presented for a vote at the Meeting or at any adjournment or postponement that may take place. If, for any unforeseen reason, any of our nominees is not available as a candidate for director,Director, the persons named as the proxy holder may vote your proxy for another candidate or other candidates nominated by our Board.

 

The trustee of the 401(k) savings plan is authorized to vote the shares of Common Stockcommon stock allocated to participant accounts as instructed by the participants. If the 401(k) trustee does not receive voting instructions from a participant, or if instructions are not received in a timely fashion, the trustee will vote the participant’sparticipant's shares of Common Stockcommon stock in the same proportions as the participants who affirmatively directed their shares of Common Stockcommon stock to be voted, unless the plan administrator determines that a pro rata vote would be inconsistent with its fiduciary duties under the Employee Retirement Income Security Act (“ERISA”("ERISA"). If the plan administrator makes such a determination, the trustee will vote the Common Stockcommon stock as the plan administrator determines is consistent with its fiduciary duties under ERISA.

 

The inspector of elections designated by the Company will use procedures consistent with Delaware law concerning the voting of shares, the determination of the presence of a quorum and the determination of the outcome of each matter submitted for a vote.

 

What are the voting requirements?

 

Each share of Common Stockcommon stock issued and outstanding on the Record Date, other than shares held by the Company or a subsidiary, is entitled to one vote on each matter presented at the Meeting. As of the Record Date, approximately 48,821,67648,850,110 shares of Common Stockcommon stock were issued, outstanding and entitled to vote.

 

The Company’sCompany's By-Laws provide that the holders of one-third of the shares of Common Stockcommon stock issued and outstanding and entitled to vote, present in person or represented by proxy, constitute a quorum for transacting business at the Meeting. Shareholders who are present in person or represented by proxy, whether they vote for, against or

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     3

abstain from voting on any matter, will be counted for purposes of determining whether a quorum exists. Broker non-votes, described below, also will be counted as present for purposes of determining whether a quorum exists.

 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement3

Table Of Contents

The affirmative vote of the holders of a plurality of the shares of Common Stockcommon stock present in person or represented by proxy and entitled to vote at the Meeting will be required for the election of a nominee to the Board of Directors (which means that the threetwo nominees who receive the most votes will be elected). The affirmative vote of the holders of a majority of the shares of Common Stockcommon stock represented and entitled to vote at the Meeting is necessary to: (i) forapprove on an advisory approval ofbasis the executive compensation practices disclosed in this proxy statementstatement; (ii) approve the amendment to the 2011 Equity Incentive Plan; (iii) approve the amendment to the 2011 Stock Option Plan for Non-Employee Directors; and (ii) to(iv) ratify the appointment of the Company’sCompany's auditor. Because your vote on executive compensation is advisory, it will not be binding upon the Company.

 

Rules of the New York Stock Exchange (“NYSE”) determine whether NYSE member organizations (“brokers”("brokers") holding shares for an owner in street name may vote on a proposal without specific voting instructions from the owner. For certain types of proposals, the NYSE has ruled that that the “broker may vote” without specific instructions and on other types of proposals the “broker may not vote” without specific client instructions. A “broker non-vote”"broker non-vote" occurs when a proxy is received from a broker and the broker has not voted with respect to a particular proposal. The proposal to ratify the selection of the auditor is a “broker may vote” matter under the rules of the NYSE. As a result, brokers holding shares for an owner in street name may vote on the proposal even if no voting instructions are provided by the beneficial owner. The other proposals to elect directors and for advisory approval of executive compensation practices are “broker may not vote” matters. As a result, brokers holding shares for an owner in street name may vote on these proposals only if voting instructions are provided by the beneficial owner.

 

The following table reflects the vote required for the proposals and the effect of broker non-votes, withhold votes and abstentions on the vote, assuming a quorum is present at the Meeting:

 

Proposal

 

Vote Required

 

Effect of Broker Non-Votes,

Withhold Votes and Abstentions

1.

Election of Directors

 

The threetwo nominees who receive the most votes will be elected.

 

Broker non-votes and withhold votes have no legal effect.

2.

Advisory vote to approve executive compensation (Say on Pay)

 

Affirmative vote of the holders of a majority of the shares of Common Stockcommon stock represented and entitled to vote at the Meeting.

 

Broker non-votes have no legal effect; abstentions have the same effect as a vote against the proposal.

3.Selection

Approval of Auditoramendment to the 2011 Equity Incentive Plan

 

Affirmative vote of the holders of a majority of the shares of Common Stockcommon stock represented and entitled to vote at the Meeting.

 

Broker non-votes have no legal effect; abstentions have the same effect as a vote against the proposal.

4.

Approval of amendment to the 2011 Stock Option Plan for Non-Employee Directors

Affirmative vote of the holders of a majority of the shares of common stock represented and entitled to vote at the Meeting.

Broker non-votes have no legal effect; abstentions have the same effect as a vote against the proposal.

5.

Selection of Auditor

Affirmative vote of the holders of a majority of the shares of common stock represented and entitled to vote at the Meeting.

Broker non-votes have no legal effect; abstentions have the same effect as a vote against the proposal.

 

Management and the Board of Directors of the Company know of no other matters to be brought before the Meeting. If any other proposals are properly presented to the shareholders at the Meeting, the number of votes required for approval will depend on the nature of the proposal. Generally, under Delaware law and our By-Laws, the number of votes required to approve a proposal is the affirmative vote of a majority of the shares of Common Stockcommon stock present in person or represented by proxy and entitled to vote at the Meeting. The proxy card gives discretionary authority to the proxy holders to vote on any matter not included in this Proxy Statement that is properly presented to the Shareholdersshareholders at the Meeting and any adjournments or postponements thereof. The persons named as proxies on the proxy card are Michael Touff, the Company’sCompany's Senior Vice President and General Counsel, and Joseph H. Fretz, the Company’s Secretary and Corporate Counsel.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement4


Table Of Contents

HOUSEHOLDINGHOUSEHOLDING OF PROXY MATERIALS

 

The broker, bank or other nominee of any shareholder who is a beneficial owner, but not the record holder, of the Company’s Common StockCompany's common stock may deliver only one copy of the proxy related materials to multiple Shareholdersshareholders sharing an address (a practice called “householding”"householding"), unless the broker, bank or nominee has received contrary instructions from one or more of the Shareholders.shareholders.

 

In addition, with respect to Shareholdersshareholders of record, in some cases, only one copy of the proxy related materials may be delivered to multiple Shareholdersshareholders sharing an address, unless the Company has received contrary instructions from one or more of the Shareholders.shareholders. Upon written or oral request, the Company will deliver free of charge a separate copy of each of the proxy related materials, as applicable, to a shareholder at a shared address to which a single copy was delivered. You can notify your broker, bank or other nominee (if you are not the record holder) or the Company (if you are the record holder) that you wish to receive a separate copy of such materials in the future, or alternatively, that you wish to receive a single copy of the materials instead of multiple copies. The Company’sCompany's contact information for these purposes is: M.D.C. Holdings, Inc., telephone number: (303) 773-1100, Attn: Corporate Secretary, 4350 South Monaco Street, Suite 500, Denver, CO 80237.

 

CORPORATECORPORATE GOVERNANCE

 

Director Independence

 

Each of Messrs. Raymond T. Baker, Michael A. Berman, David E. Blackford, Herbert T. Buchwald, Paris G. Reece III and David Siegel are independent, as is Paris G. Reece III, who was appointed to the Board on May 20, 2013.independent. NYSE listing standards require that the Board of Directors be comprised of a majority of independent directors. SEC rules and NYSE listing standards require that audit committees be comprised solely of independent directors. NYSE listing standards also require that corporate governance/nominating committees and compensation committees be comprised solely of independent directors.

 

Under the NYSE listing standards, no director qualifies as “independent”"independent" unless the Board of Directors affirmatively determines that the director has no material relationship with the Company, either directly or as a partner, shareholder or officer of an organization that has a relationship with the Company. Material relationships can include commercial, industrial, banking, consulting, legal, accounting, charitable and familial relationships, among others. The NYSE listing standards also require that, in determining the independence of any director who will serve on the Company’s Compensation Committee, the Board of Directors consider all factors specifically relevant to determining whether the director has a relationship with the Company that is material to that director’s ability to be independent from management in connection with the duties of a Compensation Committee member, including the source of compensation of such director and whether the director is affiliated with the Company (or a subsidiary or affiliate of a subsidiary).

 

The Board has adopted standards of independence to assist in determining whether a director of the Company (“Director”("Director") is independent. The standards are available on the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

 

The Company’sCompany's Board of Directors has determined the independence of Directors based on a review conducted by the Corporate Governance/Nominating Committee. This determination included consideration of the Company’s investment in corporate fixed-income and preferred stock securities offered in the normal course of business by Zions Bancorporation (“Zions”), of which Mr. Blackford is an officer, and the deposit and payroll accounts the Company maintained at two of Zions’Zions subsidiary banks. The Board also considered Zions’the participation as one of several lendersby Zions and a subsidiary bank in the Company’s new revolving credit facility, and the Company’s purchase from various parties, including California Bank & Trust, on market terms, of debt interests in certain real estate.which there are several lenders. Mr. Blackford had no direct or indirect material interest in the foregoing transactions and the Board concluded that the amounts involved were not significant.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement5

Table Of Contents

 

With respect to the determination of Mr. Reece’s independence, the Board considered that, until his retirement on August 1, 2008, he was the Executive Vice President and Chief Financial Officer of the Company, that heCompany. Mr. Reece is serving in a volunteer position as president of a non-profit organization (Cancer League of Colorado) that hasand he and his wife have been serving as members of an advisory board of another non-profit organization (Families First of Colorado), both organizations having received charitable contributions from the Company and some Company officers, and inofficers. In 2012, the Company paid Mr. Reece for consulting services in connection with a review of financial reporting proceduresoversight services and the 2011 Form 10-K. Since his retirement, Mr. Reece has also been performing limited financial oversight services for and received a carried investment (now written off) in a small movie investment company funded in part by entities controlled by the Company’s Chief Executive Officer and his brother. Also, Mr. Reece’s son has also provided video services to Richmond American Homes of Colorado, Inc., as an outside contractor for compensation of less than $35,000.$35,000 in 2013-14. The Board concluded that the amounts involved were not significant.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     5

The Board determined that each of Messrs. Raymond T. Baker, Michael A. Berman, David E. Blackford, Herbert T. Buchwald, Paris G. Reece III and David Siegel have no material relationship with the Company, each is independent under the NYSE listing standards and each meets the foregoing standards of Director independence adopted by the Board, including for Audit and Compensation Committee membership. The Board also determined that each of the foregoing Directors meets the independence standards for Audit Committee membership under the rules of the SEC. The Board also determined that each of Messrs. Baker, Berman, Blackford, Buchwald and Siegel is an “outside director”"outside director" within the meaning of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), and the Section 162(m) regulations.

 

Frequent Meetings of the Board of Directors and Board Committees

 

The Board of Directors and the Audit Committee generally hold regular monthly meetings and additional meetings as necessary. The other Board committees hold meetings, as may be required. The following table shows the frequency of the Board and Board committee meetings over the last three years:

 

 2013  2012  2011   2014    2013    2012  
Board of Directors  15   12   17   12    15    12  
Audit Committee  11   12   12   11    11    12  
Compensation Committee  11   17   10   13    11    17  
Corporate Governance/Nominating Committee  5   8   5   8    5    8  
Legal Committee  10   10   8   8    10    10  

 

Asset Management Committee

 

The Company has in place an Asset Management Committee (“AMC”("AMC"). Currently, the AMC consists of three committees (for reviewing real estate and corporate transactions) and our Chief Operating Officer is a member of each of these committees. The AMC generally meets weekly to review all proposed real estate transactions and other proposed non-real estate transactions at or above certain thresholds. Transactions that exceed certain thresholds also are reviewed by an executive committee of senior officers and the Board of Directors.

  

M.D.C. HOLDINGS, INC. -2015 Proxy Statement6

Table Of Contents

Lead Director

 

The Board has designatedBy vote of the independent directors, Herbert T. Buchwald, an independent member of the Board, aswas elected Lead Director. Mr. Buchwald isThe Lead Director presides at Board meetings if the Chairman and the Chief Operating Officer are not present and he approves the schedule of Board and committee meetings and the agendas and topics to be considered at Board and committee meetings.

In 2014, the Board expanded the duties of the Audit Committee, a memberLead Director. The responsibilities of the Compensation, Legal and Corporate Governance/Nominating Committees, and is the Company’s Audit Committee Financial Expert. Among other responsibilities, the Lead Director advisesnow include the Chairmanfollowing: approving information being sent to the Board, coordinating the activities of the Boardvarious committees; advising the Chairman as to the quality, quantity and timeliness of the flow of information necessary to permit the independent Directors to effectively and responsibly perform their duties, assists in providing effective corporate governance in the management of the affairs of the Board and the Company, advises the Chairman as to an appropriate schedule of Board and Committee meetings, provides input as to meeting agendas and topics, coordinates and provides guidance to the committee chairmen and independent Directors in the performance of their duties, coordinatesduties; coordinating the agenda for and presides at executive sessions of the independent Directors, facilitates the process of conducting Committee and Board self-evaluations, actsDirectors; acting as a liaison between the independent Directors and the Chairman of the Board as deemed necessary,needed; being available for communication with major shareholders; facilitating the process of conducting Committee and performs such other responsibilities as may be delegatedBoard self-evaluations; promoting effective practices to achieve a high standard of corporate governance; and providing guidance to the committee chairmen and independent Directors in the performance of their duties. A description of the role of the Lead Director byis posted on the Board from time to time.investor relations section of the Company's website, www.mdcholdings.com.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     6

Corporate Governance/Nominating Committee

 

The Board of Directors has established a Corporate Governance/Nominating Committee, consisting of Messrs.Mr. Siegel, Buchwald and Blackford, who serves as its Chairman.Chairman, and Messrs. Blackford and Buchwald. Each member of the committee is independent as defined in the listing standards of the NYSE. The organization, functions and responsibilities of the committee are described in the Corporate Governance/Nominating Committee charter, which is posted under the corporate governance documents on the investor relations section of the Company’sCompany's website, www.mdcholdings.com. See also “Information"Information Concerning the Board of Directors”Directors" below.

 

Corporate Governance Guidelines

 

Upon the recommendation of the Corporate Governance/Nominating Committee, the Board of Directors adopted a set of corporate governance guidelines to implement requirements of the NYSE. These guidelines, as amended, are posted under the corporate governance documents on the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

 

Hedging or Pledging of Company Stock

 

Our directorsDirectors and executive officers are prohibited from acquiring an interest in financial instruments intended to hedge or offset any decrease in the market value of the Company’s stock held directly or indirectly by that person. They also are required to inform the Company’s compliance committee and obtain pre-clearance prior to purchasing Company stock on margin, margining Company stock or pledging Company stock as collateral for a loan.

 

Clawback Policy

In January 2015, based in part on shareholder feedback, the Corporate Governance/Nominating Committee approved, a “Clawback” Policy, notwithstanding its recognition that the SEC has not yet issued clawback regulations as mandated by the Dodd-Frank Act. The Company’s Clawback Policy authorizes the Company to recover compensation previously paid to Executive Officers of the Company that was based upon any metric contained in a financial statement that was filed with the U.S. Securities and Exchange Commission during the Company’s then-current fiscal year or during one of the three prior fiscal years, which metric was materially restated.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement7

Table Of Contents

Equity Ownership Guidelines for Non-Employee Directors and for Executive Officers

 

In order to evidence the financial alignment of the Company’sCompany's Directors with the interests of the Company’s Shareholders,Company's shareholders, the Corporate Governance/Nominating Committee and the Board of Directors have established Equity Ownership Guidelines for Directors who are not employees of the Company. Under these guidelines, each Director is encouraged to acquire and maintain ownership of Common Stockcommon stock with an acquisition value, measured at the time of acquisition, of not less than ten times the annual amount of the retainer paid for serving on the Board of Directors. The annual amount of the retainer currently is $60,000 resulting in a current stock ownership goal of $600,000 for those Directors who have not previously achieved the goal. The Directors who have not yet achieved the goal have agreed, upon their future exercise of stock options, to retain the shares they acquire, net of the exercise price and taxes, up to the number of shares necessary to achieve the goal. All Directors are in compliance with the Guidelines. Three of the six non-employee Directors have attained the stock ownership goal.

 

The Company’s executive officers as a group have historically maintained a very high level of ownership of Company stock, especially when compared against other companies in the homebuilding industry. For example, Messrs. Mizel, Mandarich, Stephens and Touff beneficially own shares totaling approximately 26% of the Company’s shares.SeeBeneficial Ownership of Common Stock – Ownership of Directors and Officers, below. Nonetheless, in response to feedback received from the investor community, the Company has adopted equity ownership guidelines for executive officers in order to expressly evidence their financial alignment with the interests of the shareholders of the Company. Under the guidelines, each executive officer is encouraged to acquire and maintain ownership of Common Stockcommon stock of the Company having an acquisition value of not less than the following multiple of the executive officer’s base annual salary:

 

Executive Officer

Multiple

CEO

5X

COO

5X

All Others

1X

 

To expedite achievement of the goal set forth above, each executive officer who has not yet achieved the goal agrees to retain the shares they acquire through restricted stock awards and the future exercise of employee stock options net of taxes and any option exercise price up to the number of shares necessary to achieve the goal. Messrs. Mizel, Mandarich and Touff have achieved the stock ownership goal. Mr. Stephens, although he has not yet attained the stock ownership goal, is in compliance with the guidelines.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     7

Regularly Scheduled Executive Sessions of Non-Management Directors

 

The Company’sCompany's corporate governance guidelines provide for the non-management Directors to meet at regularly scheduled executive sessions without management present. All six of the Company’sCompany's non-management directorsDirectors are independent, as discussed above. The Lead Director presides at the executive sessions. In 2013, five2014, three executive sessions were held.

 

Communications with the Board of Directors

 

Shareholders and other interested parties may contact the independent Directors and the Board of Directors by using the procedures established by the Audit Committee for receipt of complaints and concerns regarding accounting or auditing matters. These procedures are posted under the corporate governance documents in the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

Alternatively, communications may be sent directly to Mr. Blackford,Siegel, Chairman of the Corporate Governance/Nominating Committee, at 1900 Main Street, 2ndFloor, Irvine,1800 Avenue of the Stars, Suite 900, Los Angeles, CA 92614.90067-4276. Any communications received by the Company’sCompany's compliance committee, which come within the purview of a Board committee and/or the Board, will be forwarded to the committee chair or the Lead Director, as applicable.

  

M.D.C. HOLDINGS, INC. -2015 Proxy Statement8

Table Of Contents

Committee Charters

 

The Board of Directors has adopted a charter for the Audit Committee, designed to comply with the applicable requirements of the NYSE listing standards and SEC regulations. The Board of Directors also has adopted charters for the Compensation Committee and the Corporate Governance/Nominating Committee, designed to comply with the applicable requirements of the NYSE listing standards, and a charter for the Legal Committee. These charters are posted under the corporate governance documents on the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

 

Corporate Code of Conduct

 

For many years, the Company has had in place a Corporate Code of Conduct designed to provide that all persons associated with the Company, including employees, officers and Directors, follow the Company’sCompany's compliance program and legal and ethical obligations and conduct themselves accordingly. The Company’s employees, officers and Directors receive annual training on the Corporate Code of Conduct. The Corporate Code of Conduct includes, among other things, a code of ethics for senior financial officers and Audit Committee complaint procedures, as required by the Sarbanes-Oxley Act and SEC regulations. The Corporate Code of Conduct, the code of ethics for senior financial officers and the Audit Committee complaint procedures for handling confidential complaints regarding accounting or auditing matters are posted under the corporate governance documents on the investor relations section of the Company’sCompany's website,www.mdcholdings.com.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement89


Table Of Contents

BENEFICIALBENEFICIAL OWNERSHIP OF COMMON STOCK

 

Ownership of Directors and Officers

 

Certain information, as of March 21, 2014,January 29, 2015, the Record Date, with respect to Common Stockcommon stock beneficially owned by the Company’sCompany's named executive officers, the nominees for election as Directors and the current Directors of the Company, furnished in part by each such person, appears below (unless stated otherwise, the named beneficial owner possesses the sole voting and investment power with respect to such shares). None of the shares beneficially owned by the executive officers and Directors have been pledged as security.

 

Name of Executive Officer/Director Number of
Shares of
Common
Stock Owned
Beneficially1
 Percent
of Class2

Number of

Shares of 

Common

Stock Owned

Beneficially1

 

 

Percent

of Class2

Raymond T. Baker  50,000   *

75,000

 

*

Michael A. Berman  125,000   *

150,000

 

*

David E. Blackford  133,550   *

158,550

 

*

Herbert T. Buchwald  199,098   *

191,598

 

*

David D. Mandarich  4,660,925   9.2%

4,546,976

 

9.0%

Larry A. Mizel  8,193,0333   16.2%

8,079,085

3

16.0%

Paris G. Reece III  25,000   *

50,000

 

*

David Siegel  125,000   *

150,000

 

*

John M. Stephens  13,150   *

38,150

 

*

Michael Touff  326,466   *

316,699

 

*

All current executive officers and Directors as a group (10 persons)  13,851,222   26.2%

13,756,058

 

26.0%

 

*

Represents less than one percent of the shares of Common Stockcommon stock outstanding and entitled to vote.


1

1

Includes, where applicable, shares of Common Stockcommon stock owned by related individuals or entities over whose shares such person may be deemed to have beneficial ownership. Also includes the following shares of Common Stockcommon stock subject to options that are exercisable or become exercisable within 60 days of the Record Date at prices ranging from $22.41$20.41 to $78.89 per share: Raymond T. Baker 50,000,75,000, Michael A. Berman 110,000;135,000; David E. Blackford 125,000;150,000; Herbert T. Buchwald 182,500;175,000; David D. Mandarich 1,634,000;1,520,000; Larry A. Mizel 1,634,000;1,520,000; Paris G. Reece III 25,000;50,000; David Siegel 125,000;150,000; John M. Stephens 25,000; and Michael Touff 187,334.175,001. As a group, the executive officers and Directors had the right to acquire within 60 days of the Record Date by the exercise of options an aggregate of 4,072,8343,975,001 shares of Common Stock.common stock. The exercise prices of many of the stock options are significantly higher than the current market value of our Commoncommon stock, i.e. “underwater.” See the Outstanding Equity Awards at December 31, 20132014 table below.


2

2

The percentage shown is based on the number of shares of Common Stockcommon stock outstanding and entitled to vote as of the Record Date. All shares of Common Stockcommon stock that the person or group had the right to acquire within 60 days of the Record Date are deemed to be outstanding for the purpose of computing the percentage of shares of Common Stockcommon stock owned by such person or group, but are not deemed to be outstanding for the purpose of computing the percentage of shares of Common Stockcommon stock owned by any other person or group.


3

3

Mr. Mizel has sole voting power and sole investment power over 1,697,7031,583,755 shares and shared voting power and shared investment power over 6,495,330 shares.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement910


Table Of Contents

Ownership of Certain Beneficial Owners

 

The table below sets forth information with respect to those persons (other than the officers/directorsDirectors listed above) known to the Company, as of the Record Date, to have owned beneficially 5% or more of the outstanding shares of Common Stock.common stock. The information as to beneficial ownership is based upon statements filed by such persons with the SEC under Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.

 

Name and Address of Beneficial Owner Number of
Shares of
Common
Stock Owned
Beneficially
 Percent
of Class1
 

Number of

Shares of

 Common

 Stock Owned

 Beneficially

 

 

Percent

of Class1

BlackRock, Inc.
40 East 52ndStreet
New York, NY 10022
  4,558,5502   9.3% 

 

4,225,199

 2 

 

8.7%

State Street Corporation
One Lincoln Street
Boston, MA 02111
  3,244,1563   6.6% 

 

3,244,156

 3

 

6.6%

Piper Jaffray Companies
800 Nicollet Mall Suite 500
Minneapolis, MN 55402
  2,530,3094   5.2%

Piper Jaffray Companies

800 Nicollet Mall, Suite 500

Minneapolis, MN 55402

 

 

2,530,309

 4 

 

5.2%

Oppenheimer Funds, Inc.
225 Liberty Street
New York, NY 10281

 2,510,455 55.1%

 

1

The percentage shown is based on the number of shares outstanding and entitled to vote as of the Record Date.

2

2

Schedule 13G/A filed with the SEC on January 29, 201422, 2015 disclosed that: BlackRock, Inc. has sole voting power over 4,417,9464,127,267 shares, shared voting power over no shares, sole dispositive power over 4,558,5504,225,199 shares and shared dispositive power over no shares.

3

3

Schedule 13G filed with the SEC on February 3, 2014 disclosed that: State Street Corporation has sole voting power over no shares, shared voting power over 3,244,156 shares, sole dispositive power over no shares and shared dispositive power over 3,244,156 shares.

4

4Schedule 13G/A filed with the SEC on February 13, 2014 disclosed that: the Piper Jaffray Companies have sole voting power over 2,530,309 shares, shared voting power over no shares, sole dispositive power over 2,530,309 shares and shared dispositive power over no shares.

5

Schedule 13G filed with the SEC on January 29, 2015 disclosed that: Oppenheimer Funds, Inc. has sole voting power over no shares, shared voting power over 2,510,455 shares, sole dispositive power over no shares and shared dispositive power over 2,510,455 shares; and Oppenheimer Equity Income Fund has sole voting power over 2,504,600 shares, shared voting power over no shares, sold dispositive power over no shares and shared dispositive power over 2,504,600 shares.

 

No change in control of the Company has occurred since the beginning of the last fiscal year. The Company knows of no arrangement the operation of which, at a subsequent date, may result in a change in control of the Company.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1011

Table Of Contents

PROPOSAL ONE

ELECTION OF DIRECTORS

      

The Company’sCompany's Certificate of Incorporation provides for three classes of Directors with staggered terms of office, to be divided as equally as possible. Directors of each class serve for terms of three years until election and qualification of their successors or until their resignation, death, disqualification or removal from office.

 

Our Board has eight members, consisting of three Class I Directors whose terms expire in 2016, three Class II Directors whose terms expire in 20142017 and two Class III Directors whose terms expire in 2015. At the Meeting, threetwo Class IIIII Directors are to be elected to three-year terms expiring in 2017.2018. The nominees for the Class IIIII Directors are David D. Mandarich, Paris G. Reece IIIRaymond T. Baker and David Siegel.E. Blackford. All of the nominees presently serve on the Board of Directors of the Company. Mr. Reece was appointed to the Board in May 2013 following a recommendation made by a non-management director to the Corporate Governance/Nominating Committee and that Committee’s recommendation to the Board.

Based on the recommendation of the Corporate Governance/Nominating Committee, the Board approved the nomination of Messrs. Mandarich, ReeceBaker and SiegelBlackford for election as Class IIIII Directors.

 

Unless otherwise specified, proxies will be votedFORthe election of Messrs. Mandarich, ReeceBaker and Siegel.Blackford. Management and the Board of Directors are not aware of any reasons that would cause any of Messrs. Mandarich, ReeceBaker and SiegelBlackford to be unavailable to serve as Directors. If any of them become unavailable for election, discretionary authority may be exercised by the proxy holders named in the proxy to vote for a substitute candidate or candidates nominated by the Board of Directors.

 

The Board of Directors recommends a vote FOR the election of Messrs. Mandarich, ReeceBaker and SiegelBlackford as Directors.

 

Certain information, as of March 21, 2014,January 29, 2015, the Record Date, with respect to Messrs. Mandarich, ReeceBaker and Siegel,Blackford, the nominees for election, and the continuing Directors of the Company, furnished in part by each such person, appears below:

 

Name

 

Age

 

Positions and Offices with the Companyand Other Principal Occupations

NOMINEES:

    
    

Class II IIITerms Expire in 20142015

Raymond T. Baker

64

President of Gold Crown Management Company and Co-Director of the Gold Crown Foundation

David D. MandarichE. Blackford

 66 

President, Chief Executive Officer and Chief Operating OfficerChairman of the CompanyBoard of California Bank & Trust

Paris G. Reece III59Private Investor and Community Volunteer
David Siegel57Partner, Irell & Manella LLP

CONTINUING DIRECTORS:

    
    

Class III ITerms Expire in 20152016

Raymond T. Baker63President of Gold Crown Management Company and Co-Director of the Gold Crown Foundation
David E. Blackford65President, Chief Executive Officer and Chairman of the Board of California Bank & Trust

Michael A. Berman

  Class I Terms Expire in 2016
Michael A. Berman64 63

Chairman, Applied Capital Management

Herbert T. Buchwald

 8384 

Principal in the law firm of Herbert T. Buchwald, P.A. and President and Chairman of the Board of Directors of BPR Management Corporation

Larry A. Mizel

 7172 

Chairman of the Board of Directors and Chief Executive Officer of the Company

Class IITerms Expire in 2017

David D. Mandarich

67

President and Chief Operating Officer of the Company

Paris G. Reece III

60

Private Investor and Community Volunteer

David Siegel

58

Partner, Irell & Manella LLP

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1112


Table Of Contents

Other Information Relating to Directors

 

Composition of the Board.The Company’s Board is composed of Directors who bringprovide a diverse breadth of experience and talent to our Company. Fifty percent of the Directors have Board tenure with the Company of less than 10ten years and over a thirdtwenty-five percent of the Directors have Board tenure of less than five years or less. Neweryears. New Directors bring new ideas and opinionsa fresh perspective to our Board’s deliberations. OtherRecognizing their importance, they have recently been selected to serve as Chairmen of the Audit, Compensation and Corporate Governance/Nominating committees. The remaining Directors have many years of Board tenure, which provides the Board with a deepercontinue to provide their knowledge, experience and understanding of the Company’s approach to balancing risk and reward inherent in the homebuilding industry, markets and the cycles that arewhich is fundamental to our business.achieving long term shareholder value. The professional qualifications of the Directors include homebuilding leadership, finance, accounting, legal, regulatory, real estate development, banking, residential real estate, institutional real estate lending and credit markets, among others. In short, the Board encompasses a well-rounded, diverse range of talents and experiences well-suited to guiding the Company in our challenging industry.

 

In addition, our Board is small enough to have a meaningful and effective exchange of ideas, and realize the benefitdedication of the broad range of our Directors’ professional qualifications. This is especially so givenBoard in conducting monthly meetings has provided the notable frequencyshareholders with which our Boardunusual oversight and Board committees meet, which significantly distinguishes our Company from other public companies.accountability. See Frequent Meetings of the Board of Directors and Board Committees, above.

 

The following is a brief description of the business experience during at least the past five years of each nominee for the Board of Directors of the Company and each of the continuing members of the Board. Their experience, qualifications, attributes or skills, set forth below, have led to the conclusion that each person should serve as a director,Director, in light of the registrant’s business and structure.

 

None of the business organizations identified below (excluding the Company and HomeAmerican Mortgage Corporation) are affiliates of the Company. None of the continuing directorsDirectors or directorDirector nominees holds, or has held during the past five years, any directorship in any company with a class of securities registered pursuant to Section 12 of the Exchange Act, subject to the requirements of Section 15(d) of the Exchange Act or registered as an investment company under the Investment Company Act of 1940.

 

Raymond T. Bakerhas served as President of Gold Crown Management Company, a real estate asset management company from 1978 to present. He is the founder and has served as Co-Director of the Gold Crown Foundation since 1986. He also is a member of the Board of Directors of Alpine Banks of Colorado, Steele Street State Bank & Trust, and Land Title Guarantee Company. Mr. Baker is currently serving as Chairman of the Board of the Denver Metropolitan Major League Baseball Stadium District and Chairman of the Board of the Metropolitan Football Stadium District (Denver). From February 2004 until May 2007, he served as a director of Central Parking Corporation. He has over thirty-five years experience in the real estate and banking industries. Mr. Baker became a member of the Company’sCompany's Board of Directors in January 2012. He currently is the Chairman of the Compensation Committee and a member of the Audit and Compensation Committees.Committee. His experience and knowledge of the real estate and banking industries directly complement and support the Company’s real estate activities and the financing of those activities.

 

Michael A. Bermanhas over 30thirty years experience in the financial services industry. He is a member of Applied Capital Management, a private investment management firm located in Scottsdale, Arizona, and has served as its chairman from 2002 to date. From 2005 to 2006, he also served as the chief executive officer of First Ascent Capital, a financial services firm located in New York. From July 2006 until December 2008, he served as president and chief executive officer of Real Estate Equity Exchange, Inc. (Rex & Co.), a financial services firm located in San Francisco, California. From January 1990 to March 1999, Mr. Berman was employed by The Nomura Securities Co., Ltd. (Tokyo) group of companies, where he held several senior executive positions, including that of President and CEO of Nomura Holding America Inc. and Chairman of Capital America, Nomura’sNomura's commercial real estate lending subsidiary. In April 2006, Mr. Berman became a Director of the Company and, in September 2006, he was appointed a director of HomeAmerican Mortgage Corporation (“HomeAmerican”("HomeAmerican"), the Company’sCompany's wholly owned mortgage lending subsidiary. Mr. Berman currently is the Chairmana member of the Compensation Committee. Mr. Berman’s experience as a senior executive in corporate finance, in general, and the residential mortgage market, in particular, provide the Company with a valuable resource.

 

David E. Blackfordhas over 35thirty-five years experience in the banking industry. He is employed by California Bank & Trust (CB&T), a leading California banking institution. Between 1998 and 2001, he was the bank’s managing director, serving on the board of directors and the Senior Loan Committee for Real Estate Finance. In May 2001 he was appointed chairman, president and chief executive officer of that bank, positions he currently holds. He also is an executive vice president of Zions Bancorporation, the parent company of CB&T. Prior to 1998, he served as an executive officer in several financial institutions, including Bank One and Valley National Bank. He joined the Company’sCompany's Board of Directors in April 2001. Mr. Blackford currently is the Chairmana member of the Corporate Governance/Nominating Committee and a member of the Legal Committee. His experience and knowledge of historic and current institutional real estate lending practices, the regulatory process and the volatility of the credit markets provide a unique perspective to the Board.

 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement13

Table Of Contents

Herbert T. Buchwaldis a principal in the law firm of Herbert T. Buchwald, P.A. and president and chairman of the board of directors of BPR Management Corporation, a property management company located in Denver, Colorado, positions he has held for more than the past five years. Mr. Buchwald has been engaged in the acquisition, development and management of residential and commercial real estate in Florida, New Jersey and Colorado, through both publicly and privately held ventures for more than forty years. As an attorney, he has been admitted to practice before federal and state trial and

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     12

appellate courts in Florida and Colorado. In addition, he holds an accounting degree and formerly was a practicing Certified Public Accountant. He has been a member of the Company’sCompany's Board of Directors since March 1994. Since March 2007, he has served as the Lead Director and heDirector. Mr. Buchwald is the Chairman of the Legal Committee, a member of the Audit, Compensation Legal and Corporate Governance/Nominating Committees, and the Chairman of theCompany's Audit Committee.Committee Financial Expert. The combination of his knowledge, experience and skills provide the Company with strong oversight of accounting, financial, regulatory and legal matters, as well as the operation of the Company’sCompany's real estate businesses.

 

David D. Mandarichhas been associated with the Company since 1977. He was elected President and Chief Operating Officer of the Company in June 1999, a position he currently holds. He previously had been elected Chief Operating Officer in March 1996, Co-Chief Operating Officer in September 1994 and Executive Vice President-Real Estate in April 1993. He was a Director from September 1980 until April 1989, and has been a Director continuously since March 1994. A skilled and experienced leader in the homebuilding industry, Mr. Mandarich provides the Board with the benefit of his judgment and his knowledge and understanding of the Company’sCompany's homebuilding business and operations.

 

Larry A. Mizelfounded the Company in 1972 and has served as a Director and Chairman of the Board since its inception. He was appointed Chief Executive Officer of the Company in 1988, a position he currently holds. Mr. Mizel has provided the Company with leadership and judgment, serving as the Chief Executive Officer and Chairman of the Board of Directors, and working to further the long-term interests of the Company’s Shareholders.Company's shareholders. One of the most experienced leaders in the homebuilding industry, his knowledge and foresight provides the Board with invaluable guidance.

 

Paris G. Reece IIIwas formerly the Company’s Chief Financial Officer and Principal Accounting Officer, and retired on August 1, 2008. Since his retirement, Mr. Reece has performed consulting work and served in a volunteer position as the President of the Cancer League of Colorado, a leading non-profit organization that was established more than 40forty years ago to raise money for cancer research and patient care. Mr. Reece was appointed toHe joined the Company’sCompany's Board of Directors onin May 20, 2013. He currently is a memberthe Chairman of the Audit Committee. As a Certified Public Accountant (Texas)(Texas, retired), a former Chief Financial Officer and a highly respected person within the homebuilding industry, Mr. Reece is uniquely qualified to provide the Company with strong oversight of accounting and financial matters, as well as the operation of the Company’sCompany's homebuilding and financial services businesses.

 

David Siegelhas been a partner in the law firm of Irell & Manella LLP for more than twenty years, where he leads that firm’sfirm's securities litigation practice and formerly was the firm’sfirm's Managing Partner.  Mr. Siegel’sSiegel's law practice, for which he is nationally recognized, is concentrated on securities class actions, corporate governance, risk management, SEC reporting standards and regulatory compliance.  Mr. Siegel has chaired and is a frequent speaker at various seminars on securities litigation, class actions, and trial techniques.  He has been named by his peers as one of the “Best"Best Lawyers in Commercial Litigation”Litigation" in The Best Lawyers in America guide.  Mr. Siegel has been a member of the Company’sCompany's Board of Directors since June 2009. He currently is the Chairman of the Corporate Governance/Nominating Committee and a member of the Legal Committee. Mr. Siegel’sSiegel's knowledge and experience in corporate governance and litigation matters provide the Company with significant guidance and oversight.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1314


Table Of Contents

INFORMATIONINFORMATION CONCERNING THE BOARD OF DIRECTORS

 

During 2013,2014, the Board of Directors held 15twelve meetings. The Directors also considered Company matters and hadparticipated in numerous communications with the Chairman of the Board of Directors and other officials of the Company wholly apart from the formal Board meetings. In 2013,2014, all of the Company’sCompany's Directors attended at least 90%96% of the aggregate number of meetings of the Board of Directors and the committees of the Board of Directors on which they served. Directors are expected to attend the Company’sCompany's annual meeting of Shareholders and, toshareholders. To facilitate their attendance, the annual meetings typically are scheduled the same day as a monthly Board meeting. In 2013,2014, all of the Directors attended the Annual Meeting.

 

Board Leadership and Risk Oversight

 

Larry A. Mizel serves as Chairman of the Board of Directors and the Chief Executive Officer of the Company. Mr. Mizel, who founded our Company, has servedhasserved for 42forty-three years and is the largest shareholder of the Company. He provides effective leadership and guidance as the Chairman in the development of the Company’sCompany's risk profile, pursuit of its strategic goals and recognition of business opportunities that present themselves.

 

Herbert T. Buchwald serves as the Company’sCompany's independent Lead Director. The independent Lead Director presides at the executive sessions of the independent directorsDirectors and his authority also includes advisingapproving the Chairman as to an appropriate schedule of Board and Committee meetings providing the Chairman of the Board with input as to the preparation ofand the agendas and topics to be considered at the Board and Committee meetings, coordinating the activities of the various Committees of the Board, advising the Chairman as to the quality, quantity and timeliness of the flow of information from management; and coordinating and developing the agenda for executive sessions of the Board’sBoard's independent directors.Directors. See Corporate Governance – Lead Director, above.

 

The Board of Directors convenes on a monthly basis and is comprised of a majority of independent directors.Directors. This independent majority and our regulatory governance practices, including periodic executive sessions of the independent directorsDirectors at which the Lead Director presides, provide an effective and independent oversight of management.

 

Our Board of Directors bears the responsibility for maintaining oversight over the Company’s management and exposure to risk. The Board, itself and through its Committees, regularly discusses our material risk exposures,exposure, the potential impact on the Company and the efforts of management it deems appropriate to deal withmanage the risks that are identified. In meetings with senior management, the head of the internal audit department and the external independent auditors, the Audit Committee reviews regulatory, financial and accounting risk exposure, reserves and the Company’s internal controls. The Corporate Governance/Nominating Committee, with the guidance of corporate and outside counsel, considers the risks associated with corporate governance. The Compensation Committee considers risks associated with the elements contained in the Company’s compensation programs. The Legal Committee considers the risks that arise from material litigation, regulatory issues and other legal issues. Our Committees generally report to the Board on a monthly basis.

 

For the foregoing reasons, the Company has determined that its leadership structure is appropriate given the Company’s specific circumstances, the management of risk and the Board’s administration of its oversight function.appropriate.

 

Audit Committee

 

The Audit Committee of the Board of Directors, which has been established in accordance with Section 3(a)(58)(A) of the Exchange Act, consists of Messrs. Baker, ReeceBuchwald and Reece. Mr. Buchwald who serves as Chairman. Mr. Berman retired fromwas the Committee in May 2013 andChairman until the chair position rotated on November 1, 2014, when Mr. Reece joined at that time.became the new Chairman. Each member of the Audit Committee is “independent”"independent" and “financially literate”"financially literate" in the judgment of the Board of Directors, as defined in the listing standards of the NYSE and the rules of the SEC. In addition, the Board of Directors has determined that Mr. Buchwald is an “audit"audit committee financial expert”expert" as defined by applicable SEC regulations. The Board believes that his experience and qualifications described above under “Other"Other Information Relating to Directors”Directors" qualify him to act as the Committee’sCommittee's audit committee financial expert.

 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement15

Table Of Contents

The Audit Committee met 11eleven times during 2013.2014. The organization, functions and responsibilities of the Audit Committee are described in the restated charter for the Audit Committee, which is posted on the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     14

The Audit Committee’sCommittee's functions include: assisting the Board in its oversight of the Company’sCompany's compliance with legal and regulatory requirements, oversight of the Company’sCompany's external auditors, review of the Company’sCompany's financial statements, review of the annual audit plan and results of the audit, review of any significant modification in accounting policies, oversight of the duties of the Company’sCompany's internal audit departmentand discussion of policies with respect to risk assessment and risk management.

 

Compensation Committee

 

The Compensation Committee consists of Messrs. Buchwald, Baker, Berman and Buchwald. Mr. Berman who serves aswas the Chairman until the chair position rotated on November 1, 2014, when Mr. Baker became the new Chairman. During 2013,2014, the Compensation Committee met 1113 times. Each member of the committee is independent in the judgment of the Board of Directors, as defined in the listing standards of the NYSE as recently modified by that exchange in 2013. The Compensation Committee approves executive compensation plans, reviews salaries, bonuses and other forms of compensation for officers and key employees of the Company, establishes salary levels, benefits and other forms of compensation for employees and addresses other compensation and personnel matters as the Board of Directors from time to time may request. The organization, functions and responsibilities of the Compensation Committee are described in the Compensation Committee’sCommittee's restated charter, which is posted on the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

 

For a discussion of the Company’sCompany's compensation philosophy and a description of the Company’sCompany's processes and procedures for the consideration and determination of executive and director compensation, see “Compensation"Compensation Processes and Procedures”Procedures" and “Compensation"Compensation Discussion and Analysis”Analysis" below.

 

Corporate Governance/Nominating Committee

The Corporate Governance/Nominating Committee consists of Messrs. Siegel,Blackford, Buchwald and Siegel. Mr. Blackford who serves as Chairman. Mr. Berman retired fromwas the Committee inChairman until the chair position rotated on November 2013 and1, 2014, when Mr. Siegel joined at that time.became the new Chairman. Each member of the committee is independent in the judgment of the Board of Directors, as defined in the listing standards of the NYSE. During 2013,2014, the committee met fiveeight times. The organization, functions and responsibilities of the Corporate Governance/Nominating Committee are described in the committee’scommittee's charter, which is posted on the investor relations section of the Company’sCompany's website, www.mdcholdings.com. The functions of the Corporate Governance/Nominating Committee include development of and recommendations as to corporate governance principles and the Company’sCompany's Code of Conduct, identification of individuals qualified to become Board members, the review of Director independence, the selection process for Director nominees and oversight of the self-evaluations of the Board and the Audit, Compensation and Corporate Governance/Nominating Committees.

 

Procedures for nominating persons for election to the Board are contained in the Company’sCompany's By-Laws and, accordingly, those procedures constitute the Company’sCompany's policy with regard to the nomination and consideration of Director candidates recommended by Shareholders.shareholders. The Corporate Governance/Nominating Committee will consider candidates identified by Shareholdersshareholders following the procedures set forth in the By-Laws. There have been no changes to these procedures in the last year.

  

The By-Laws provide that nominations of persons for election to the Board of Directors may be made at a meeting of Shareholdersshareholders by any shareholder entitled to vote for the election of Directors at the meeting who complies with the notice procedures set forth in the By-Laws. Specifically, such nominations shall be made pursuant to timely notice in writing to the Secretary of the Company. To be timely, a shareholder’sshareholder's notice shall be delivered to, or mailed and received at, the principal offices of the Company not less than 60 days nor more than 90 days prior to the meeting; provided, however, that in the event that less than 75 days’days' notice or prior public disclosure of the date of the meeting is given or made to Shareholders,shareholders, notice by the shareholder to be timely must be so received not later than the close of business on the 10th10th day following the day on which such notice of the date of the meeting was mailed or such public disclosure was made. Such shareholder’sshareholder's notice shall set forth in writing:

  

M.D.C. HOLDINGS, INC. -2015 Proxy Statement16

Table Of Contents

(a)

as to each person whom the shareholder proposes to nominate for election or re-election as a Director:

 

(i)

(i)

the name, age, business address and residence address of such person,


 

(ii)

(ii)

the principal occupation or employment of such person,


 

(iii)

(iii)

the class and number of shares of the Company which are beneficially owned by such person and


 

(iv)

(iv)

any other information relating to such person that is required to be disclosed in solicitations of proxies for election of Directors pursuant to Rule 14(a) under the Securities Exchange Act of 1934 and any other applicable laws or rules or regulations of any governmental authority or of any national securities exchange or similar body overseeing any trading market on which shares of the Company are traded, and

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     15

(b)

as to the shareholder giving the notice:

 

(i)

(i)

the name and record address of the shareholder and


 

(ii)

(ii)

the class and number of shares of the Company beneficially owned by the shareholder.

  

The chairman of the meeting shall, if the facts warrant, determine and declare to the meeting that a nomination was not made in accordance with the foregoing procedure, and, if so determined, shall so declare to the meeting and the defective nomination shall be disregarded.

 

The Corporate Governance/Nominating Committee believes that all candidates for the Board, including candidates recommended by Shareholders,shareholders, should have experience in appropriate areas and disciplines. While the Committee does not have a specific diversity policy, in identifying directorDirector nominees, the Committee considers, in addition to applicable requirements of law and of the NYSE, the diversity of the candidate’scandidate's experience and qualifications, including business experience, specific expertise, strength of character, judgment, and other factors deemed appropriate in adding value to the composition of the Board. The Committee considers, and thereby assesses, the diversity of experience and qualifications of the candidate and the Board members when recommending candidates for nomination by the Board. Other than for compliance with the procedures set forth in the By-Laws, there is no difference in the manner in which the Corporate Governance/Nominating Committee evaluates nominees for directorDirector based on whether the nominee is recommended by a shareholder. At such times as may be appropriate, the Corporate Governance/Nominating Committee will lead the search for individuals qualified to become members of the Board, seeking candidates who have diversity of experience and qualifications in appropriate areas and disciplines. The Committee has authority to engage search firms to identify candidates for nomination to the Board.

 

Legal Committee

 

The Legal Committee consists of Mr. Buchwald, who serves as Chairman, and Messrs. Blackford Siegel and Buchwald, allSiegel. All Legal Committee members are independent members of the Board of Directors. In 2013,2014, the Legal Committee met 10eight times. The Legal Committee provides oversight and review of significant legal affairs of the Company, and it has been active in reviewing legal issues affecting the Company’sCompany's business with the Company’sCompany's inside and outside counsel. The organization, functions and responsibilities of the Legal Committee are described in the committee’scommittee's charter, which is posted in the investor relations section of the Company’sCompany's website, www.mdcholdings.com.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1617


Table Of Contents

EXECUTIVEEXECUTIVE OFFICERS

 

Set forth below are the names and offices held by the executive officers of the Company as of the Record Date. The Board of Directors, after reviewing the functions performed by the Company’sCompany's officers, has determined that, for purposes of Item 401 of SEC Regulation S-K, only these officers are deemed to be executive officers of the Company.

 

The executive officers of the Company hold office until their successors are duly elected and qualified or until their resignation, retirement, death or removal from office. Biographical information on Messrs. Mizel and Mandarich, who serve as Directors and executive officers of the Company, is set forth under “Election"Election of Directors”Directors" above. Biographical information for Messrs. Stephens and Touff is set forth below.

 

Name

Age

Offices Held as of March 21, 2014January 29, 2015

Larry A. Mizel

71

72

Chairman of the Board of Directors and Chief Executive Officer

David D. Mandarich

66

67

President, Chief Operating Officer and a Director

John M. Stephens

45

46

Senior Vice President, Chief Financial Officer and Principal Accounting Officer

Michael Touff

69

70

Senior Vice President and General Counsel

John M. Stephenswas elected Senior Vice President, Chief Financial Officer and Principal Accounting Officer onin February 13, 2012. He previously was with Standard Pacific Corp., one of the country’s largest homebuilders, serving as Chief Financial Officer from February 2009 through June 2011, Senior Vice President from May 2007 through June 2011, Corporate Controller from November 1996 through February 2009, and Treasurer from May 2001 until October 2002 and from November 2009 through June 2011. Prior to Standard Pacific, Mr. Stephens was an audit manager with the international accounting firm Arthur Andersen LLP. Mr. Stephens also is an officer, director or both of many of the Company’s subsidiaries.

 

Michael Touffwas elected Senior Vice President and General Counsel of the Company in July 1999, having been elected previously as Vice President and General Counsel in December 1994. From August 1992 through December 1994, he was an officer in the law firm of Ireland, Stapleton, Pryor & Pascoe, P.C. Prior to August 1992, Mr. Touff was an officer in the law firm of Holmes & Starr, a Professional Corporation. Mr. Touff also is an officer, director or both of several of the Company’sCompany's subsidiaries.

  

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1718


Table Of Contents

COMPENSATIONCOMPENSATION PROCESSES ANDPROCEDURES

 

Scope of Authority of Compensation Committee

 

The Compensation Committee has the authority to oversee all employee compensation levels, including benefits. Its goal is to have the Company develop compensation levels that will attract, retain, reward and motivate employees, that are competitive with those prevailing in the marketplace and are consistent with shareholder interests. The Committee also administers the Company’sCompany's equity and other compensation plans, as they may be amended from time to time. The Committee may delegate the day-to-day administrative duties of these plans to Company officers, employees and agents.

 

The primary components of the Company’sCompany's executive compensation have been: a base salary, annual performance-based bonuses and equity-based, long-term incentive awards. The Compensation Committee also has discretionary authority to award other forms of executive compensation.

 

The Compensation Committee reviews and establishes the base salaries for the executive officers annually. The base salaries of Mr. Mizel, the Chief Executive Officer, and Mr. Mandarich, President and Chief Operating Officer, were established in accordance with their employment agreements with the Company. The base salaries for Mr. Stephens, Senior Vice President and Chief Financial Officer, and Mr. Touff, Senior Vice President and General Counsel, were established in the Committee’sCommittee's discretion.

 

Annual bonuses may be awarded to the Chief Executive officer and the President and Chief Operating Officer pursuant to the terms of the 2013 Performance-Based Plan, which was approved by the shareholders in 2013. Under the terms of that Plan, the Committee can only exercise negative discretion, and not positive discretion, regarding the amount of any awards payable under its terms. Annual bonuses for the Chief Financial Officer and General Counsel may be awarded based on each individual’s achievement of Key Performance Indicators (“KPIs”) established for his position.

 

The Compensation Committee also has discretionary authority to determine awards of stock options and/or restricted stock to the executive officers and may exercise that authority based on its subjective assessment and determination of the individual’sindividual's performance, contributions to the Company and role in achieving the Company’sCompany's results and objectives.

 

Historically, the Company’sCompany's Board of Directors, and not the Compensation Committee, has exercised the authority to consider and determine Director compensation, including retainer and meeting fees. The non-employee Directors receive equity compensation pursuant to the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors approved by the Shareholdersshareholders in 2011 (the “2011 Director Plan”), under which each non-employee Director is granted options to purchase 25,000 shares of Common Stockcommon stock annually. The options are fully vested on the date of the grant and exercisable six months thereafter.

 

Role of Executive Officers regarding Employee and Executive Compensation

 

Mr. Mizel and Mr. Mandarich, with the assistance of the Company’s human resources department, made recommendations to the Compensation Committee with respect to the structure of the compensation plans and proposals for compensation levels for Company employees, including executive officers. The resources and processes used in making these recommendations involve a review of employee performance with respect to established goals, and overall Company performance subjectively compared to other public homebuilders and the Company’sCompany's business plan.

 

The Compensation Committee took these recommendations into account, together with a variety of other inputs, in its decision making process.

  

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1819


Table Of Contents

Role of Compensation Consultants

 

The Compensation Committee has the authority to retain outside counsel, consultants and other advisors to assist it in evaluating compensation or in otherwise discharging its duties and responsibilities. In 2013,2014, after consideration of independence factors as required by the NYSE, the Compensation Committee engaged Pearl Meyer & Partners (the “Consultant”) to advise the Committee regarding the structuring of executive compensation for 20132014 and 20142015 and compensation disclosures to be made in this proxy statement. The Consultant also assists the Committee in determining appropriate peers for purposes of comparing (but not benchmarking) market compensation, and provides other related services. The Consultant was similarly engaged the prior year to provide advice as to compensation and disclosures.

 

The Consultant has not provided any services for the Company other than the services it provided to the Compensation Committee. After considering, among other things,matters, the absence of any business or personal relationship between the Consultant and any member of the Compensation Committee or any executive officer of the Company, the Compensation Committee has concluded the Consultant’s work does not raise any conflict of interest.

 

Executive Compensation Decision Making

 

The Compensation Committee conducted a series of meetings attended by all the Committee members, beginning in October 2013September 2014 and continuing through February 25, 2014,January 2015, at which time the Committee made determinations regarding 2013 and 2014 executive officer compensation. The following table summarizes the roles of the Compensation Committee, the Consultant, and executive management in the executive officer compensation decision making:

 

Responsible Party

Roles and Responsibilities

Compensation Committeeof the Board of Directors



The Committee currently is comprised of threeIndependent Directors and reports to the Board.

Oversees all executive officer compensation levels, includingbenefits, having a goal to maintain compensation levels that arecomparable to the Board’s relationshipmarketplace and in conformity with shareholders on matters pertaining to executive compensation. 

shareholderinterests.

  SeeksAdministers the views of the Company’s institutional shareholders concerning compensation metrics, executive compensation and performance goals.

  Retains independent counsel, consultantsCompany's current equity and other adviserscompensation plans and any additional plans adopted by the Company.

Reviews and approves corporate goals and objectives relevant to assist it in evaluating compensation or in otherwise discharging its responsibilities.

CEO compensation.

Evaluates CEOthe CEO's performance in relationlight of set goals and objectives, and determines and approves the CEO's compensation level based on this evaluation.
Makes recommendations to the overall performance of the Company.

  Has theBoard with respect to, and has authority to determine and approve non-CEO compensation, packages for our executive officers.

  Reviewsincentive-compensation plans and approves all programs in which our executive officers participate, including equity, retirement and other benefitequity-based plans.

  Reviews theProduces a compensation committee report on executive compensation philosophy, compensation metrics and amounts, andas required by the results of shareholder say-on-pay votes, before establishing executive compensation.

  Considers comparable metricsSEC to be included in the Company’s public homebuilder peer group.

Company's annual proxy statement or annual report on Form 10-K filed with the SEC.

Consultant to the Compensation Committee

Pearl Meyer & Partners, as an independent consultant retained directly by theCompensation Committee, providesconsulting advice on matters of governance andexecutive compensation

Provides advice and opinionguidance on the appropriateness and competitiveness of our compensation programs relative to Company performance and market practice.

Performs all functions at the direction of the Compensation Committee

Attends Compensation Committee meetings (including executive sessions)sessions, as required).

Provides advice and opinionsguidance regarding good governance regardingexecutiveissues bearing on the executive compensation decision making.

determinations.

Provides market data, as requested.

Consults on various compensation matters and recommends compensation program designs and practices.

  With the cooperation of management, works to conductConducts an assessment of the risks arising from our compensation programs.

Confers with the CEO on behalf of the Compensation Committee concerning compensation, levels, incentives and goals.

Assists in selection of the Company’s peers.

Chairman and CEO

With the support of other membersof the management team

Reviews performance of the other executive officers and makes recommendations to the Compensation Committee with respect to their compensation.

With the support of other membersof the management teamConfers with the Compensation Committee concerning design and development of compensation and benefit plans for Company employees.

employees.

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement1920


Table Of Contents

Peer Data

 

The Compensation Committee utilized peer data as a tool when it considered incentives and compensation plan design. While peer data was reviewed and considered by the Committee, it was not utilized for benchmarking purposes. Rather, the peer group information was considered for broad subjective comparisons and not as an objective metric. The homebuilder peer group companies (the “Peer Group”"Peer Group") referenced for these purposes consisted of: Lennar Corporation, D.R. Horton, Inc., the Ryland Group, Inc., Toll Brothers, Inc., Hovnanian Enterprises, Inc., Standard Pacific Corp., KB Home, M/I Homes Inc., NVR, Inc., Pulte Homes, Meritage Homes Corporation and Beazer Homes, USA.

The Committee chose these companies because of their similarities to MDC’sMDC's core business and markets, recognizing that their structure and business strategies may significantly vary from those of our Company. SubstantialSignificant differences between MDC and the Peer Group include (1) MDC senior management (excluding options) owns almostapproximately 20% of the Company’s outstanding stock, the highest aboveamong the closest Peer Group member,members, and (2) MDC’s annual dividend yield of approximately 3.4%4.0% appreciably exceeds the closest Peer Group member.

 

The Compensation Committee appreciatesrecognizes that the total revenue, size, the market capitalization and risk profile of companies in the Peer Group may differ substantially.substantially vary. Nevertheless, the Committee believes that the companies in the Peer Group were appropriate for reference becausepurposes since they compete for the same executive talent. The Compensation Committee refers to the Peer Group not only for compensation purposes, but also for business model and risk evaluation purposes, as discussed in more detail, below.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement2021


Table Of Contents

COMPENSATIONCOMPENSATION DISCUSSION ANDANALYSIS

 

Executive Summary


 

The Compensation Discussion and Analysis (“CD&A”) addresses:

 

Our compensation philosophy and objectives;
The background underlying CEO, COO and other executive compensation;
The elements of executive compensation;
The Compensation Committee’s 2013 and 2014 executive compensation determinations; and
Why the Compensation Committee chooses to pay each element of compensation.

Our compensation philosophy and objectives;


The background underlying CEO, COO and other executive compensation;


The elements of executive compensation;


The Compensation Committee’s 2014 executive compensation determinations; and


The underlying rationale for the Compensation Committee to select each element of compensation.

 

Executive Compensation Philosophy & Objectives


 

Our philosophy continues to utilize executive compensation to retain and reward executive leadership for purposes of creating sustainable long-term value for our shareholders. An important tool has been the use of long-term equity incentives, such as stock options and restricted stock awards, which allow our leadership team to benefit when shareholders benefit. Our consistent emphasis on long-term incentives has resulted in leadership team ownership of Company stock that is among the highest in our home building Peer Group.

 

The homebuilding industry is highly cyclical, and it is important that executive compensation be balanced, to take that into account. The Compensation Committee (the “Committee”) believes that our Company’s executive compensation can best be aligned with the long-term interests of the shareholders by taking all of the following factors into account:

 

The tenure, experience and importance of our executive officers
Risk management and financial stability
Annual performance of the Company
The long-term prospects of the Company within the homebuilding industry

The tenure, experience and importance of our executive officers


Risk management and financial stability


Annual performance of the Company


The long-term prospects of the Company within the homebuilding industry

 

The Committee believes that incentive compensation must reflect the Company’s philosophy on risk management and financial stability, as well as short and long termlong-term returns on shareholder equity. The Committee recognizes that most of the companies in the Peer Group strive to operate with a higher debt to equity ratio and a larger leveraged inventory of real estate. Our Company endeavors to avoid a higher risk exposure than the Peer Group with a goal of maintaining a three to four year supply of land.

 

The Committee believes that fair and appropriate compensation is in the best interests of the Company and its shareholders. The Committee seeks to establish “target” annual incentive levels based on performance goals that are transparent and directly aligned with the long-term interests of shareholders. The Committee considers the impact that annual goals may have on the Company’s overall risk profile and financial position, keeping in mind that the annual goals must also contribute to the long-term interests of the Company.

 

Based on shareholder input and the advice of its Consultant, as reflected in its determinations for 2013,2014, the Committee also seeks to size awards to reflect the degree of accomplishment relative to the established performance goals by paying partial bonuses for partial accomplishments or by paying bonuses above target bonuses for performance that exceeds the performance goals, subject to a maximum threshold. Both target and maximum annual incentive levels are established to provide a competitive paycompensation program within the homebuilding industry.

  

M.D.C. HOLDINGS, INC. -2015 Proxy Statement22

Table Of Contents

Background underlying CEO, COO and other Executive Compensation


 

We believe that our ability to retain and motivate our executive officers with their exceptional skills, experience and capacity to succeed in our competitive industry has been essential to the success of our Company and a significant factor in creating long-term value for our shareholders. Our Chief Executive Officer, Larry A. Mizel, and our President and Chief Operating Officer, David D. Mandarich, the principals who have guided the Company for almost 4243 years and 3738 years, respectively, are senior veterans of the U.S. homebuilding industry. We believe that our continued financial improvement over the past two years, highlighted byAs a significant improvement in most financial measures in 2013,result of their leadership, which has prepared the Company to grow shareholder equity in the coming year. Our achievements are directly linked to the leadership provided by Messrs. Mizel and Mandarich. Their focus and emphasisprimarily been focused on balancing risk and reward, mitigating potential losses and maintaining the financial integrity of the Company, is evidencedwe have experienced three years of solid financial results following the severe downturn in the homebuilding industry. Additionally, during 2014, we have experienced an appreciable increase in our active community count and backlog, driven by our two investment grade ratings (one of only two homebuilders with at least two investment grade ratings). With eight consecutive quarters of positive net income through the 2013 fourth quarter, and successful land acquisition efforts inand sales efforts. These results have established a solid baseline for the second half of 2012 and all of 2013, we are well positioned for growth

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     21

in 2014Company to build shareholder equity over the coming and future years. The Compensation Committee strongly believes that appropriately compensating theseour seasoned executives appropriatelyaptly serves to encourage and reward their continued service and is in the best interests of our shareholders.

 

The following are operational and financial highlights for 2013:2014:

 

We reduced our interest costs and extended our next senior note maturity to 2020 by eliminating $500 million of existing senior notes and issuing $250 million of new senior notes


We increased our line of credit from $450 million to $550 million and extended the maturity of the line by one year to December of 2019


Net income was $63.1 million, or $1.29 per diluted share vs. net income of $314.4 million, or $6.34 per diluted share


Net income of $314.4M, or $6.34 per diluted share vs. $62.7M, or $1.29 per diluted share in 2012

Pre-tax income more than doubled overall and more than tripled for the homebuilding segment
Includes

2013 included a benefit from $187.6Ma $187.6 million reversal of deferred tax asset valuation allowance for the homebuilding segment while 2014 included a charge resulting from $22.5 million in 2013 second quarter

debt extinguishment-related expenses

Home sale revenues increased 41% year-over-year to $1.63B

Home sale revenues increase slightly to $1.65 billion in 2014, despite a 13% decrease in the value of beginning backlog


Gross margin from home sales of 17.0% in 2014 vs. 17.8% in 2013


Our SG&A rate declined to 12.3%, a year-over-year improvement of 80 basis points


 

Double-digit increases for both home deliveries and average selling price
Net operating margin for homebuilding improved by 340 basis points to 6.2%
Improvement in both gross margin from home sales and

SG&A rate

was at lowest rate in almost 10 years

Pace of monthly net home orders improved 21% to 2.5
Acquired almost 8,000 lots in 168 communities, including 128 new communities
Active community count is now growing, setting the stage for success in 2014 and beyond
$350M of 30 year unsecured bonds issued at 6.0% interest rate
$450M unsecured line of credit negotiated with an accordion feature to increase up to $1.0B
Liquidity improved by 75% to $1.24B
Stockholders’ equity increased by 38% to $1.21B
Industry-leading $1.00 per share dividend paid for 2013 (in advance in December 2012)

We increased our active subdivision count to 159, up 9% year-over-year


The value of net new orders increased 19% year-over-year to $1.83 billion


Our backlog value at year end of $663.2 million was up 31% from 2013


We acquired 4,213 lots in 112 communities, including 82 new communities

 

This CD&A discusses the compensation of our executive officers for fiscal year 2013 and the incentives established for 2014. In 2013,2014, the named executive officers were:

 

Larry A. Mizel, Chairman and CEO;
David D. Mandarich, President and Chief Operating Officer;
John M. Stephens, Senior Vice President, Chief Financial Officer and Principal Accounting Officer; and
Michael Touff, Senior Vice President and General Counsel

Larry A. Mizel, Chairman and CEO;


David D. Mandarich, President and Chief Operating Officer;


John M. Stephens, Senior Vice President, Chief Financial Officer and Principal Accounting Officer; and


Michael Touff, Senior Vice President and General Counsel

M.D.C. HOLDINGS, INC. -2015 Proxy Statement23

Table Of Contents

 

Elements of Executive Compensation


 

Our executive compensation program, in which all of our executive officers participate, is comprised of three primary elements: (i) a base salary, (ii) an annual incentive bonus; and (iii) a long-term equity incentive award comprised of stock options. The following table describes each element and outlines its purpose:

 

Element of Executive

Officer Compensation

Description

Description

Purpose

Base Salary

Ongoing

Minimum cash compensation based on the executive officer’s role at MDC and any employment agreement.agreement, if any. Salary levels are evaluated annually and may be increased for length of service, competitive reasons or to recognizein recognition of a promotion or job change.

change in responsibilities.

��

Provide a degree of financial certainty and stability.

Retention and attraction of executive talent.

Recognize their experience, length of service, competitive market conditions and reward individual performance through periodic increases.

Annual Incentive Award

Awards for the CEO and COO are made annually under the 2013 Performance-Based Compensation Plan. KPIs are established for the CFO and General Counsel. WhetherCounsel annually. The extent to which an award is earned and the amount is determined by the Compensation Committee depending upon Companyindividual’s and the Company’s performance typically against pre-established goals.

Motivate executive officers to achieve key annual goals and position the Company for longer-term success.

Reward executive officers for individual performance and overall Company performance during the year.

Long-Term Equity Awards

Awards typically are granted annually under the Company’s 2011 Equity Incentive Plan. Each executive officer is eligible to receive an award at the discretion of the Compensation Committee based upon performance and long-term potential.

Provide an incentive for executive officers to achieve long-term, sustainable success for the Company and to create shareholder value.

Attract, motivate, reward and retain executive talent.

 

In addition, based on their decades of service to the Company, Messrs. Mizel and Mandarich will receive medical insurance benefits, as more fully described under “Post-Retirement Medical and Pensionthe “Medical Insurance Benefits” section below. TheseThe medical benefits were first established in 1997 and last modified in 2008. Messrs. Mizel and Mandarich were also previously eligible for post-retirement pension benefits, which were terminated in 2013. The post-retirement pension benefits accrued to the termination date will bewere distributed to them in October 2014. The “Post-Retirement Medical and Pension Benefits” section below discusses this in further detail.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement2224


Table Of Contents

Consideration of Say on Pay Vote

Overview


 

The Compensation Committee considered investor feedback and the 2012 Say on Pay vote prior to making compensation decisions at the start of 2013. The 2013 advisory vote on executive compensation resulted in a majority (96%) affirmative vote at the Company’s March 18, 2013 Annual Meeting of Shareholders.

Outreach Effort

On behalf of the Compensation Committee, the Company undertookundertakes an outreach effort to contact major Company shareholders prior toof the finalization of compensation decisions made at the start of 2013, and again prior to the finalization of compensation decisions made at the beginning of 2014. The objective of this effort wasCompany to seek thetheir current views of Company shareholders concerning executive compensation, metricsin general, and the compensation and gain a greater understandingphilosophy of the Say on Pay voting, so that shareholder feedback could be considered for compensation decisions.

In its outreach efforts,Committee, in particular. During 2014, the Company contacted unaffiliated shareholders, in an effort to discuss each investor’s views on compensation and compensation metrics. The outreach efforts targeted voting decision makers, proxy departments and/or compliance departments. The Company compiled detailed feedback for the Compensation Committee regarding their discussions with shareholders. The Company’sCommittee’s outreach effort extended to shareholders representing more than 40% of the Company’s unaffiliated shareholders.

At the beginning of fiscal year 2014, the Committee established the 2014 Performance Goal under the 2013 Executive Officer Performance-Based Compensation Plan (the”2013 Performance-Based Plan”) as set forth in a Form 8-K dated February 25, 2014. Following the Annual Meeting of Shareholders on May 19, 2014 and a marked decline in the number of ”for” votes on the Say-on-Pay proposal, the Committee reviewed the Company’s compensation processes and procedures and engaged in discussions with its independent compensation consultant and a number of the Company’s largest shareholders. On September 22, 2014 the Committee determined to exercise its discretion under the 2013 Performance-Based Plan and reduced the potential bonus payout under the 2014 Performance Goal to range from zero to a maximum of $6.0 million (with a reduced target bonus level of $4.0 million) as set forth below:

Before

 

As Modified

EPS

 

Bonus (millions)

 

EPS

 

Bonus (millions)

$4.01

 

$10.00 max

    

3.61

 

9.00

 

$3.61

 

$6.00 max

3.31

 

8.25

 

3.31

 

5.67

3.21

 

8.00

 

3.21

 

5.33

3.01

 

7.50

 

3.01

 

5.00

2.81

 

7.00

 

2.81

 

4.67

2.71

 

6.75

 

2.71

 

4.50

2.61

 

6.50

 

2.61

 

4.33

2.41

 

6.00 target

 

2.41

 

4.00 target

2.21

 

5.00

 

2.21

 

3.33

2.01

 

4.00

 

2.01

 

2.67

1.81

 

3.00

 

1.81

 

2.00

>1.60

 

2.00

 

>1.60

 

2.00

≤1.60

 

-0-

 

≤1.60

 

-0-

By linking the 2014 Performance Goal to the Company’s Pretax EPS, the Committee determined that the annual bonus would be directly dependent on the actual defined performance specified by the Committee. The Committee strives to align the executive’s interest with the shareholders by balancing short-term objectives with long-term rewards. The Committee believes that short-term performance should be based on factors that the executives can directly influence. The Committee addresses long-term shareholder returns through long-term equity compensation.

The 2014 Performance Goal was achieved at the target level and constituted approximately 80% of the CEO’s and COO’s total compensation for the year.

Consideration of shareholder feedback in prior years contributed to the Company’s pursuit of agreements with the CEO and COO for the early termination, as of June 30, 2013, of the non-qualified retirement benefits contained in their respective employment agreements, resulting in a reduction of expense for the Company and a significant reduction in their compensation attributed to “Change in Pension Value and Nonqualified Deferred Compensation Earnings” (see “2014 Summary Compensation Table” below).

 

The Consultant, on behalf of the Compensation Committee, contacted ISS and Glass Lewis to solicit their views concerning executive compensation and corporate governance. The Chairman of the Compensation Committee also participated in the discussions. The Consultant reported the results of thesethe discussions towere considered by the Committee which were considered in advance ofmaking its executive compensation determinations made at the start of 2013 and again at the beginning of 2014.determinations.

  

Upon completing its evaluation, and upon conferring with its Consultant, the Compensation Committee made its determinations on compensation actions for 2013 performance and 2014 plans, as discussed in more detail below.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement25

Table Of Contents

  

Elements of Compensation & Specific Compensation Decisions - 20132014


 

Base Salary

 

The determination of base salary levels is a subjective assessment made by the Committee annually taking into consideration the followingthefollowing factors as a whole:

 

Experience and tenure
Base salary levels for comparable positions in the Peer Group
Individual and Company performance
Internal equity
Level of responsibility
The executive’s employment agreement (if any)
Shareholder input
The advice of its Consultant

Experience and tenure


Base salary levels for comparable positions in the Peer Group


Individual and Company performance


Level of responsibility


The executive’s employment agreement (if any)


Communications with shareholders


Tax consequences under IRS Section 162(m)


The advice of its Consultant

 

The Compensation Committee determined to keepmaintain the 2013 base salaries of Messrs. Mizel, Mandarich, Stephens, and Touff unchanged from their 20122013 levels. The Committee believes that thesetheir base salary amounts are appropriate in light of the various factors it considered in making the specific base salary determinations. Theconsidered. Their base salaries have remained unchanged for several years.

 

2013

2014 Annual Incentive Bonus Awards

 

The shareholder approvedshareholder-approved 2013 Performance-Based Plan was designed to motivate and reward executives for their respective contributions in achieving the Company’s annual financial goals. The 20132014 Performance Goal for Messrs. Mizel and Mandarich was established in accordance with this shareholder approvedthe shareholder-approved plan and the minimum, target and maximumrevised range of thresholds were included in a Form 8-K filed with the 2013 Proxy Statement for review bySEC on September 24, 2014 (see details in the shareholders in advance of their Say on Pay vote.Summary above).

 

RequiringThe Compensation Committee believes there is a strong link between long-term shareholder value and (1) return on equity and (2) earnings per share. As such, for 2014 the commentsCommittee based the performance goal for our Chief Executive Officer (CEO) and Chief Operating Officer (COO) on achieving specified objectives for both return on equity and consolidated pre-tax income per share, excluding any charges or expenses incurred in connection with debt extinguishment (“Pretax EPS”). When establishing the 2014 Performance Goal, the Committee considered the appropriateness of the Company shareholders,thresholds established for Pretax EPS given the Company’s emphasis on risk management, financial stability and long-term value. The design of the 2014 Performance Goal contained two key Performance Objectives:

First, a condition precedent for payment under the 2014 Performance Goal that the adjusted pre-tax return on beginning equity (excluding any charges or expenses incurred in connection with the early extinguishment of debt) must exceed 6.5 percent.

Second, Pretax EPS had been achieved in accordance with a range of thresholds with corresponding bonus levels ranging from zero to a maximum of $6.0 million (see details in the Summary above).

For 2014, the Committee believed that it was important to closely align its annual incentive bonus (the 20132014 Performance Goal under the 2013 Performance-Based Plan) with the continued growthperformance of the Company’s homebuildingpretax earnings in 2013.light of the Company’s internal forecasts, general and industry economic conditions and the goals for the year in balancing risk and reward. 

 

Therefore,When establishing the design of the 2013revised 2014 Performance Goal, contained two key Performance Objectives, as disclosed previously in the 2013 Proxy Statement:

First, a condition precedent that the adjusted pre-tax return on beginning equity (excluding any charge for debt extinguishment) must exceed 6% in order foranybonus to be paid under the 2013 plan.

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     23

Second, a rangeCommittee carefully considered the appropriateness of homebuilding pre-tax income per weighted average diluted shares outstanding (excluding any charge for debt extinguishment) (“Homebuilding EPS”) thresholds were established to reward performance achieved in the homebuilding operations as follows:
At least $0.76 to qualify for the minimum bonus level of $3.5 million;
At least $0.90 to qualify for the target bonus level of $6.0 million; and
At least $1.87 to qualify for the maximum bonus level of $10.0 million.

The 2013 Performance Goal reflected the thresholds established for HomebuildingPretax EPS given thegiven:

General and industry specific economic conditions;


The Company’s 2012 performance and its continuedinternal forecasts, emphasis on risk management, financial stability, and long-term value.value;


Guidance from an independent compensation consultant;


The 2013 and 2014 say-on-pay voting results; and


Feedback from discussions with shareholders.

 

The annual incentiverevised 2014 Performance Goal was achieved at the maximum amounttarget level.

The Company achieved an adjusted pre-tax return on beginning equity of $10 million. In particular:10.1%, exceeding the required threshold of 6.5%, which was a condition precedent.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement26

Table Of Contents

The Company achieved a Pretax EPS of $2.52, calculated as follows:


2014 Consolidated pretax income

 $100,475,000 

Add back: Charges and expenses incurred in connection with the early retirement of $250 million of senior notes due December 2014 and $250 million of senior notes due July 2015

  22,446,000 1

2014 Adjusted consolidated pretax income

 $122,928,000 

Divided by: 2014 Weighted average diluted shares outstanding

  48,817,566 

2014 Pretax EPS

 $2.52 

 

1

The Company achieved

Includes a pre-tax returnloss on beginning equityearly extinguishment of 15%, exceedingdebt of $18.2 million and an impairment of $4.3 million incurred in connection with the required thresholdredemption of 6%, which wasmarketable securities in a condition precedent.

The Company achieved a Homebuilding EPSloss position to partly fund the early extinguishment of $2.05, calculated as follows:debt.

2013 Homebuilding pretax income $100,323,000
2013 Weighted average diluted shares outstanding  48,831,785
2013 Homebuilding EPS $2.05

 

The Compensation Committee was authorized, in its discretion, to reduce the incentive payout. BasedAs described in the Form 8-K filed with the SEC on its review ofSeptember 24, 2014 the executives’ accomplishments in 2013,Committee had previously reduced the bonus opportunity available to the executives. The Committee determined that no further reduction was warranted.

 

Neither theThe General Counsel nor(the “CLO”) and the Chief Financial Officer participate in(the “CFO”) are not covered by the 2013 Performance-Based Plan. In the judgment of the Compensation Committee, these two positions are primarily responsible for accounting, finance, legal and regulatory compliance and their incentive compensation should not receive incentive compensation tied to specific yeardirectly depend on the Company’s financial performance. Instead, the General Counsel and the Chief Financial Officer were entitled to an annualawarded a bonus of up toopportunity measured by specific goals established by the Committee, their attainment and a specifiedbonus payment commensurate with a percentage of their base pay. For 2013, theThe Compensation Committee consultedconsults with the Chief Executive Officer and the President and Chief Operating Officer, with regard to the CFO’s and devised a list of KPIs for each position.the CLO’s achievements. For 2014, the Committee established the following KPIs.

 

Chief Financial Officer

 

Shareholder relations management and oversight
Timely and accurate handling of financial regulatory filings
Oversight of accounting, finance and treasury functions, including capital markets and bank financing transactions, if applicable
Successful completion of special projects

Shareholder relations management and oversight


General CounselTimely and accurate handling of financial regulatory filings


Oversight of accounting, finance and treasury functions, including capital markets and bank financing transactions, if applicable

Litigation management
Regulatory compliance
Successful completion of special projects
Oversight of risk management

Successful completion of special projects

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement24General Counsel

Litigation management


Back to Contents

Regulatory compliance


Successful completion of special projects


Oversight of risk management

For 2013,2014, the KPIs were weighted equally. The Compensationequally, with bonus amounts based on the level of performance achieved:

A target bonus of 100% of base salary if the Committee determined that each KPI was achieved.


A maximum bonus of 200% of base salary if the extent to whichCommittee determined that each ofKPI has been exceeded at a level doubling the KPIs were met and allocatedtargeted performance.


Other bonus levels as a percentage of achievement to each,base salary in the total of which constituted the annual bonuses awarded to Mr. Stephens and to Mr. Touff. The chart below shows the bonus payable at target and maximum levels, as well as the final bonus paidevent some KPIs were achieved or exceeded and/or others were not achieved or were partially achieved, based on the Compensation Committee’s assessmentproportionate KPI performance that was achieved.

Based on its evaluation of performance for each metric:

    Target Bonus Maximum Bonus Proposed Bonus
Based on Performance
KPI (Total = 100% of Base) (Total = 200% of Base) Against KPIs
    %$ %$ %$
Shareholder relations management and oversight 25%$106,250 50%$212,500 25%$106,250
Timely and accurate handling of financial regulatory filings 25%$106,250 50%$212,500 25%$106,250
Oversight of accounting, finance and treasury functions, including capital markets and bank financing transactions, if applicable 25%$106,250 50%$212,500 25%$106,250
             
Successful completion of special projects 25%$106,250 50%$212,500 25%$106,250
TOTAL 100%$425,000 200%$850,000 100%$425,000
             
Litigation management 25%$88,320 50%$176,640 31.8%$112,500
             
Regulatory compliance 25%$88,320 50%$176,640 31.8%$112,500
             
Successful completion of special projects 25%$88,320 50%$176,640 31.8%$112,500
             
Oversight of risk management 25%$88,320 50%$176,640 31.8%$112,500
TOTAL 100%$353,279 200%$706,558 127.4%$450,000
             

Forrelative to the established KPIs, the Committee awarded Mr. Stephens and Mr. Touff $100,0002014 annual incentive bonuses of $340,000 and $50,000 respectively,$450,000 ($50,000 of the total actual bonuswhich was paid in restricted stock), respectively. The restricted stock was granted and valued as of the date of the Committee’s action, vesting equally over three years, starting with the first anniversary of the award date.  The restricted stock was awarded under our 2011 Equity Incentive Plan.

  

M.D.C. HOLDINGS, INC. -2015 Proxy Statement27

Table Of Contents

2013

2014 Long-Term Equity Incentive Compensation

 

The Compensation Committee is committed tostrongly believes in granting long-term equity awards that are performance vested.areperformance based. In 2012, the CEO and COO receivedwere awarded long-term incentive compensation only in the form of performance-based stock options. At the same time, theThe Committee determined that no additional option grants would be made to them in 2013 or 2014. Nobefore 2015. Consequently, no long-term equity awards have been grantedwere made to the CEO and/or the COO in either 2013 and none are contemplated for 2014.

 

On February 6, 2014,January 26, 2015, the Compensation Committee awarded each of Messrs. Stephens andMr. Touff a stock option award under the 2011 Equity Incentive Plan covering 25,000 shares. EachThe option vests (become(becomes exercisable) as to 33-1/3%25% of the shares over four years commencing on each of the third, fourth and fifthfirst anniversary datesdate of the grant if the executivehe is employed on those dates.

Post-Retirement Pension Benefits

 

Post-Retirement Medical and Pension Benefits

For the past 16 years, the CEO and COO were entitled to a non-qualified retirement benefit and also health benefits under their employment agreements for the duration of each executive’s life (described in more detail below under “Employment Agreements”). The non-qualified retirement benefits rewarded the CEO for his 42 years of service to the Company and the COO for his 37 years of service with the Company. These benefits were first awarded to the CEO and COO as a part of their employment agreements in 1997.

In response to concerns expressed by significant institutional investors regarding the non-qualified retirement benefits, and in accordance with the recommendation of an independent compensation consultant to the Company’s Compensation Committee, onOn October 18, 2013, the Company reached agreements (collectively, the “Second Amendments”) with the CEO and COO for the early termination, as of June 30, 2013, of the non-qualified retirement benefits contained in their respective Employment Agreements.employment agreements. Pursuant to the

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     25

Second Amendments, the Company will paypaid each of Messrs. Mizel and Mandarich, on October 20, 2014, a deferred lump sum in the amount of $14.8 million and $16.0 million, respectively, which was the benefit amount accrued by the Company as of June 30, 2013, without interest, in full satisfaction of their past, present and future non-qualified retirement benefit. The payout will occur on October 20, 2014. The Company’s termination of the non-qualified retirement benefit is irrevocable. As a result of the termination, the Company ceased recognizing expense related to the retirement benefits in 2013.benefits.

 

Medical Insurance Benefits

Under the terms of their employment agreements, the CEO and COO continue to be entitled to medical insurance benefits for the duration of each executive’s life (described in more detail below under “Employment Agreements”).

Other Compensation

 

Other compensation received by our executive officers for 20132014 consists of their 401(k) employer contributions, incremental travel expenses incurred by the Company in support of not-for-profit organizations (as approved by the Board of Directors) and cell phone allowances.

 

The Board of Directors of the Company has determined that it is in the best interests of the Company for its CEO and its COO to take advantage of the Company’sCompany's aircraft for non-Company business purposes, when the aircraft is not being employed in the ordinary course of Company business. The CEO and the COO reimburse the Company for their non-businessnon-Company use of the aircraft.

 

The objective of these benefits is to provide amenities to the executive officersCEO and COO that allow them to more efficiently utilize their time and to support them in effectively contributing to the success of the Company.

  

Elements of Compensation & Specific Compensation Decisions - 2014

Prior to finalizing executive compensation decisions relating to 2014, the Committee took the following actions:

Reviewed the executive compensation philosophy, compensation metrics and amounts, and the results of shareholder say-on-pay votes in prior years.
Sought the views of the top 13 non-affiliated shareholders of the Company concerning compensation metrics and compensation, including views regarding the Company’s performance goals.
Reviewed comparative metrics for the Company and twelve of its publically traded homebuilding peers.

The Committee made the following determinations regarding executive compensation for 2014.

2014 Base Salary

The executive officers did not receive a base salary increase for 2014.

2014 Annual Incentive Bonus

Recognizing the comments of the Company’s shareholders, the Committee believed that it was important to closely align its annual incentive bonus (the 2014 Performance Goal under the 2013 Performance-Based Plan) with the continued growth of the Company’s earnings in 2014.

Therefore, the design of the 2014 Performance Goal contains two key Performance Objectives:

First, there is a condition precedent for payment under the 2014 Performance Goal that the adjusted pre-tax return on beginning equity (excluding any charge for debt extinguishment) must exceed 6.5 percent.

Second, earnings per share (pre-tax income divided by weighted average fully diluted shares outstanding for 2014, excluding any charges or expenses incurred in the early extinguishment of debt) (“Pretax EPS”) must be achieved, using a range of fourteen possible thresholds (with corresponding bonus levels ranging from zero to a maximum of $10.0 million). The CEO and COO must achieve Pretax EPS of:

At least $1.61 to qualify for the minimum bonus level of $2.0 million;

At least $2.41 to qualify for the target bonus level of $6.0 million; and

At least $4.01 to qualify for the maximum bonus level of $10.0 million.

These thresholds were established based on the Compensation Committee’s review of internal Company forecasts as well as general and industry specific economic conditions, keeping in mind the Company’s emphasis on risk management, financial stability, and generating long-term shareholder value. The maximum bonus of $10.0 million for 2014 is equal to the bonus earned by the executives for 2013 and requires the executives toincrease Pre-tax EPS by more than 50% for 2014. If Pre-tax EPS in 2014 is less than the $4.01 maximum threshold, the bonus for the executives will decrease as compared to the 2013 bonuses. An increase in the bonus paid to the CEO and COO for 2014 is not possible under the 2014 Performance Goal.

For 2014, the Compensation Committee consulted with the CEO and the COO, and determined that the Key Performance Indicators (“KPIs”) for the Chief Financial Officer and the General Counsel for 2014 will be the same as the KPIs used for 2013. Those KPIs have been communicated to the General Counsel and the Chief Financial Officer. After the close of the year, the Compensation Committee will receive feedback from the CEO and COO regarding the respective performance

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement2628


Table Of Contents

of each executive regarding his KPIs. The Compensation Committee will then make an independent assessment of the qualitative performance of the General Counsel and the Chief Financial Officer relative to the KPIs, and determine the amount of bonuses, if any, to be awarded.

EMPLOYMENTAGREEMENTS

 

2014 Long-Term Equity Incentive Compensation

The Compensation Committee is committed to granting long-term equity awards that are performance vested. As discussed above, in 2012, the CEO and COO received long-term incentive compensation in the form of performance-based stock options with a three year time limit set for the achievement of the established performance vesting goals. The term of the grant was for three years in lieu of any further equity grants until 2015. Accordingly, no additional option grants have been made to these executives in 2013 or 2014. At the discretion of the Committee, both the CFO and General Counsel may receive part of their annual bonuses in the form of equity awards. Additionally, both executives are eligible to receive stock options for 2014 performance. The amount, exercise price and vesting schedule for any equity components of compensation for our CFO and General Counsel for 2014 performance will be determined at or shortly after the end of the year.

EMPLOYMENT AGREEMENTS

Messrs. Mizel and Mandarich

 

The Company entered into employment agreements with Mr. Mizel and Mr. Mandarich, which have been amended over time and most recently as of October 18, 2013. The agreements provide for the executives’executives' continued employment with the Company: Mr. Mizel as Chairman and Chief Executive Officer, and Mr. Mandarich as President and Chief Operating Officer. The agreements specify a minimum base salary, incentive compensation and medical benefits during the executive’sexecutive's employment as well as medical benefits upon the executive’sexecutive's retirement, disability or termination.

 

On March 8, 2012, the employment agreements were amended to provide a double trigger on the non-equity vesting portions of the agreements’ change-in-control provision and to increase the percentage threshold in the change-in-control definition from 20% to 50%.

 

Previously, the employment agreements provided for the payment of retirement benefits to each of Messrs. Mizel and Mandarich upon the executive’s retirement, disability or termination. In response to concerns expressed by significant institutional investors, and in accordance with the recommendation of an independent compensation consultant to the Company’s Compensation Committee, onOn October 18, 2013 the Company entered into amendments toreached agreements (collectively, the employment agreements“Second Amendments”) with Messrs. Mizelthe CEO and Mandarich that terminatedCOO for the retirement benefits. Pursuant to the amendments, the Company will pay to eachearly termination, as of Mr. Mizel and Mr. Mandarich a deferred lump sum in the amount of $14,803,349 and $15,992,254 respectively (the amounts accrued on the books of the Company through June 30, 2013, with respect toof the Company’s estimated liability to pay the benefits)non-qualified retirement benefits contained in full satisfaction of their past, present and future retirement benefits. These payments will be made to the executives on October 20, 2014. As a result, the Company no longer incurs ongoing retirement benefit accruals.respective employment agreements as described above.

 

Material terms of the employment agreements are summarized below.

 

Employment Term: The agreements automatically extend for two-year terms unless (1) the Company or the executive elects to terminate by six months written notice, or (2) the executive is terminated earlier. Neither party has given notice of termination.

 

Base Salaries: Mr. Mizel’sMizel's base salary may not be less than $1,000,000 per year. Mr. Mandarich’sMandarich's base salary may not be less than $830,000 per year. The base salary for the executive may only be reduced below his prior year’syear's base salary with the consent of the executive and the Company.

 

Incentive Compensation: The Company pays the executive annual incentive compensation pursuant to incentive compensation plans, which are performance-based. Details of the incentive plans are described more fully in “Compensation"Compensation Processes and Procedures”Procedures" and “Compensation"Compensation Discussion and Analysis – Elements of Compensation”Compensation" above.

 

Retirement Benefits: These have now been terminated, as noted above.

Medical Insurance Benefits: The Company provides medical insurance benefits to Messrs. Mizel and Mandarich for the duration of their lives. This applies to each of them while he is employed and for the rest of his life after employment. The medical insurance coverage and benefits are at least comparable to those provided to the executive at the time the agreement was signed. The medical insurance benefits also provide comparable coverage for the executive’sexecutive's spouse for the duration of the executive’sexecutive's life and, if she survives the executive, for an additional sixty months after his death.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     27

With the approval of Messrs. Mizel and Mandarich, the supplemental health insurance coverage previously provided to them was terminated at the end of 2010.

 

Long-Term Disability Benefits: The Company will provide the executive with long-term disability benefits. Under the benefits, the annual after-tax amount received by the executive would equal the after-tax amount of his base salary for the year in which he becomes disabled. This long-term disability benefit would be paid monthly until the earlier of the end of the executive’sexecutive's disability, prior to his becoming totally disabled. If the executive dies or becomes totally disabled during his employment, he or his estate will be entitled to receive all benefits earned under his performance-based plan and equity plans.

 

Vacation: The executive is entitled to receive six weeks of vacation each year without carryover from year to year.

 

Termination for Cause: The executive may be terminated for cause, as defined in their employment agreements. If either is terminated for cause, he will only be entitled to his base salary earned through the date of termination and will not be entitled to any other amounts under his employment agreement.

 

Termination Without Cause: If the executive is terminated without cause he will be entitled to receive:

 

an amount equal to his aggregate base salary during the three years prior to his termination; and


an amount equal to 300%, for Mr. Mizel, and 200%, for Mr. Mandarich, of the annual incentive compensation paid for the year prior to termination.

 

In addition, the executive’sexecutive's options and other rights under the equity plans would vest immediately and the executive, his spouse and his dependents would be entitled to continued medical benefits. Under the employment agreements, termination without cause includes the Company’sCompany's election not to extend the term of the employment agreement and the Company’sCompany's termination of the Performance-Based Plan.

  

M.D.C. HOLDINGS, INC. -2015 Proxy Statement29

Table Of Contents

Change in Control Provisions: If a change in control of the Company occurs, all of the options, dividend equivalents and other rights granted to Messrs. Mizel and Mandarich under the equity plans and other Company plans would accelerate and become exercisable immediately before the occurrence of the transaction that caused the change in control. If the transaction is not completed, the options would remain subject to the restrictions to which they were originally subject.

 

If a change in control occurs, followed within two years by a material change, the executive can terminate his employment (if he has not already been terminated) within thirty days of the material change. If the executive terminates his employment due to a change in control, then:

 

he will receive an amount equal to his aggregate base salary during the three years prior to his termination;


he will receive an amount equal to 300%, for Mr. Mizel, and 200%, for Mr. Mandarich, of the annual incentive compensation paid for the year prior to termination;


he will be entitled to the accelerated vesting of options and rights; and


if the change in control involved a two-tier tender offer, at the executive’sexecutive's election the Company will either: (1) pay the executive the difference between the exercise price of the otherwise unvested options and the price offered in the first tier; or (2) adjust the option terms to provide the executive with an equivalent value.

 

Excess Parachute Payments: Certain payments that Messrs. Mizel and Mandarich may receive could be subject to an excise tax as an “excess"excess parachute payment”payment" under the Internal Revenue Code. This could occur following a change in control, a material change, or through other payments made to the executives. In their employment agreements, Messrs. Mizel and Mandarich have agreed to be paid those amounts, if any, in annual installments and over the shortest period of time in which they may be paid and not be treated as “excess"excess parachute payments."

Change in Control and Material Change Defined

 

A “change"change in control," which is defined more fully in the employment agreements, occurs when:

 

a report on Schedule 13D is filed with the SEC that discloses that any person is the beneficial owner of fifty percent (50%) or more of the combined voting power of the then-outstanding securities of the Company. However, it will not be a change in control if that person is the Company or one of its subsidiaries, an employee benefit plan sponsored by the Company, or any Director as of the date of the employment agreements or his or her affiliate;

 

any person purchases securities through a tender offer or exchange offer if after the offer is completed the person in question is the beneficial owner of fifty percent (50%) or more of the combined voting power of the then-outstanding securities of the Company. However, it will not be a change in control if that person is the Company or one of its subsidiaries, an employee benefit plan sponsored by the Company, or any Director as of the date of the employment agreements or his or her affiliate;

 

the Company’s ShareholdersCompany's shareholders approve a consolidation or merger after which the Company would not be the continuing or surviving corporation;

 

the Company’s ShareholdersCompany's shareholders approve a consolidation or merger in which shares of Company’s Common StockCompany's common stock would be converted into cash, securities or other property;

 

the Shareholdersshareholders approve any sale, lease, exchange or other transfer of all or substantially all the assets of the Company; or

 

the majority of the Board of Directors ceases to be composed of Directors who were on the Board at the beginning of any twelve-month period. However, it will not be a change in control if the election or nomination of each new director was approved by the vote of two-thirds of the Directors in office who were directors at the beginning of that twelve month period.

 

A “material"material change," which is defined more fully in the employment agreements, occurs when:

 

the Company makes certain adverse changes in the executive’sexecutive's reporting relationship, titles, functions or duties;

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     28

the Company (without the executive’s consent) terminates the Performance-Based Plan or amends it to provide for reduced payments to the executive;

 

the Company assigns or reassigns the executive, without his written permission, to another place of employment 50 miles or more from his residence;

 

the Company reduces the executive’sexecutive's base salary, annual incentive compensation, retirement benefits, long-term incentive compensation, or the manner in which the compensation is determined, or breaches the employment agreement; or

 

a purchaser of all or substantially all of the Company’sCompany's assets or any successor or assignee of the Company fails to assume the employment agreement.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement30

Table Of Contents

 

See “Potential"Potential Payments Upon Termination or Change in Control”Control" below for additional information.

 

Certain Other Change in Control Agreements

 

Mr. Touff entered into a change in control agreement with the Company effective July 30, 2008. The agreement will terminate on the earlier of termination of the Mr. Touff’s employment or the end of the current one-year term of the agreement. However, unless either party elects by notice in writing delivered to the other at least 90 days prior to December 31 of the current term, the term of the agreement will be renewed automatically for successive one-year terms. In addition, if the agreement has not been terminated prior to a change in control (as defined below), upon a change in control, the term of the agreement will extend automatically following such Change in Control for two years.

 

The definition of change in control is generally the same as the definition in the description of the employment agreements above.

 

For purposes of the agreement, a change in control event occurs if a change in control is followed by a material change within two years. A material change is defined in the agreements to occur if:

 

Mr. Touff’s employment is terminated without cause (as defined in the agreements);

 

the Company makes certain adverse changes in Mr. Touff’sTouff 's reporting relationship, titles, functions or duties;

 

the Company assigns or reassigns Mr. Touff, without his written permission, to another place of employment more than thirty miles from his residence;

 

the Company reduces Mr. Touff’sTouff's base salary, annual or long-term incentive compensation, or the manner in which the compensation is determined unless the reduction applies to other officers of the Company; or

 

a purchaser of all or substantially all of the Company’sCompany's assets or any successor or assignee of the Company fails to assume the agreement.

 

Pursuant to the agreement, if a change in control event occurs, Mr. Touff may elect within 90 days after the change in control event to terminate his employment, if not previously terminated by the Company, and to receive a change in control payment. The change in control payment equals two times the sum of: (i) Mr. Touff’s annual base salary in effect immediately prior to the change in control event, plus (ii) the amount of Mr. Touff’s last regular annual bonus, provided that the amount of the annual bonus shall not exceed 50% of the annual base salary in effect immediately prior to the change in control event.

 

If a change in control event occurs, Mr. Touff also would be entitled to continue to participate in the Company’sCompany's employee benefit plans, policies and arrangements that provide insurance and medical benefits on the same basis as provided prior to the change in control event for a period of twelve months after the date of termination of his employment.

 

If a change in control as defined above occurs, all options, dividend equivalents and other rights granted to Mr. Touff under any Company equity incentive plan will be accelerated and become exercisable immediately prior to the closing of the change in control. If the change in control is not concluded, the election to exercise such options and other rights shall be of no effect and the options shall remain subject to their original restrictions.

 

Any amounts payable pursuant to the change in control agreement are in addition to any payments otherwise payable to Mr. Touff pursuant to any agreement, plan or policy of the Company. Certain payments that Mr. Touff may receive could be subject to an excise tax as an “excess"excess parachute payment”payment" under the Internal Revenue Code. This could occur following a change in control or a change in control event, either alone or together with other payments made to Mr. Touff. In the agreement, Mr. Touff has agreed to be paid those amounts, if any, in annual installments and over the shortest period of time in which they may be paid and not be treated as “excess"excess parachute payments."

 

Mr. Stephens has also entered into a change in control agreement with the Company effective February 1, 2012, which is similar to Mr. Touff’s except that the change in control payment would equal the sum of his annual base salary and his target annual bonus. Mr. Stephens’ agreement also provides that, other than in the event of his death, if the Company terminates his employment other than for cause or disability (as defined in the agreement) under circumstances where he would not be entitled to the change in control payment described above, then he is entitled to receive an amount equal to his annual base salary.

 

See “Potential"Potential Payments Upon Termination or Change in Control”Control" below for additional information.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement31

Table Of Contents

 

The Compensation Committee believes that the potential payments in these limited change in control circumstances fit well within the Company’sCompany's overall compensation philosophy. The termination and change in control payments are calculated based on the base salaries and the annual bonuses paid to the executives. The Committee believes that the long-

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     29

termlong-term interests of our Shareholdersshareholders are aligned with the executives in that their compensation is, in turn, aligned with the success of the Company. The potential change of control compensation varies with the compensation previously paid to the executive, affords stability to the Company’sCompany's leadership and is consistent with the philosophy of the Committee to provide compensation that assures retention, incentive and reward to the executive team.

 

COMPENSATIONCOMPENSATION COMMITTEE REPORT

 

The following Report of the Compensation Committee shall not be deemed to be “filed”"filed" with the SEC or to be subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended. The report shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except that it will be deemed “furnished”"furnished" in the Company’sCompany's Annual Report on Form 10-K for 2013,2014, but shall not be deemed incorporated by reference into any filing as a result of being furnished in the Annual Report.

The Compensation Committee hereby confirms that it has reviewed and discussed the Compensation Discussion and Analysis with management and, based on the review and discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.

 

COMPENSATION COMMITTEE

Michael A. Berman,Chairman
Raymond T. Baker
Herbert T. Buchwald

COMPENSATION COMMITTEE

 

Raymond T. Baker, Chairman

Michael A. Berman

Herbert T. Buchwald

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3032


Table Of Contents

20142013 SUMMARY COMPENSATION TABLE

 

For the fiscal years ended December 31, 2014, 2013 2012 and 2011,2012, the following table summarizes the compensation of the Company’s named executive officers.

              Change in      
              Pension      
              Value and      
              Nonqualified      
            Non-Equity Deferred      
        Stock Option Incentive Plan Compensation All Other    
Name and    Salary Bonus Awards Awards Compensation Earnings Compensation Total 
Principal Position Year  ($)  ($)  ($)1,2  ($)2  ($)3  ($)4  ($)  ($) 

Name and

PrincipalPosition

Year

 

Salary

($)

  

Bonus

($)

  

Stock Awards

($)1

  

Option Awards

($)1

  

Non-Equity Incentive

Plan Compensation ($)2

  

Changes in Pension

Value and Nonqualified Deferred Compensation Earnings

($)3

  

All Other Compensation

($)

  

Total

($)

 
Larry A. Mizel,  2013  $1,000,000   N/A   N/A   N/A  $10,000,000  $930,281  $138,542  $12,068,823 

2014

 $1,000,000  

N/A

  

N/A

  

N/A

  $3,500,000  

N/A 

  $118,435  $4,618,435 
Chairman and CEO  2012  $1,000,000   N/A   N/A  $1,855,000  $3,500,000  $1,847,550  $462,157  $8,664,707 

2013

 $1,000,000  

N/A

  

N/A

  

N/A

  $10,000,000  $930,281  $138,542  $12,068,823 
  2011  $1,000,000   N/A  $1,908,000   N/A   N/A  $1,442,518  $327,366  $4,677,884 

2012

 $1,000,000  

N/A

  

N/A

  $1,855,000  $3,500,000  $1,847,550  $462,157  $8,664,707 
David D. Mandarich,  2013  $830,000   N/A   N/A   N/A  $10,000,000  $1,390,193  $5,460  $12,225,653 

2014

 $830,000  

N/A

  

N/A

  

N/A

  $4,000,000  

N/A 

  $360  $4,830,360 
President and Chief  2012  $830,000   N/A   N/A  $1,855,000  $3,500,000  $2,491,450  $342,860  $9,019,310 

2013

 $830,000  

N/A

  

N/A

  

N/A

  $10,000,000  $1,390,193  $5,460  $12,225,653 
Operating Officer  2011  $830,000   N/A  $1,908,000   N/A   N/A  $1,738,611  $224,342  $4,700,953 

2012

 $830,000  

N/A

  

N/A

  $1,855,000  $3,500,000  $2,491,450  $342,860  $9,019,310 
John M. Stephens,  2013  $425,000  $325,000  $99,971  $360,010   N/A   N/A  $3,925  $1,213,906 

2014

 $425,000  $340,000  $99,990  $245,745  

N/A 

  

N/A 

  $720  $1,111,455 
Senior Vice President, Chief Financial Officer and Principal Financial Officer  2012  $389,583  $325,000  $204,100  $426,585   N/A   N/A  $42,468  $1,387,736 
Senior Vice President, Chief Financial

2013

 $425,000  $325,000  $99,971  $360,010  

N/A 

  

N/A 

  $3,925  $1,213,906 

Officer and Principal Financial Officer

2012

 $389,583  $325,000  $204,100  $426,585  

N/A 

  

N/A 

  $42,468  $1,387,736 
Michael Touff,  2013  $353,279  $400,000  $50,000  $360,010   N/A   N/A  $5,820  $1,169,109 

2014

 $353,279  $400,000  $49,995  $245,745  

N/A 

  

N/A 

  $720  $1,049,739 
Senior Vice President  2012  $353,279  $350,000  $37,485  $202,750   N/A   N/A  $13,528  $957,042 

2013

 $353,279  $400,000  $50,000  $360,010  

N/A 

  

N/A 

  $5,820  $1,169,109 
and General Counsel  2011  $353,279  $110,000   N/A   N/A   N/A   N/A  $13,520  $476,799 

2012

 $353,279  $350,000  $37,485  $202,750  

N/A 

  

N/A 

  $13,528  $957,042 

1

The amounts shown in the “Stock Awards” column for Messrs. Mizel and Mandarich were granted as part of the payout under the shareholder approved performance-based plan in effect at that time, and they do not represent a standalone award.

2The amounts shown in the “Stock Awards”"Stock Awards" column and the “Option Awards”"Option Awards" column are based on the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. For Messrs. Mizel and Mandarich in 2012, the option awards were performance based, and therefore the value shown above is the aggregate grant date fair value of the awards multiplied by the probable outcome of the performance conditions as of the grant date. Assuming achievement of the highest level of performance for the options granted in 2012, the grant date fair value of the performance-based equity awards for each executive was $3,710,000. For a description of the assumptions used in valuing the awards, please see Note 19 (Stock Based Compensation) to the Consolidated Financial Statements in the Company’sCompany's Annual Report on Form 10-K for the year ended December 31, 2012. Please see the “Grants"Grants of Plan-Based Awards”Awards" table below for more information about the awards granted in 2013.2014. No optionequity awards were granted in 20132014 or 20112013 to the CEO or the COO.

32

These non-equity incentive plan compensation amounts were paid in cash in accordance with the terms of the shareholder approvedshareholder-approved Performance-Based Plan, as in effect for the year indicated, as compensation for that year’syear's performance. The amounts were paid in the subsequent year. No amounts were paid for 2011.

43

This reflects the aggregate change for the year noted in the present value of accumulated Retirement Benefits and Medical Insurance Benefits provided for under Mr. Mizel’sMizel's and Mr. Mandarich’sMandarich's respective employment agreements. These amounts do not represent realized compensation; rather, they represent accounting accruals related to the benefits required under Generally Accepted Accounting Principles (GAAP). As noted in the Post-Retirement Medical and Pension Benefits section above, the Company reached agreements on October 18, 2013 with the CEO and COO for the early termination, effective as of June 30, 2013, of the non-qualified retirement benefits contained in their respective Employment Agreements.employment agreements. Pursuant to these agreements,the amendments, on October 20, 2014, the Company will paypaid to each of Messrs.Mr. Mizel and Mr. Mandarich a deferred lump sum in the amount of $14.8 million and $16.0 million respectively (the amounts accrued on the books of the Company as ofthrough June 30, 2013 with respect to the Company’s estimated liability to pay Retirement Benefits),the benefits) in full satisfaction of their past, present and future non-qualified retirement benefit. For 2013, the amount reflects the increase in the amount accrued through June 30. See Pension Benefits At December 31, 2013 table below.benefits.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3133


Table Of Contents

All Other Compensation

 

The table below provides a breakdown of all other compensation for 20132014 for the named executive officers:

  

 Non-Business Use Dividends on 401(k)     
Name of Aircraft  Restricted Stock  Match4 Other3 Total  

Non- Business

Useof Aircraft

  

401(k)

Match3

  

Other4

  

Total

 
Larry A. Mizel $1     $5,100 $133,442 $138,542   --1  --  $118,435  $118,435 
David D. Mandarich  2     $5,100 $360 $5,460   --2  --  $360  $360 
John M. Stephens       $3,205 $720 $3,925   --   --  $720  $720 
Michael Touff       $5,100 $720 $5,820   --   --  $720  $720 

1

The incremental costs of non-business use of the Company’sCompany's aircraft are calculated as the total variable operating costs directly associated with non-business trips, these costs include fuel, pilot travel related costs, catering, landing fees, flight communication, trip-related maintenance. The totalFor his non-business use of these costs were $357,522, offsetthe aircraft in full by reimbursements made by2014, Mr. Mizel reimbursed the Company $267,000, which is an amount in excess of the incremental cost to the Company.

2

The incremental costs of non-business use of the Company’sCompany's aircraft are calculated as the total variable operating costs directly associated with non-business trips, these costs include fuel, pilot travel related costs, catering, landing fees, flight communication, trip-related maintenance. The totalFor his non-business use of these costs were $19,896, offsetthe aircraft in full by reimbursements made by2014, Mr. Mandarich reimbursed the Company $50,000, which is an amount in excess of the incremental cost to the Company.

3

Any 401(k) match paid by the Company in 2015 which will be based on 2014 401(k) deferrals will be made after filing this Proxy Statement. As such, they will be included in the 2016 Proxy Statement.

4

For Mr. Mizel, the amount shown for “Other” includes $132,722$117,715 of travel expensesincremental costs incurred by the Company in support of Mr. Mizel’sMizel's service to not-for-profit organizations as approved by the Company’sCompany's Board. Incremental costs include fuel, pilot travel related costs, catering, landing fees, flight communication, trip-related maintenance. The remainder of the amount shown for Mr. Mizel and all of the amounts shown for the other NEOs represent cell phone allowances.

4401(k) match represents amounts paid in 2014 based on 2013 401(k) deferrals.

 

SECURITIESSECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

 

The following table provides information, as of December 31, 2013,2014, with respect to the Company’s existing equity compensation plans.

 

  (a) (b) (c) 
  Shares to be issued Weighted-average Number of shares remaining available 
  upon exercise of exercise price of for future issuance under equity 
  outstanding options, outstanding options, compensation plans (excluding 
Plan category warrants and rights warrants and rights shares reflected in column(a)) 
Equity compensation plans          
approved by shareholders  5,282,366 $40.83  1,763,856 
Equity compensation plans not          
approved by shareholders       
TOTAL  5,282,366 $40.83  1,763,856 
  

(a)

  

(b)

  

(c)

 
Plan category 

Shares to be issued

upon exercise of

outstanding options,

warrants and rights

  

Weighted-average

exercise price of

outstanding options,

warrants and rights

  

Number of sharesremaining available for future issuance underequity compensationplans (excluding sharesreflected in column (a))

 
Equity compensation plans approved by shareholders  4,855,916  $37.45   1,502,552 

Equity compensation plans not approved by shareholders

  --   --   -- 

TOTAL

  4,855,916  $37.45   1,502,552 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement34

Table Of Contents

 

GRANTSGRANTS OF PLAN-BASED AWARDS IN 20132014

 

The following table sets forth certain information with respect to awards granted during 20132014 to our named executive officers. All equity awards were made under the 2011 Equity Incentive Plan.

 

  Estimated Future Payouts Exercise or Grant Date Fair 
  Under Equity Incentive Plan Base Price of Value of Stock and 
  Awards Target Option Awards Option Award 
Name Grant Date (#)  ($/Sh)  ($) 

Grant Date

 

Estimated Future

Payouts Under Equity

Incentive Plan

Awards Target

(#)

  

Exercise or

Base Price of

Option Awards

($/Sh)

  

Grant Date Fair

Value of Stock and

Option Award

($)

 
Michael Touff 02/01/2013  25,0001  $39.75  $360,010 

02/06/2014

  25,0001  $29.05  $245,745 
Michael Touff 02/01/2013  2,5152   N/A  $99,971 

02/06/2014

  1,7212  

N/A

  $49,995 
John M. Stephens 02/01/2013  25,0001  $39.75  $360,010 

02/06/2014

  25,0001  $29.01  $245,745 
John M. Stephens 02/01/2013  2,5152   N/A  $99,971 

02/06/2014

  3,4422  

N/A

  $99,990 

1

The options granted will become exercisable as to 33-1/3% of the shares on each of the third, fourth and fifth anniversary dates of the grant. The options granted were part of the applicable executive’s 2013 compensation package.

2

The restricted stock awards will vest equally over three years, starting with the first anniversary of the grant date. The restricted stock awards granted were part of the applicable executive’s 20122013 compensation package. Dividends are paid on the restricted stock.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3235


Table Of Contents

OUTSTANDINGOUTSTANDING EQUITY AWARDS AT DECEMBER 31, 20132014

 

The following table below sets forth information with respect to all unexercised option and unvested restricted stock awards to our named executive officers that were outstanding as of December 31, 2013.2014. Options will become exercisable as to unvested shares and restricted stock will vest (restrictions will lapse) if the named executive officer remains employed on the vesting date. The share amounts and option exercise prices in this table have been adjusted, as necessary, to reflect increases resulting from the stock split and stock dividends declared by the Company in prior years.

  

 Option Awards Stock Awards 
 Number of Number of      Number of    
 Securities Securities      Shares or Market Value of 
 Underlying Underlying Option   Units of Stock Shares or Units of 
 Unexercised Unexercised Exercise Option That Have Not Stock That Have 
 Options (#) Options (#) Price Expiration Vested Not Vested  

Option Awards

  

Stock Awards

 
Name Exercisable Unexercisable  ($) Date (#)  ($)  

Number of

Securities

Underlying Unexercised

Options (#) Exercisable

  

Number of

Securities

Underlying Unexercised

Options (#) Unexercisable

  

Option

Exercise

Price

($)

  

Option

Expiration

Date

  

Number of

Shares or

Units of Stock

That Have Not

Vested

(#)

  

Market Value of

Shares or Units of Stock That Have

Not Vested

($)

 
Larry A. Mizel  78,000     62.14  11/22/2014        90,000   -   61.98  

12/30/2015

   -   - 
  78,000     65.10  11/22/2014      
  78,000     68.06  11/22/2014      
  90,000     61.98  12/30/2015      
  90,000     68.18  12/30/2015      
  90,000     57.05  12/29/2016        90,000   -   68.18  

12/30/2015

   -   - 
  90,000     62.76  12/29/2016        90,000   -   57.05  

12/29/2016

   -   - 
  90,000     38.01  12/20/2017        90,000   -   62.76  

12/29/2016

   -   - 
  90,000     41.81  12/20/2017        90,000   -   38.01  

12/20/2017

   -   - 
  90,000     29.45  12/30/2018        90,000   -   41.81  

12/20/2017

   -   - 
  90,000     32.40  12/30/2018        90,000   -   29.45  

12/30/2018

   -   - 
  60,000  30,0001   31.04  12/31/2019        90,000   -   32.40  

12/30/2018

   -   - 
  60,000  30,0001   34.14  12/31/2019        90,000   -   31.04  

12/31/2019

   -   - 
  30,000  60,0002   28.86  12/30/2020        90,000   -   34.14  

12/31/2019

   -   - 
  30,000  60,0002   31.75  12/30/2020        60,000   30,0001  28.86  

12/30/2020

   -   - 
  500,000     24.50  03/08/2022        60,000   30,0001   31.75  

12/30/2020

   -   - 
           20,0003   735,200   500,000   -   24.50  

03/08/2022

   -   - 
           40,0004   1,470,400   -   -   -   -   20,0002   529,400 
           60,0005   2,205,600   -   -   -   -   40,0003   1,058,800 
David D. Mandarich  78,000     62.14  11/22/2014        90,000   -   61.98  

12/30/2015

   -   - 
  78,000     65.10  11/22/2014        90,000   -   68.18  

12/30/2015

   -   - 
  78,000     68.06  11/22/2014        90,000   -   57.05  

12/29/2016

   -   - 
  90,000     61.98  12/30/2015        90,000   -   62.76  

12/29/2016

   -   - 
  90,000     68.18  12/30/2015        90,000   -   38.01  

12/20/2017

   -   - 
  90,000     57.05  12/29/2016        90,000   -   41.81  

12/20/2017

   -   - 
  90,000     62.76  12/29/2016        90,000   -   29.45  

12/30/2018

   -   - 
  90,000     38.01  12/20/2017        90,000   -   32.40  

12/30/2018

   -   - 
  90,000     41.81  12/20/2017        90,000   -   31.04  

12/31/2019

   -   - 
  90,000     29.45  12/30/2018        90,000   -   34.14  

12/31/2019

   -   - 
  90,000     32.40  12/30/2018        60,000   30,0001   28.86  

12/30/2020

   -   - 
  60,000  30,0001   31.04  12/31/2019        60,000   30,0001   31.75  

12/30/2020

   -   - 
  60,000  30,0001   34.14  12/31/2019        500,000   -   24.50  

03/08/2022

   -   - 
  30,000  60,0002   28.86  12/30/2020        -   -   -   -   20,0002   529,400 
  30,000  60,0002   31.75  12/30/2020        -   -   -   -   40,0003   1,058,800 
  500,000     24.50  03/08/2022      
           20,0003   735,200 
           40,0004   1,470,400 
           60,0005   2,205,600 

   

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3336

Table Of Contents

  Option Awards  Stock Awards 

Name

 

Number of

Securities Underlying Unexercised

Options (#)

Exercisable

  

Number of

Securities

Underlying Unexercised

Options (#)

Unexercisable

  

Option

Exercise

Price

($)

  

Option

Expiration

Date

  

Number of

Shares or

Units of Stock

That Have Not

Vested

(#)

  

Market Value of Shares or Units of Stock That Have

Not Vested

($)

 

John M. Stephens

  -   75,0004   20.41  

02/01/2022

   -   - 
   -   25,0005   39.75  

02/01/2023

   -   - 
   -   25,0006   29.01  

02/06/2024

   -   - 
   -   -   -   -   5,0007  132,350 
   -   -   -   -   1,6768   44,364 
   -   -   -   -   3,4429   91,110 

Michael Touff

  30,000   -   61.98  

12/30/2015

   -   - 
   30,000   -   57.05  

12/29/2016

   -   - 
   30,000   -   38.01  

12/20/2017

   -   - 
   30,000   -   29.45  

12/30/2018

   -   - 
   30,000   -   31.04  

12/31/2019

   -   - 
   16,667   8,3331   28.86  

12/30/2020

   -   - 
   -   25,00010   24.50  

03/08/2022

   -   - 
   -   25,0005  39.75  

02/01/2023

   -   - 
   -   25,0006  29.01  

02/06/2024

   -   - 
   -   -   -   -   76511   20,250 
   -   -   -   -   1,6768   44,364 
   -   -   -   -   1,7219   45,555 

  Option Awards Stock Awards 
  Number of Number of      Number of    
  Securities Securities      Shares or  Market Value of 
  Underlying Underlying  Option   Units of Stock  Shares or Units of 
  Unexercised Unexercised  Exercise Option That Have Not  Stock That Have 
  Options (#) Options (#)  Price Expiration Vested  Not Vested 
Name Exercisable Unexercisable  ($) Date (#)  ($) 
John M. Stephens    75,0006   20.41  02/01/2022      
     25,0007   39.75  02/01/2023      
            7,5008   275,700 
            2,51512   99,971 
Michael Touff  39,000     59.18  11/22/2014      
   30,000     61.98  12/30/2015      
   30,000     57.05  12/29/2016      
   30,000     38.01  12/20/2017      
   30,000     29.45  12/30/2018      
   20,000  10,0001   31.04  12/31/2019      
   8,334  16,6662   28.86  12/30/2020      
     25,0009   24.50  03/08/2022      
     25,0007   39.75  02/01/2023      
            65010   23,894 
            1,14811   42,182 
            2,51512   99,971 
1

This option vests as to the remaining shares on December 30, 2014.31, 2015.

2

This option vests as to 50% of the shares covered thereby on each of December 31, 2014 and 2015.
3

The restrictions on these shares lapse on February 5, 2014.4, 2015.

43

The restrictions on these shares lapse as to 50% of the shares on each of February 4, 2014 and 2015.

5The restrictions on these shares lapse as to 33-1/3% of the shares on each of February 9, 2014, 2015 and 2016.

64

This option vests as to 33-1/3% of the shares covered thereby on each of February 1, 2015, 2016 and 2017.

75

This option vests as to 33-1/3% of the shares covered thereby on each of February 1, 2016, 2017 and 2018.

86

This option vests as to 33-1/3% of the shares covered thereby on each of February 1, 2017, 2018 and 2019.

7

The restrictions on these shares lapse as to 50% of the shares on each of February 1, 2015 and 2016.

8

The restrictions on these shares lapse as to 50% of the shares on each of February 1, 2015, and 2016.

9

The restrictions on these shares lapse as to 33-1/3% of the shares on each of February 1, 2014, 2015, 2016 and 2016.2017.

910

This option vests as to 33-1/3% of the shares covered thereby on each of March 8, 2015, 2016 and 2017.

10The restrictions on these shares lapse on December 30, 2014.

11

The restrictions on these shares lapse as to 33-1/3%50% of the shares on each of March 8, 2014, 2015 and 2016.

12The restrictions on these shares lapse as to 33-1/3% of the shares on each of February 1, 2014, 2015, and 2016.


M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3437


Table Of Contents

OPTIONOPTION EXERCISES AND STOCK VESTED IN 20132014

 

The following table provides additional information about value realized by the named executive officers on option award exercises and restricted stock award vestings during the year ended December 31, 2013.2014.

 

 Option Awards Stock Awards 
 Number of Shares Value Realized on Number of Shares Value Realized on  

Option Awards

  

Stock Awards

 
Name Acquired on Exercise (#)  Exercise ($)  Acquired on Vesting (#)  Vesting ($)  

Number of

Shares Acquired

on Exercise (#)

  

Value Realized

on Exercise ($)

  

Number of

Shares Acquired

on Vesting (#)

  

Value Realized

on Vesting ($)

 
Larry A. Mizel        40,000  $1,549,400   -   -   60,000  $1,771,000 
David D. Mandarich        40,000  $1,549,400   -   -   60,000  $1,771,000 
Michael Touff        1,837  $62,007   -   -   1,872  $54,240 
John M. Stephens        2,500  $99,375   -   -   3,339  $103,142 

 

PENSIONPENSION BENEFITS AT DECEMBER 31, 20132014

 

The following table shows, as of December 31, 2013,2014, the present value of accumulated Retirement Benefits and Medical Insurance Benefitspost-retirement medical insurance benefits under the employment agreements of Mr. Mizel and Mr. Mandarich. The Retirement Benefits (butpost-retirement pension benefits, but not the Medical Insurance Benefits) have beenBenefits, as discussed in the “Employment Agreements” section above, were terminated as of June 30, 2013.

 

        Present Value of   
      Present Value of Accumulated   
    Number of Years Accumulated Medical Insurance Payments During 
    Credited Retirement Benefits Benefits Last Fiscal Year 
Name Plan Name Service (#) ($) ($) ($) 
Larry A. Mizel Employment Agreement N/A $14,803,3491 $273,308  N/A 
David D. Mandarich Employment Agreement N/A $15,992,2541 $267,896  N/A 
Michael Touff N/A N/A  N/A  N/A  N/A 
John M. Stephens N/A N/A  N/A  N/A  N/A 
1Represents the estimated present value of accumulated pension benefits as of June 30, 2013 as a result of the agreements reached between the Company and the CEO and COO for the early termination of their non-qualified retirement benefits contained in their respective Employment Agreements. See the 2013 Summary Compensation Table above for further details.

Name

Plan Name

Number of Years

Credited

Service (#)

 

Present Value of Accumulated

Medical Insurance

Benefits

($)

 

Payments

During Last

Fiscal Year

($)

 

Larry A. Mizel

Employment Agreement

N/A

 $273,308 

N/A

 

David D. Mandarich

Employment Agreement

N/A

 $267,896 

N/A

 

Michael Touff

N/A

N/A

 

N/A

 

N/A

 

John M. Stephens

N/A

N/A

 

N/A

 

N/A

 

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3538


Table Of Contents

POTENTIALPOTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

 

The following table shows potential payments to our named executive officers under existing contracts for various scenarios involving a change in control or termination of employment, assuming a December 31, 20132014 termination date. Please see the narrative above under “Employment Agreements”"Employment Agreements" and “Certain"Certain Other Change in Control Agreements”Agreements" for a description of payments contemplated by these agreements.

 

Name Benefit Termination w/o
Cause or Material
Change
  Change in
Control
  After Change in
Control – Material
Change or w/o
Cause1
  Voluntary
Termination
  Death  Disability 

Benefit

 

Termination w/o Cause or Material Change

  

Change in

Control

  

After Change in Control – Material Change or w/o

Cause1

  

Voluntary Termination

  

Death

  

Disability

 
Larry A. Severance Pay $3,000,0002      $3,000,0002             

Severance Pay

 $3,000,000     $3,000,000            
Mizel Ann. Incentive Comp. $10,500,0003      $10,500,0003             

Ann. Incentive Comp.

 $30,000,0003     $30,000,0003             
 Stock/Option Vesting $4,679,4004  $4,679,4004  $4,679,4004             

Stock/Option Vesting

 $1,588,2004  $1,588,2004  $1,588,2004             
 Health Care Benefits $273,3085      $273,3085  $273,3085  $49,8265  $273,3085 

Health Care Benefits

 $273,3085      $273,3085  $273,3085  $52,1305  $273,3085 
David D. Severance Pay $2,490,0002      $2,490,0002             

Severance Pay

 $2,490,0002      $2,490,0002             
Mandarich Ann. Incentive Comp. $7,000,0003      $7,000,0003             

Ann. Incentive Comp.

 $20,000,0003      $20,000,0003             
 Stock/Option Vesting $4,679,4004  $4,679,4004  $4,679,4004             

Stock/Option Vesting

 $1,588,2004  $1,588,2004  $1,588,2004             
 Health Care Benefits $267,8965      $267,8965  $267,8965  $78,6565  $267,8965 

Health Care Benefits

 $267,8965      $267,8965  $267,8965  $78,9275  $267,8965 
John M. Severance Pay $425,00011      $425,00012             

Severance Pay

 $425,0006      $425,0007             
Stephens Bonus Payment        $425,00013             

Bonus Payment

         $425,0008             
 Stock/Option Vesting $375,6716  $1,262,9217  $1,262,9217             

Stock/Option Vesting

 $267,8239  $722,32310  $722,32310             
 Health Care Benefits        $15,73110             

Health Care Benefits

         $15,78511             
Michael Severance Pay        $706,5588             

Severance Pay

         $706,55812             
Touff Bonus Payment        $353,2799             

Bonus Payment

         $353,27913             
 Stock/Option Vesting $166,0476  $427,8787  $427,8787             

Stock/Option Vesting

 $110,1689  $110,16810  $110,16810             
 Health Care Benefits        $9,96510             

Health Care Benefits

         $10,42611             

1

On March 8, 2012, the employment agreements for Messrs. Mizel and Mandarich were amended to require both a change in control and a material change. Prior to that date, both could have elected to terminate their employment after a change in control and receive the identified benefits. Following both a change in control and a material change, Mr. Stephens and Mr. Touff may elect to terminate employment and receive the identified benefits.

2

Calculated as the aggregate base salary earned by the executive during the prior three years. This amount does not include any amount that may be payable upon a two-tier tender offer that results in a change of control. See footnote 4 below.

3

Under the executive’sexecutive's employment agreement, this is calculated as of December 31, 20132014 at 300% for Mr. Mizel and 200% for Mr. Mandarich of the “Annual"Annual Incentive Compensation”Compensation" paid for 2012.2013. These amounts vary significantly from year to year. For example, if a termination occurred in 2015, the amount for Mr. Mizel and Mr. Mandarich would be reduced to $12,000,000 and $8,000,000, respectively. See “Employment Agreements”"Employment Agreements" above for a description of these provisions.

4

Amount is the value of unvested restricted stock at December 31, 20132014 plus an amount representing the difference between MDC’s stock price at December 31, 20132014 and the exercise price of unvested options, to the extent that the stock price exceeds the exercise price. Under the executive’s Employment Agreement,executive's employment agreement, the vesting of all options, dividend equivalents and other rights granted under equity incentive plans and any other Company plans would be accelerated so as to permit the executive to fully exercise all outstanding options and rights, if any, granted to the executive. In the event a change in control involves a two-tier tender offer, the Company would pay the executive (at the executive’sexecutive's election) the difference between the exercise price of the otherwise unvested options and the price offered in the first tier, or adjust the option terms to provide the executive with an equivalent value.

5

The amount shown is the total projected medical insurance benefit obligation for the executive, which would provide medical benefits that are at least comparable to those provided to the executive at the time his employment agreement was signed. After the end of his employment term, the date the executive becomes totally disabled, the date of the executive’sexecutive's termination without cause or the executive’sexecutive's election to terminate his employment following a change in control (but not in the event of termination for cause), the Company will pay the medical insurance benefit for the duration of the executive’sexecutive's life. The medical insurance benefit also provides comparable coverage for the executive’sexecutive's spouse for duration of the executive’sexecutive's life and, if she survives him, for an additional 60 months after his death. This amount is estimated based on 20132014 costs incurred by the Company.

6

6Upon the Company’s termination of Mr. Stephens’ employment other than for cause, death or disability, he shall be entitled to receive an amount equal to his annual base salary at the rate in effect immediately before the termination of employment.

7

Calculated as one times Mr. Stephens’ annual base salary as of December 31, 2014.

8

Calculated as one times Mr. Stephens’ annual target annual bonus for 2014.

9

Represents the value of all unvested restricted stock awards, which would become fully vested upon a termination by the Company without cause pursuant to the terms of the restricted stock award agreement.

710

Amount is the value of unvested restricted stock at December 31, 2013,2014, plus an amount representing the difference between MDC’s stock price at December 31, 20132014 and the exercise price of unvested options, to the extent that the stock price exceeds the exercise price. If a change in control occurs, all options, dividend equivalents and other rights granted to the employee under any Company equity incentive plans shall be accelerated and shall become exercisable immediately prior to the closing of the change in control so as to permit the employee fully to exercise all outstanding options and rights.

811

Calculated as two times Mr. Touff’s annual base salary as of December 31, 2013.
9Calculated as two times the amount equal to Mr. Touff’s last regular annual bonus, provided that for these purposes such regular annual bonus amount shall not exceed 50% of his annual base salary at the rate in effect immediately before the change in control event.
10

If a change in control event occurs, the employee shall also be entitled to continue to participate in each of the Company’sCompany's employee benefit plans, policies or arrangements which provide insurance and medical benefits on the same basis as was provided to the employee prior to the change in control event for a period of 12 months after the date of termination of employee’semployee's employment. Amount represents the estimated cost of 12 months of benefits for each employee.

12

11Calculated as two times Mr. Touff's annual base salary as of December 31, 2014.

13

UponCalculated as two times the Company’s termination of Mr. Stephens’ employment other than for cause, death or disability, he shall be entitled to receive an amount equal to Mr. Touff's last regular annual bonus, provided that for these purposes such regular annual bonus amount shall not exceed 50% of his annual base salary at the rate in effect immediately before the termination of employment.change in control event.

12Calculated as one times Mr. Stephens’ annual base salary as of December 31, 2013.
13Calculated as one times Mr. Stephens’ annual target annual bonus for 2013.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3639


Table Of Contents

20142013 DIRECTOR COMPENSATION

 

In May 2013, based upon an analysis and recommendation of the Compensation Committee’s independent consultant regarding director compensation being paid by comparable sized public companies, in general, and other companies in the homebuilding industry, in particular, the Board of Directors approved increases in the compensation of the non-employee Directors as described below.

From January through May 2013,During 2014, each Director (excluding the Lead Director) who was not an officer of the Company (“("non-employee Director”Director") was paid $4,000$5,000 per month as a retainer and $2,500$3,000 per meeting for attending Board meetings. Effective June 1, 2013, the Company increased the retainer to $5,000 per month and increased the fee for attendance at Board meetings to $3,000 per meeting. From January through May 2013, eachEach respective Board committee member (also excluding the Lead Director) was paid $2,500$3,000 per meeting for attending meetings of the Audit Committee, and $2,000$2,500 per meeting for attending meetings of the Compensation and the Corporate Governance/Nominating Committees. Effective June 1, 2013, the Company increased the Audit Committee meeting fee to $3,000 and the meeting fee for the Compensation and the Corporate Governance/ Nominating Committees to $2,500. Each Director on the Legal Committee received $2,000 per month for service on that committee. The chairman of the Compensation Committee and the chairman of the Corporate Governance/Nominating Committee received a retainer (in addition to meeting fees) in the amount of $1,250 per month. Beginning in November of 2014, the Chairman of the Audit Committee received a retainer (in addition to meeting fees) in the amount of $1,250 per month.

 

Mr. Berman received a retainer of $2,000 per month during 20132014 for services as a director of HomeAmerican. There were four meetings of the HomeAmerican board during 2013.2014. Mr. Berman attended all of the meetings.

 

In consideration for performing all of the duties and responsibilities of the Lead Director, Mr. Buchwald received monthly compensation of $27,500$32,500 during January through May 2013,2014, in lieu of all other cash compensation paid to independent Directors, including retainer fees and Board and committee meeting fees. Effective June 1, 2013, the Lead Director’s monthly compensation (in lieu of all other cash compensation) was increased to $32,500.

 

Pursuant to the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors, approved by the Shareholdersshareholders in 2011, each non-employee Director is granted vested options to purchase 25,000 shares of Common Stockcommon stock annually. The options are not exercisable until six months after grant. Each Director also is reimbursed for expenses related to his attendance at Board of Directors and committee meetings.

 

The following table sets forth information regarding the compensation of the Company’sCompany's non-employee Directors for the fiscal year ended December 31, 2013.2014. The two Directors (Messrs. Mizel and Mandarich) who are executive officers receive no compensation for serving as Directors in addition to the compensation received as executive officers.

 

Name Fees Earned
or Paid in Cash
($)
 Option Awards
($)1
 Change in
Pension Value
and Nonqualified
Deferred
Compensation
Earnings
 All Other
Compensation
($)
 Total
($)
  

Fees Earned

or Paid in Cash

($)

  

Option Awards

($)1

 

Change in

Pension Value

and Nonqualified

Deferred

Compensation

Earnings

 

All Other

Compensation ($)

 

Total

($)

 
Raymond T. Baker $146,500  $189,248  N/A N/A $335,748  $164,000   151,078 

N/A

 

N/A

 $315,078 
Michael Berman $183,000  $189,248  N/A N/A $372,248  $167,500   151,078 

N/A

 

N/A

 $318,578 
David E. Blackford $148,000  $189,248  N/A N/A $337,248  $152,500   151,078 

N/A

 

N/A

 $303,578 
Herbert T. Buchwald $365,000  $189,248  N/A N/A $554,248  $390,000   151,078 

N/A

 

N/A

 $541,078 
Paris G. Reece III2 $86,500  $189,248  N/A N/A $275,748 

Paris G. Reece III

 $131,500   151,078 

N/A

 

N/A

 $282,578 
David Siegel $120,500  $189,248  N/A N/A $309,748  $142,000   151,078 

N/A

 

N/A

 $293,078 

1

Each non-employee Director was granted 25,000 options on August 1, 20132014 at an exercise price of $31.30$26.82 per share. The dollar amount shown for each Director is the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. For details on the assumptions used to calculate the fair value of options granted, see Note 21 (Stock Based Compensation) to the Consolidated Financial Statements in the Company’sCompany's Annual Report on Form 10-K for the year ended December 31, 2013.2014. As of December 31, 2013,2014, Messrs. Baker, Berman, Blackford, Buchwald, Reece and Siegel had outstanding option grants of 75,000; 135,000; 150,000; 175,000; 50,000; 110,000; 125,000; 182,500; 25,000; and 125,000150,000 shares, respectively.

2Mr. Reece was selected as a director in May 2013 and served for a portion of the year with a term expiring in 2014.

 

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement3740


Table Of Contents


COMPENSATIONCOMPENSATION POLICIES AND PRACTICES AND RISK MANAGEMENT

 

The Company believes that its compensation policies and practices for its employees, including executive officers, do not create risks that are reasonably likely to have a material adverse effect on the Company.

 

COMPENSATIONCOMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

 

The following persons served as members of the Compensation Committee during 2013:2014: Raymond T. Baker, Michael A. Berman and Herbert T. Buchwald and Raymond T. Baker.Buchwald. None of the committee members were, during the last fiscal year, officers or employees of the Company, none were formerly officers of the Company and none had a material interest in a “related person”"related person" transaction since the beginning of 2013.2014. During 2013,2014, none of our executive officers served as a member of the board of directors or compensation committee of any other company that has one or more executive officers serving as a member of our Board or Compensation Committee.

 

PROPROPOSAL TWOPOSALTWO

ADVISORY VOTE ONEXECUTIVE COMPENSATION

 


Pursuant to Section 14A of the Securities Exchange Act, as amended and SEC Rule 14a-21(a), we are providing our Shareholdersshareholders the opportunity to vote on a non-binding, advisory resolution to approve the compensation of our named executive officers (say on pay), which is described in this Proxy Statement. Currently, we are providing these advisory votes on annual basis. Following the 20142015 Annual Meeting the next advisory say on pay vote will be held at our 20152016 Annual Meeting of Shareholders.

 

“RESOLVED, that the shareholders hereby approve on an advisory basis the compensation of the Company’s named executive officers, as disclosed in this Proxy Statement pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion.”

 

As described above under “Compensation DiscussionsDiscussion and Analysis,” we believe that our ability to retain and motivate named executive officers with the skills, experience and capacity to succeed in our competitive industry has been essential to the success of our Company and a significant factor in creating long-term value for our Shareholders.shareholders. Our compensation philosophy recognizes the value of rewarding our executive officers for their past performance and motivating them to continue to excel in the future. We endeavor to deliver fair and appropriate compensation to our executive officers that is in the best interests of the Company and its shareholders.

 

The Board of Directors believes the Company’s compensation programs are tailored to retain and motivate key executives in alignment with maintaining and creating long-term value for our Shareholders.shareholders. The Board of Directors urges you to review carefully the Compensation Discussion and Analysis section of this Proxy Statement, which describes our compensation philosophy and programs in greater detail.

 

The Board of Directors recommends that you vote in favor of the Company’s executive compensation as described in this Proxy Statement by voting FOR this proposal.

  

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement 3841

Table Of Contents

PROPOSALTHREE

APPROVAL OF AN AMENDMENT TO THE M.D.C. HOLDINGS, INC.2011 EQUITY INCENTIVE PLAN

At our 2011 Annual Meeting, our shareholders approved the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan (the “2011 Equity Plan”). At our 2013 Annual Meeting, our shareholders approved an amendment of the 2011 Equity Plan to increase the number of shares by 1,000,000 for a total of 2,600,000 shares of common stock to be available for issuance to our employees under the plan. On January 26, 2015, based on the recommendation of our Compensation Committee and its independent compensation consultant, Pearl Meyer, our Board approved, subject to shareholder approval, an amendment (the “Amendment”) to Section 4.1 of the 2011 Equity Plan to increase the number of shares of common stock available under the plan by an additional 1,675,000 shares. A copy of the Amendment is set forth in Appendix A and incorporated by reference.

The Amendment revises the first two sentences of Section 4.1 by replacing the number 2,600,000 with the number 4,275,000. With the Amendment, the first two sentences of Section 4.1 are as follows:

4.1     Number of Shares. Subject to adjustment as provided in Section 14, the maximum number of shares of Stock available for issuance under the Plan shall be 4,275,000 shares. Subject to adjustment as provided in Section 14, 4,275,000 shares of Stock available for issuance under the Plan shall be available for issuance pursuant to Incentive Stock Options.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement42

Table Of Contents

Reasons for the Plan Amendment

Our Board of Directors believes that attracting and retaining highly qualified officers and key employees, and motivating them to serve the Company and its affiliated entities and to expend maximum efforts, is important to our growth and success. In this regard, equity awards have been and will continue to be an important element of our compensation program because stock options, restricted stock and other equity awards enable our officers and key employees to acquire or increase their proprietary interest in the operations and future success of our Company, thereby promoting a close identity of interests between such individuals and our shareholders.

Approximately 1,006,581 shares remain available for grant under the 2011 Equity Plan. While being judicious in the granting of stock options, restricted stock and other equity awards, the amount of shares granted (as indicated in the chart below) can vary from year-to-year and, without the Amendment, the Company will be unduly limited in the structure of the awards that it may grant. Under New York Stock Exchange listing standards, shareholder approval is required for us to increase the authorized shares under the Plan.

The Company’s burn rates for 2014 and the prior two years (under both the 2011 Equity Plan and the 2011 Director Plan) remain at reasonable levels depicted as follows:

Fiscal Year

 

Options Granted

 

Full-Value Grants

 

FV Multiplier

 

Adjusted Total

 

Weighted Avg. Shares Outstanding

 

Burn Rate

 

Unadjusted

Burn Rate

  

(A)

 

(B)

 

( C )

 

(D = A + (B x C)

 

( E )

 

(F = D / E)

 

(G = ( A + B )/ E)

2014

 

257,500

 

39,021

 

2.0

 

335,542

 

48,815,541

 

0.7%

 

0.61%

2013

 

237,500

 

25,072

 

2.0

 

287,644

 

48,453,119

 

0.6%

 

0.54%

2012

 

1,382,500*

 

48,613

 

2.0

 

1,479,726

 

47,660,629

 

3.1%

 

3.00%

* Options covering 1,000,000 shares were granted for a three year period.

As shown above, the Company’s burn rate for each of the prior two years was less than 1% and its average burn rate over the last three years was only 1.5%. Based on prior experience, the Company expects the additional shares, if approved by the shareholders, to last approximately three to five years.

Accordingly, the Company recommends approval of the Amendment. 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement43

Table Of Contents

Summary of Material Terms of the 2011 Equity Plan

The following discussion of the material features of the 2011 Equity Plan is qualified by reference to the full text of the plan, which was Exhibit 10.1 to the Company’s Form 8-K filed on April 29, 2011.

Administration: The 2011 Equity Plan is administered by our Compensation Committee or any committee designated by our Board of Directors consisting of non-employee directors as defined in Rule 16b-3 under Section 16 of the Securities Exchange Act of 1934 and outside directors as defined in Treasury Regulation § 1.162-27(e)(3). For purposes of this summary of the 2011 Equity Plan, the Compensation Committee or other designated committee will be referenced as the "Committee."

Subject to the terms and conditions of the 2011 Equity Plan, the Committee is authorized to select participants who are employees of the Company or its subsidiaries, determine the awards to be made, set terms and conditions of such awards, and determine the form of award agreements. The Committee also has the authority, among other things, to:

adopt rules and regulations relating to the 2011 Equity Plan;


correct any defect, supply any omission, or reconcile any inconsistency in the 2011 Equity Plan or any award agreement;


interpret the 2011 Equity Plan and award agreements; and


make all other determinations which may be necessary or desirable for the administration of the 2011 Equity Plan.

Eligibility: Any employee of the Company or its subsidiaries is eligible to receive awards under the 2011 Equity Plan. There are four executive officers (including two employee Directors) and approximately 1000 non-executive officer employees who are eligible under the 2011 Equity Plan.

Shares Subject to the Plan: If the Amendment is approved by the shareholders, and subject to the adjustments upon changes in capitalization described below, 4,275,000 shares of our common stock will be authorized for issuance of awards under the 2011 Equity Plan and the 4,275,000 shares of common stock also will be authorized for issuance pursuant to incentive stock options. As of the Record Date, there were 1,519,924 shares subject to outstanding grants/awards, 1,006,581 shares available for (but not yet subject to) a grant or award, plus an additional 1,675,000 shares authorized by the Amendment (if the Amendment is approved by our shareholders). If our shareholders do not approve the Amendment, the 2011 Equity Plan’s total authorized shares will remain at 2,600,000 shares, with a total remaining unused capacity of approximately 1,006,581 shares.

The maximum number or value of shares of common stock that may be granted to any individual under the 2011 Equity Plan in any calendar year shall not exceed the shares available for issuance under the plan, subject to the adjustments upon changes in capitalization described below. The shares underlying terminated awards and awards that are forfeited will remain available for issuance under the 2011 Equity Plan and shares that are utilized to pay an award's exercise price or tax withholding obligations will not count against the 2011 Equity Plan's share limits.

The closing price of a share of the Company’s common stock as reflected on the New York Stock Exchange on the Record Date was $25.14.

Stock Options and Stock Appreciation Rights: The Committee is authorized to grant stock options, including both incentive stock options (“ISOs”), which can result in potentially favorable tax treatment to the participant, and non-qualified stock options (“NSOs”), and stock appreciation rights (“SARs”). The exercise price per share of common stock subject to an option or SAR must be at least the fair market value of the underlying stock at the date of grant of a stock option or SAR; provided, however, that an ISO granted to a participant who is the holder of record of more than 10% of the Company’s stock will have an exercise price of at least 110% of the fair market value of the underlying stock at the date of grant. The term of each option and SAR and the times at which each option or SAR shall be exercisable generally will be fixed by the Committee, except no option or SAR will have a term exceeding 10 years. Upon the termination of an option holder’s or SAR holder's employment with us, the ability to exercise vested options and SARs will be determined in the discretion of the Committee as set forth in the applicable award agreement. Upon the termination of an option holder’s or SAR holder's employment, all of that person’s options and SARs will expire in accordance with the terms of the applicable award agreement; provided, however, that incentive stock options shall not be exercisable for more than three (3) months after the participant ceases to be an employee for any reason other than death or disability, or more than one (1) year after the participant ceases to be an employee due to death or disability. Options may be exercised by payment of the exercise price.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement44

Table Of Contents

The exercise price of an NSO or ISO shall be payable to the Company in full, in any method permitted under the award agreement, including: (i) in cash or in cash equivalents acceptable to the Company; (ii) by tendering unrestricted shares of stock already owned by the participant (for at least six (6) months or such other period as may be required by the Committee in order to comply with applicable law and to avoid adverse accounting consequences) on the date of exercise to the extent the shares of stock have a fair market value on the date of exercise equal to the aggregate exercise price of the shares as to which such NSO or ISO shall be exercised, provided that, in the case of an ISO, the right to make payment in the form of already owned shares of stock may be authorized only at the time of grant, (iii) any other method approved or accepted by the Committee in its sole discretion, including, but not limited to a cashless (broker-assisted) exercise (although limitations might apply to certain executive officers), or (iv) any combination of the foregoing.

At the discretion of the Committee, the payment upon exercise of an SAR may be in cash, shares of stock or any combination thereof, or in any other manner approved by the Committee in its sole discretion. The Committee’s determination as to the form of settlement will be set forth in the award agreement.

The exercise of an NSO or SAR is conditioned on the withholding of taxes.

Restricted Stock and Restricted Stock Units: The Committee may grant shares of restricted stock or restricted stock units under the 2011 Equity Plan. The Committee determines in the award agreement the restriction period during which the restricted stock or the restricted stock units are subject to a substantial risk of forfeiture based upon the passage of time, the achievement of performance goals or the occurrence of other events determined by the Committee. Except as provided in the 2011 Equity Plan or an award agreement, the restricted stock or the restricted stock units may not be sold, assigned or otherwise transferred until the end of the restriction period as specified by the Committee. The Committee may impose other conditions, including a requirement that the participant pay a specified amount to purchase each share of restricted stock, restrictions based upon the achievement of specific performance goals, time-based restrictions on vesting, or holding requirements or sale restrictions upon vesting. Unless otherwise provided by the Committee, participants forfeit any unvested shares of restricted stock or restricted stock units upon termination of service. Participants holding restricted stock generally may vote the shares. The Committee may provide in an award agreement that the holder of restricted stock may receive any dividends paid. Participants holding shares of restricted stock units shall have no rights of shareholders. The Committee may provide in an award agreement that the holder of such restricted stock units shall be entitled to receive dividend equivalents.

Performance Awards: The Committee may condition any award under the 2011 Equity Plan on the fulfillment of conditions and the attainment of performance goals over such periods as the Committee determines in writing and sets forth in the award agreement between the Company and the participant. To the extent compliance with Section 162(m) of the Internal Revenue Code is desired, the “Committee” for this purpose shall be comprised solely of two or more “outside directors” under Section 162(m). Performance goals pursuant to Section 162(m) of the Code will be established by the Committee within 90 days after the beginning of the applicable performance period, and in no event after passage of more than 25% of the period to which the performance goal relates. Performance goals are based on the attainment of specified target levels with respect to one or more selected measures of business or financial performance. Performance goals may include alternate and multiple goals and shall be based on one or more of the following criteria: (a) total shareholder return; (b) return on assets, return on equity, or return on capital employed; (c) measures of profitability such as earnings per share, corporate or business-unit net income, net income before extraordinary or one-time items, earnings before interest and taxes, or earnings before interest, taxes, depreciation and amortization; (d) cash flow from operations; (e) gross or net revenues or gross or net margins; (f) levels of operating expense or other expense items reported on the income statement; (g) measures of customer satisfaction and customer service; (h) safety; (i) annual or multi-year average production growth; (j) efficiency or productivity measures such as annual or multi-year absolute or per-unit operating and maintenance costs; (k) satisfactory completion of a major project or organizational initiative with specific criteria set in advance by the Committee; (l) debt ratios or other measures of credit quality or liquidity; (m) strategic asset sales or acquisitions in compliance with specific criteria set in advance by the Committee; (n) sales and marketing measures, such as annual or multi-year “net-back” sales or the introduction of new products in accordance with specific goals set in advance by the Committee; (o) staffing and retention and (p) any criteria that are stated in the shareholder-approved Executive Officer Performance–Based Compensation Plan (as amended).

Following completion of the applicable performance period, the Committee certifies in writing the extent to which a participant has attained the applicable performance goals and the resulting value of the participant’s award. The Committee retains the discretion to eliminate or reduce, but not increase, the amount that would otherwise be payable to a participant who is a “covered employee” within the meaning of Section 162(m) of the Code. However, no such reduction may increase the amount correspondingly paid to any other participant.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement45

Table Of Contents

The Committee will, in the award agreement, state the results that will transpire if a participant terminates service due to death or disability prior to completion of the applicable performance period. For example, the final award value may be determined at the end of the performance period on the basis of the performance goals attained during the entire performance period, but will then be prorated for the number of months of the participant’s service during the performance period. The Committee may also provide that, if a participant’s service terminates prior to completion of the applicable performance period for any other reason, the participant forfeits the performance award, unless the Committee determines otherwise. Participants may not sell or transfer a performance award, other than by will or the laws of descent and distribution, prior to the end of the applicable performance period. In the event that the performance goals are not satisfied, the award shall not become vested or payable, as applicable.

Other Stock-Based Awards: The Committee may adopt other incentive arrangements under which participants may acquire shares of stock by purchase, grant or otherwise, or receive an award payable in cash or stock, the value of which may be determined in whole or in part based on the value of the stock. Any such arrangements will be subject to the general provisions of the 2011 Equity Plan.

Adjustments Upon Changes in Capitalization: The 2011 Equity Plan provides that, in the event of any change in our capital structure that effects an increase or decrease in the number of shares of our common stock without receipt of consideration, the maximum number of shares of stock for which awards may be made under the plan shall be proportionately increased or decreased, and the number and kind of shares for which awards are outstanding may be proportionately increased or decreased. Any adjustment in outstanding options or SARs will not increase the aggregate exercise price or grant price payable with respect to shares that are subject to the unexercised portion of the option or SAR, in compliance with Section 409A of the Code. Except as otherwise provided in another agreement, upon a change of control the Committee may take any action it deems necessary or desirable with respect to any awards including, among other things, providing that the awards are fully vested or payable. In the event of a reorganization in which the Company is the surviving entity and no change of control occurs, any previous award will generally apply solely to securities to which the holder of the number of securities subject to such award would have been entitled immediately following such reorganization and, in the case of options or SARs, with a corresponding proportionate adjustment of the exercise price or grant price per share. Adjustments to shares of stock will be made by the Committee whose determination will be final and the Committee may provide in award agreements for different provisions to apply to an award. However, any provisions may be modified by the Committee to avoid any tax that would otherwise be due under Section 409A of the Code.

Substitute Awards: Awards may be granted in substitution for, or in assumption of, outstanding awards previously granted by an entity acquired by the Company or an affiliate or with which the Company or an affiliate combines.

Other Terms: The terms of the 2011 Equity Plan will permit the Committee to impose performance conditions with respect to any award. Performance conditions may require that an award be forfeited, in whole or in part, if performance objectives are not met, or require that the time of exercisability of an option be linked to achievement of performance conditions.

Each award agreement may contain other terms and conditions not inconsistent with the 2011 Equity Plan as may be determined by the Committee in its discretion. Unless otherwise provided by the Committee, no consideration is to be received by the Company for the granting of options or other awards.

No awards may be granted under the 2011 Equity Plan ten years after the date the plan is approved by the shareholders.

Our Board of Directors may terminate, amend or modify the 2011 Equity Plan; provided that no such termination, amendment or modification may adversely affect any outstanding award without the consent of the award holder. However, no amendment or modification may become effective without shareholder approval if required by applicable law or regulatory requirement. The listing standards of the New York Stock Exchange require that all equity compensation plans, and any material revisions to the plans, be subject to shareholder approval, with certain limited exemptions.

Awards granted under the 2011 Equity Plan generally are not transferrable other than upon death, in certain family transfers, or pursuant to a court-approved domestic relations order.

The 2011 Equity Plan will be governed by the laws of the State of Delaware except for conflict of law provisions.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement46

Table Of Contents

Federal Tax Consequences of the 2011 Equity Plan

The following is a general summary as of January 2015 of the federal income tax consequences to us and to U.S. participants to awards granted under the 2011 Equity Plan and does not attempt to describe all possible federal or other tax consequences of such participation or tax consequences based on particular circumstances. The federal tax laws may change and the federal, state and local tax consequences for any participant will depend upon his or her individual circumstances. Tax consequences for any particular individual may be different. This summary is not intended to be exhaustive and does not discuss the tax consequences of a participant’s death or provisions of income tax laws of any municipality, state or other country. Each participant is advised to consult his or her individual tax advisor concerning his or her personal tax consequences.

Incentive Stock Options: For federal income tax purposes, the holder of an ISO has no taxable income at the time of the grant or exercise of the ISO. If such person retains the common stock for a period of at least two years after the stock option is granted and one year after the stock option is exercised, any gain upon the subsequent sale of the common stock will be taxed as a long term capital gain. A participant who disposes of shares acquired by exercise of an ISO prior to the expiration of two years after the stock option is granted or before one year after the stock option is exercised will recognize ordinary income or loss equal to the difference between the exercise price and fair market value of the stock as of the date of exercise. Any additional gain or loss recognized upon any later disposition of the shares would be short or long term capital gain or loss depending on whether the shares had been held by the participant for more than one year. The difference between the option exercise price and the fair market value of the shares on the exercise date of an ISO is an adjustment in computing the holder’s alternative minimum taxable income and may be subject to an alternative minimum tax which is paid if such tax exceeds the participant’s regular income tax for the year.

Non-statutory Stock Options and Stock Appreciation Rights: A participant who receives an NSO or SAR generally will not recognize taxable income on the grant of such option or SAR but will recognize ordinary income at the time of exercise of the stock option or SAR equal to the difference between the option or SAR exercise price and the fair market value of the stock on the date of exercise. Any additional gain or loss recognized upon any later disposition of the shares would be short or long term capital gain or loss depending on whether the shares had been held by the participant for more than one year.

Restricted Stock: A participant acquiring restricted stock generally will recognize ordinary income equal to the fair market value of the shares on the “determination date.” The determination date is the date on which the participant acquires the shares unless the shares are subject to a substantial risk of forfeiture and are not freely transferable, in which case the determination date is the earlier of (i) the date on which the shares become freely transferable or (ii) the date on which the shares are no longer subject to a substantial risk of forfeiture. If the determination date is after the date on which the participant acquires the shares, the participant may elect, pursuant to Section 83(b) of the Code, to have the date of acquisition be the determination date by filing an election with the Internal Revenue Service no later than 30 days after the date on which the shares are acquired. If the participant is an employee, such ordinary income generally is subject to withholding of income and employment taxes. Upon the sale of shares acquired pursuant to a restricted stock award, any gain or loss, based on the difference between the sale price and the fair market value on the determination date, will be taxed as capital gain or loss.

Restricted Stock Units: A participant generally will recognize no income upon the receipt of a restricted stock unit award. Upon the settlement of such an award, participants normally will recognize ordinary income in the year of receipt in an amount equal to the cash received and the fair market value of any substantially vested shares received. If the participant is an employee, such ordinary income generally is subject to withholding of income and employment taxes. If the participant receives shares of restricted stock, the participant generally will be taxed in the same manner as described under “Restricted Stock.” Upon the sale of any shares received, any gain or loss, based on the difference between the sale price and the fair market value on the determination date (as defined under “Restricted Stock”), will be taxed as capital gain or loss.

Income Tax Effects for our Company: We generally will be entitled to a tax deduction in connection with an award under the 2011 Equity Plan in an amount equal to the ordinary income recognized by a participant at the time the participant recognizes such income (for example, upon the exercise of an NSO or the vesting of restricted stock), except to the extent such deduction is limited by applicable provisions of the Code.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement 47

Table Of Contents

Internal Revenue Code Section 409A: Section 409A of the Internal Revenue Code governs the federal income taxation of certain types of nonqualified deferred compensation arrangements. A violation of section 409A generally results in an acceleration of the recognition of income of amounts intended to be deferred and the imposition of a federal excise tax of 20% on the recipient of the award who are our employees over and above the income tax owed plus possible penalties and interest. The types of arrangements covered by section 409A are broad and may apply to certain awards available under the 2011 Equity Plan. As required by section 409A, certain nonqualified deferred compensation payments to specified employees may be delayed to the seventh month after such employee's separation from service.

New Plan Benefits

All awards under the 2011 Equity Plan will be granted at the Committee's discretion. Therefore, the benefits and amounts that will be received or allocated under the 2011 Equity Plan are not presently determinable.

The Board of Directors recommends a vote FOR the approval of the Amendment to the 2011 Equity Incentive Plan.

PBack to ContentsROPOSALFOUR

APPROVAL OF AN AMENDMENT TO THE M.D.C. HOLDINGS, INC. 2011 STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS

At our 2011 Annual Meeting, our shareholders approved the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors (the “2011 Director Plan”) and authorized a total of 1,000,000 shares of common stock to be available for issuance to our outside Directors under the plan. On January 26, 2015, based on the recommendation of our Compensation Committee and its independent compensation consultant, Pearl Meyer, our Board approved, subject to shareholder approval, an amendment (the “Amendment”) to Section 4.1 of the 2011 Director Plan to increase the number of shares of common stock available under the plan by an additional 325,000 shares. A copy of the Amendment is set forth in Appendix B and incorporated by reference.

The Amendment revises the first sentence of Section 4.1 by replacing the number 1,000,000 with the number 1,325,000. With the Amendment, the first sentence of Section 4.1 is as follows:

4.1     Number of Shares. Subject to adjustment as provided in Section 9, the maximum number of shares of Stock available for issuance under the Plan shall be 1,325,000 shares.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement48

Table Of Contents

Reasons for the Plan Amendment

Our Board of Directors believes that attracting and retaining highly qualified outside Directors, and motivating them to serve the Company and its affiliated entities, is important to our growth and success. There is significant competition for non-employee Directors with the skills required to oversee the products and services we offer. Our success depends in part upon attracting and retaining such experienced, knowledgeable individuals. In this regard, stock options are an important element in the attraction, retention and compensation of our outside Directors in that stock options provide the outside Directors an opportunity to acquire or increase a direct proprietary interest in the future success of our Company, thereby further promoting a close identity of interests between these individuals and our shareholders.

A total of only 425,000 shares remain available for grant under the 2011 Director Plan. In order to maintain capacity and the ability to grant stock options to our outside Directors, the Company wishes to increase the amount of shares authorized under the 2011 Director Plan. Under New York Stock Exchange listing standards, shareholder approval is required for us to increase the authorized shares under the Plan.

As discussed under Proposal Three above, the Company’s burn rates (under both the 2011 Equity Plan and the 2011 Director Plan) for 2014 and the prior two years remain at reasonable levels. Based on prior experience, the Company expects the additional shares, if approved by the shareholders, to last approximately three to five years.

Accordingly, the Company recommends approval of the Amendment. 

Summary of Material Terms of the 2011 Director Plan

The following discussion of the material features of the 2011 Director Plan is qualified by reference to the text of the 2011 Director Plan, which was Exhibit 10.2 to the Company’s Form 8-K filed on April 29, 2011.

Administration: The 2011 Director Plan will be administered by the Board of Directors. Subject to the terms and conditions of the 2011 Director Plan, the Board of Directors is authorized to take all action and make all determinations required or permitted under the plan and to conduct its general administration. The Board has the duty and power, among other things, to:

interpret the 2011 Director Plan and option agreements;


correct any defect, supply any omission, or reconcile any inconsistency in the 2011 Director Plan or any option agreement;


determine all rights under the plan; and


adopt any rules for plan administration, interpretation and application consistent with the plan.

Shares Subject to the Plan: If the Amendment is approved by the shareholders, and subject to the adjustments upon changes in capitalization described below, 1,325,000 shares of our common stock will be authorized for issuance of options under the 2011 Director Plan. As of the Record Date, there were 375,000 shares subject to outstanding options, 425,000 shares available for (but not yet subject to) a grant, plus an additional 325,000 shares authorized by the Amendment (if the Amendment is approved by our shareholders). If our shareholders do not approve the Amendment, the 2011 Director Plan’s total authorized shares will remain at 1,000,000 shares, with a total remaining unused capacity of 425,000 shares. The shares underlying terminated options will remain available for issuance under the 2011 Director Plan and shares that are utilized to pay an award's exercise price or tax withholding obligations will not count against the 2011 Director Plan's share limit.

The closing price of a share of the Company’s common stock as reflected on the New York Stock Exchange on the Record Date was $25.14.

Eligibility: Only non-employee Directors are eligible to receive awards under the Director Plan. There are six non-employee Directors eligible to participate in the 2011 Director Plan.

Stock Options: Grants of non-statutory stock options (“NSOs”) are made automatically to non-employee Directors each August 1st during the term of the 2011 Director Plan providing each non-employee Director with the right to purchase 25,000 shares of common stock. Automatic grants of such awards commenced on August 1, 2011 and will continue on each August 1 until the earlier of (1) the termination of the 2011 Director Plan 10 years following shareholder approval or (2) the earlier termination of the 2011 Director Plan. No consideration will be received by the Company for the granting of options.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement49

Table Of Contents

Each option is evidenced by an option agreement, which states the number of shares it covers. The options are fully vested at grant and become exercisable six months after grant, subject to such requirements as may be established by the Board and stated in the option agreement. The exercise price per share of common stock subject to an option must be at least the fair market value of the underlying stock at the date of grant of the stock option. Each option terminates on its tenth anniversary, unless terminated sooner as follows: each option held by a participant will terminate if the participant is removed as a Director during the option period for cause (as defined in the 2011 Director Plan and determined by the Board); if a participant dies during the option period, the option may be exercised by those empowered to do so under the participant’s will or by the laws of descent and distribution at any time during the term of the option, but not thereafter. Options may be exercised by payment of the exercise price.

The exercise price of an option is payable to the Company in full, in any method permitted under the option agreement, including: (i) in cash or in cash equivalents acceptable to the Company; (ii) by tendering unrestricted shares of stock already owned by the participant (for at least six (6) months or such other period as may be required by the Committee in order to comply with applicable law and to avoid adverse accounting consequences) on the date of exercise to the extent the shares of stock have a fair market value on the date of exercise equal to the aggregate exercise price of the shares as to which such option shall be exercised, (iii) any other method approved or accepted by the Compensation Committee in its sole discretion, including, but not limited to a cashless (broker-assisted) exercise (although limitations might apply to certain executive officers), or (iv) any combination of the foregoing.

Adjustments Upon Changes in Capitalization: The 2011 Director Plan provides that, in the event of any changes in our capital structure that effects an increase or decrease in the number of shares of our common stock without receipt of consideration, the maximum number of shares of stock for which options may be granted under the 2011 Director Plan shall be proportionately increased or decreased, and the number and kind of shares for which options are outstanding shall be proportionately increased or decreased. Any adjustment in outstanding options will not increase the aggregate exercise price payable with respect to shares that are subject to the unexercised portion of the option, in compliance with Section 409A of the Code. Except as otherwise provided in an option agreement, upon a change of control the Committee may take any action it deems necessary or desirable with respect to any options including, among other things, providing that the options are fully exercisable or providing that the holders of the options will receive a cash payment in exchange for cancellation of the options. In the event of a reorganization in which the Company is the surviving entity and no change of control occurs, any option will generally apply solely to securities to which the holder of the number of securities subject to such award would have been entitled immediately following such reorganization and with a corresponding proportionate adjustment of the exercise price per share. Adjustments to shares of stock will be made by the Board whose determination will be final and the Board may provide in option agreements for different provisions to apply to an option. However, any provisions may be modified by the Compensation Committee to avoid any tax that would otherwise be due under Section 409A of the Code.

Substitute Options: Options may be granted in substitution for, or in assumption of, outstanding options previously granted by an entity acquired by the Company or an affiliate or with which the Company or an affiliate combines.

Other Terms:      Each option agreement may contain other terms and conditions not inconsistent with the 2011 Director Plan as may be determined by the Committee in its discretion.

No options may be granted under the 2011 Director Plan ten years after the date the plan was approved by the shareholders.

Our Board of Directors may terminate, amend or modify the 2011 Director Plan. However, no amendment or modification may become effective without shareholders approval if required by applicable law or regulatory requirement. The listing standards of the New York Stock Exchange require that all equity compensation plans, and any material revisions to the plans, be subject to shareholder approval, with certain limited exemptions.

Options granted under the 2011 Director Plan generally are not transferrable other than upon death, in certain family transfers, or pursuant to a court-approved domestic relations order.

The 2011 Director Plan will be governed by the laws of the State of Delaware except for conflict of law provisions.

M.D.C. HOLDINGS, INC. -2015 Proxy Statement50

Table Of Contents

Federal Tax Consequences of the 2011 Director Plan

The following is a general summary as of January 2015 of the federal income tax consequences to us and to U.S. participants to awards granted under the 2011 Director Plan and does not attempt to describe all possible federal or other tax consequences of such participation or tax consequences based on particular circumstances. The federal tax laws may change and the federal, state and local tax consequences for any participant will depend upon his or her individual circumstances. Tax consequences for any particular individual may be different. This summary is not intended to be exhaustive and does not discuss the tax consequences of a participant’s death or provisions of income tax laws of any municipality, state or other country. Each participant is advised to consult his or her individual tax advisor concerning his or her personal tax consequences.

Non-statutory Stock Options: A non-employee Director who receives an NSO generally will not recognize taxable income on the grant of such option but will recognize ordinary income at the time of exercise of the stock option equal to the difference between the option exercise price and the fair market value of the stock on the date of exercise. Any additional gain or loss recognized upon any later disposition of the shares would be short or long term capital gain or loss depending on whether the shares had been held by the participant for one year or more.

Income Tax Effects for our Company: We generally will be entitled to a tax deduction in connection with an award under the 2011 Director Plan in an amount equal to the ordinary income recognized by a participant at the time the participant recognizes such income.

Internal Revenue Code Section 409A: Section 409A of the Internal Revenue Code governs the federal income taxation of certain types of nonqualified deferred compensation arrangements. A violation of section 409A generally results in an acceleration of the recognition of income of amounts intended to be deferred and the imposition of a federal excise tax of 20% on the recipient of the award who are our employees over and above the income tax owed plus possible penalties and interest. The types of arrangements covered by section 409A are broad and may apply to awards available under the 2011 Director Plan.

New Plan Benefits

All options under the 2011 Director Plan are granted automatically and, therefore, the benefits and amounts that will be received or allocated under the Director Plan are generally determinable. Each option covers twenty-five thousand (25,000) shares. The following table sets forth the current value of shares subject to awards that are automatically granted annually under the 2011 Director Plan to the below individuals. The actual dollar value may be different that the amount that is listed below.

New Plan Benefits 

M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors 

Name of Non-Employee Director

Dollar Value ($)

Number of Units

All non-employee directors as a group

N/A1

150,000

1Not applicable since plan is a stock option plan.

The Board of Directors recommends a vote FOR the approval of the Amendment to the 2011 Stock Option Plan for Non-Employee Directors. 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement51

Table Of Contents

AUDITCOMMITTEE REPORT

 

The following Report of the Audit Committee shall not be deemed to be “filed”"filed" with the SEC or to be subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended. The report shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

 

Management is responsible for the Company’sCompany's internal controls and the financial reporting process. The Company’sCompany's independent registered public accounting firm, Ernst & Young LLP (“("outside auditors”auditors"), are responsible for performing an independent audit of the Company’sCompany's consolidated financial statements in accordance with auditing standards generally accepted in the United States of America and for issuing a report thereon. The Audit Committee generally meets monthly, or more often as necessary, to fulfill its responsibility to monitor and oversee these processes, as described in the Audit Committee Charter.

 

The Audit Committee reviewed and discussed the audited consolidated financial statements of the Company for the year ended December 31, 20132014 with the Company’sCompany's management, the outside auditors and the Company’sCompany's internal audit department. The Audit Committee has discussed with the Company’sCompany's independent auditors the matters required to be discussed by Public Company Accounting Oversight Board (PCAOB) AU 380 (Communications With Audit Committees).

 

The Audit Committee has received the written disclosures and the letter from the Company’sCompany's independent auditors required by applicable requirements of the PCAOB regarding the independent auditor’sauditor's communications with audit committees concerning independence, and has discussed with the auditors their independence status.

 

Based on the review and discussions described above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in the Company’sCompany's Annual Report on Form 10-K for the year ended December 31, 20132014 for filing with the SEC.

 

AUDIT COMMITTEE

Herbert T. Buchwald,Chairman

Raymond T. Baker

AUDIT COMMITTEE

Paris G. Reece III, Chairman

Raymond T. Baker

Herbert T. Buchwald

 

TRANSACTIONSTRANSACTIONS WITH RELATED PERSONS

 

The Company leases its headquarters office space at 4350 S. Monaco Street, Denver CO 80237. Approximately 5,437 square feet in the Company’sCompany's office building at 4350 S. Monaco Street is subleased by an entity affiliated with Mr. Mizel, for which it paid rent in 20132014 to the Company of approximately $109,570.

One of the Company’s subsidiaries leased office space from an entity affiliated with Mr. Mizel. After receiving confirmation that the terms of the lease were on market terms, the Board of Directors approved the lease in April 2010. In April 2013 the Company allowed the lease to expire. Prior to expiration, the lessor was paid a total of $23,355 in 2013.$106,805.

 

During 2013, the Company paid a firm owned by Carol Mizel, Mr. Mizel’sMizel's spouse, $120,000 for consulting services in connection with corporate and consumer marketing, merchandising, design work, human resources development, product development, and such other matters as were requested by the Company’sCompany's senior management. The firm, Mizel Design and Decorating Company, provided these services under an Independent Contractor Agreement with the Company, dated as of January 1, 2005. The Company also provides Ms. Mizel with office space in the Company’sCompany's office building at 4350 S. Monaco Street, which has an estimated annual rental value of approximately $5,000.

 

Effective as of January 1, 2005, and August 2, 2007, Larry A. Mizel, Chief Executive Officer, and David D. Mandarich, President and Chief Operating Officer, each entered into lease agreements for their non-business use of Company aircraft when the aircraft are not required for Company business. The lease agreements require payment of the Incremental Expenses incurred by the Company for each non-business use, as defined in the lease agreements. The Incremental Expenses represent the maximum reimbursement permitted by the Federal Aviation Administration in Federal Aviation Regulation Part 91.501(d). The executive officers also pay the federal excise tax for the non-business use of the aircraft. Copies of the lease agreements have been filed with the SEC on Form 8-K and Form 10-Q. At the end of 2012,2013, Mr. Mizel and Mr. Mandarich had cash balances of $144,000$44,000 and $27,000,$20,000, respectively, deposited with the Company for future non-business aircraft use. During 2013,2014, they deposited additional amounts with the Company, in advance, of $225,000$325,000 and $15,000,$60,000, respectively. They each incurred $325,000$267,000 and $20,000,$50,000, respectively, in actual lease payments for 2013.2014. Accordingly, they each had a cash balance at the end of the year of $44,000$102,000 and $22,000,$30,000, respectively. In addition, when seats on the aircraft are available on a business flight and occupied for non-business purposes, income is imputed to the executive officer, who pays federal income tax based on the SIFL rules of the Internal Revenue Service.

  

In 2013, Mr. Reece’s son purchased a Richmond American home from one of the Company’s subsidiaries for approximately $688,000 on the same terms offered to the public, and Mr. Reece provided financing for his son in the amount of approximately $610,000 for the purchase transaction.

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement39

52

Table Of Contents

REVIEWREVIEW OF TRANSACTIONS WITH RELATED PERSONS

 

Our policies require that full information be disclosed regarding transactions with related persons, without mandating how such transactions are to be addressed, so that they may be considered on their own merits. Specifically, our Corporate Code of Conduct, in addressing conflicts of interest, notes that personal interests of our employees and Directors and their family members can sometimes come into conflict, or create the appearance of a conflict, with the Company’sCompany's interest. Accordingly, the Code of Conduct requires all employees (including our executive officers) and our Directors to immediately report conflicts of interest or transactions that create the appearance of a conflict of interest. These reports are to be made immediately to a Company compliance officer (as identified in the Code of Conduct), the Company’sCompany's Asset Management Committees, or, for members of the Company’sCompany's Board of Directors, to the Audit Committee, for a determination as to compliance with the Code of Conduct.

 

In addition, the Audit Committee’sCommittee's charter provides for the Committee to be informed of related party transactions. In support of this and the Company’sCompany's SEC reporting requirements, the following written procedure has been adopted. Specifically, the Directors and executive officers are to report to the Company’sCompany's legal department all related party transactions between the Company (or any of its subsidiaries) and any of the executive officers and Directors, including any of their family members.

 

SECTIONSECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

 

The Company’sCompany's executive officers and Directors and certain beneficial owners of more than ten percent of the Company’s Common StockCompany's common stock are required under Section 16(a) of the Securities Exchange Act of 1934, as amended, to file initial reports of ownership and reports of changes in ownership of Common Stockcommon stock of the Company with the SEC and furnish copies of those reports to the Company. Based solely upon a review of the copies of reports furnished to the Company and, in certain cases, written representations, the Company believes that during the year ended December 31, 2013,2014, all such reports were filed on a timely basis.

 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement53

Table Of Contents

PROPOSPROPOSAL THREEAL FIVE

INDEPENDENT REGISTEREDPUBLIC ACCOUNTING FIRM

 

The Audit Committee is responsible for the selection, oversight, retention and termination of our independent auditors. The Audit Committee has selected Ernst & Young LLP, a registered public accounting firm, as our independent auditors for 2014.2015. The Audit Committee and the Board seek shareholder ratification of this selection. The Audit Committee may, in its discretion, direct the appointment of another independent registered public accounting firm at any time during the fiscal year.

 

The Board of Directors recommends a vote FOR ratification of the selection of Ernst & Young LLP as the Company’sCompany's independent registered public accounting firm.

 

A representative of Ernst & Young LLP is expected to be present at the Meeting and will have the opportunity to make a statement if so desired and will be available to respond to appropriate questions.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement40

Audit Fees and All Other Fees

 

A summary of the fees of Ernst & Young LLP for the years ended December 31, 20132014 and 20122013 are set forth below:

 

 2013 Fees 2012 Fees  

2014Fees

  

2013 Fees

 
Audit Fees1 $1,037,448  $875,594  $920,840  $1,037,448 
Audit-Related Fees        --   -- 
Tax Fees2  45,717   30,000   37,000   45,717 
All Other Fees3  2,147   2,147   2,680   2,147 
TOTAL FEES $1,083,250  $907,741 

Total Fees

 $960,520  $1,083,250 

 

1

Consists of fees and expenses for the audit of consolidated financial statements, SAS 100 interim reviews and the audit of internal control over financial reporting services rendered in connection with the offering of senior notes and services rendered in connection with statutory and regulatory filings (includes the audit of HomeAmerican).

2

2

Consists of fees and expenses for miscellaneous tax consulting services.

3

3

Consists of fees for access to Ernst & Young LLP online resources.

Audit Committee Pre-Approval Procedures

 

Under the procedures established by the Audit Committee, all audit services and all non-audit services by the Company’sCompany's auditors are to be pre-approved by the Audit Committee, subject to the de minimus exception provided under Section 202 of the Sarbanes-Oxley Act of 2002. In certain cases, pre-approval is provided by the committee for up to a year as to particular categories of services, subject to a specific budget. The committee also has delegated to each of its members the authority to grant pre-approvals, such pre-approvals to be presented to the full committee at the next scheduled meeting. For 20132014 and 2012,2013, all of thefees included under the headings “Audit-Related"Audit-Related Fees,” “Tax Fees”" "Tax Fees" and “All"All Other Fees”Fees" above were pre-approved by the Audit Committee.

 

M.D.C. HOLDINGS, INC. -2015 Proxy Statement54

Table Of Contents

OTHEROTHER MATTERS

 

Management and the Board of Directors of the Company know of no matters to be brought before the Meeting other than the proposals set forth above. If you grant a proxy, each of the persons named as proxy holder, Michael Touff and Joseph H. Fretz, or their nominees or substitutes, will have the discretion to vote your shares on any additional matters properly presented for a vote at the Meeting. If for any unforeseen reason, any of our nominees are not available as a candidate for director,Director, the proxy holder may vote your proxy for such other candidate or candidates nominated by our Board.

 

M.D.C. HOLDINGS, INC. - 2014 Proxy Statement     41

SHAREHOLSHAREHOLDER DERPROPOSALS

 

Any proposal a shareholder desires to present at the 20152016 Annual Meeting of Shareholders and to have included in the Company’sCompany's proxy soliciting materials pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended, must be received in writing by the Secretary of the Company not later than November 27, 2014.October 5, 2015. However, if the date of the 20152016 Annual Meeting changes by more than 30 days from the date of the 20142015 Annual Meeting, then the deadline is a reasonable time before the Company begins to print and mail its proxy materials as the Company shall inform the Shareholders.shareholders.

 

For shareholder proposals submitted outside the Rule 14a-8 process, the Company’sCompany's By-Laws provide that only business properly brought before a meeting will be conducted. For business to be properly brought before a meeting by a shareholder, the shareholder must give timely notice thereof in writing to the Secretary of the Company. To be timely, the notice must be delivered to, or mailed and received at, the principal executive offices of the Company not less than 60 days nor more than 90 days prior to the meeting; however, in the event that less than 75 days’days' notice or prior public disclosure of the date of such meeting is given or made to Shareholders,shareholders, notice by the shareholder to be timely must be so received not later than the close of business on the 10thday following the day on which notice of the date of the meeting was mailed or such public disclosure was made. A shareholder’sshareholder's notice to the Secretary shall set forth as to each matter the shareholder proposes to bring before the meeting: (i) a brief description of the business desired to be brought before the meeting and the reasons for conducting such business at the meeting, (ii) the name and record address of the shareholder proposing such business, (iii) the class and number of shares of the Company which are beneficially owned by the shareholder and (iv) any material interest of the shareholder in such business.

 

If notice of a proposal is not submitted in writing and received by the Company at the address appearing on the first page of this proxy statement by the dates described above, then the proposal will be deemed untimely under Rule 14a-4 of the Securities Exchange Act of 1934 and the persons appointed as the Company’sCompany's proxies will have the right to exercise discretionary voting authority with respect to the proposal.

 

INCORPORATIONINCORPORATION BY REFERENCE

 

The Company hereby incorporates by reference into this Proxy Statement Note 13 (Deferred Compensation Retirement Plans) and Note 21 (Stock-Based Compensation) to the Consolidated Financial Statements from Item 8 of its annual report on Form 10-K for the fiscal year ended December 31, 2013,2014, filed with the Securities and Exchange Commission on February 5, 2014.January 28, 2015.

 

By the order of the board of directors,

 

Larry A. Mizel

Chairman of the Board

BY THE ORDER OF THE BOARD OF DIRECTORS,

 

 

Larry A. Mizel

Chairman of the Board

M.D.C. HOLDINGS, INC. - - 20142015 Proxy Statement4255

Table Of Contents

APPENDIXA

SECOND AMENDMENT

TO

M.D.C. HOLDINGS, INC.

2011 EQUITY INCENTIVE PLAN

The following Second Amendment to the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan, effective April 27, 2011 (the "Plan"), was adopted by the Board of Directors of M.D.C. Holdings, Inc. on January 26, 2015, subject to approval of the Company’s shareholders. Capitalized terms used herein shall have the meanings ascribed in the Plan.

The first two sentences of Section 4.1 of the Plan are amended to read as follows:

4.1     Number of Shares. Subject to adjustment as provided in Section 14, the maximum number of shares of Stock available for issuance under the Plan shall be 4,275,000 shares. Subject to adjustment as provided in Section 14, 4,275,000 shares of Stock available for issuance under the Plan shall be available for issuance pursuant to Incentive Stock Options.

M.D.C. HOLDINGS, INC.

By:

Date:, 2015

M.D.C. HOLDINGS, INC. -2015 Proxy Statement56

Table Of Contents

APPENDIXB

FIRST AMENDMENT

TO

M.D.C. HOLDINGS, INC.

2011 EQUITY INCENTIVE PLAN

The following Second Amendment to the M.D.C. Holdings, Inc. 2011 Stock Option Plan for Non-Employee Directors, effective April 27, 2011 (the "Plan"), was adopted by the Board of Directors of M.D.C. Holdings, Inc. on January 26, 2015, subject to approval of the Company’s shareholders. Capitalized terms used herein shall have the meanings ascribed in the Plan.

The first two sentences of Section 4.1 of the Plan are amended to read as follows:

4.1     Number of Shares. Subject to adjustment as provided in Section 9, the maximum number of shares of Stock available for issuance under the Plan shall be 1,325,000 shares.

Back to Contents

M.D.C. HOLDINGS, INC.

By: 

This page intentionally left blank.

Date:, 2015

Back to Contents
M.D.C. HOLDINGS, INC. -2015 Proxy Statement57

This page intentionally left blank.


This page intentionally left blank.